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Fused in sarcoma (FUS) is a DNA/RNA-binding protein that modulates gene 
expression by associating with a wide range of transcription-related factors 
in the nucleus and/or cytoplasm of neurons. Abnormal expression of FUS or 
mutant forms of FUS were reported to be involved in the pathologies of 
amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration 
(FTLD). Since both ALS and FTLD include neurodegeneration, the synapse 
weakening process might be exhibited prior to the neuronal death. However, 
there are many missing gaps and mechanisms not well explained. 
In this PhD study, the nature and consequence of abnormal FUS were 
investigated in terms of the potential pathology that would be involved in ALS, 
FTLD and other possible neurodegenerative diseases. By utilising main 
pathogenic factors of FUS (nuclear localisation signal (NLS) mutation and 
hypomethylation), both morphological and neurophysiological alterations by 
abnormal expression and propagation of FUS were investigated. 
First, cytosolic accumulation of FUS was investigated using FUS-P525L 
mutant form, which has mutation on NLS region that is required for nuclear 
internalisation of FUS. FUS-P525L was shown to have quicker translocation 
though the dendrites than that of FUS-WT and this difference resulted in the 
reduction of spine density in the apical dendrites of FUS-P525L cells. FUS-
P525L cells were shown to have increased synaptic conductance and 
intrinsic excitability and the excitability was returned to the control level when 
Calcium-permeable AMPA receptor (CP-AMPAR) blocker IEM-1460 was 
applied. And had decreased basal synaptic transmission and inhibited 
induction of both long-term potentiation (LTP) and long-term depression 
(LTD).  
Second, FUS mutant with enhanced cation-π interaction was investigated by 
using FUS-16R mutant form, which has 16 additional arginine residues 
therefore increases the chance of hypomethylation. The spine density of 
FUS-16R cells were shown to be reduced in both basal and apical dendrites 
compared to FUS-WT cells. In addition, intrinsic excitability and basal 
synaptic transmissions were reduced in FUS-16R cells.  
Together, the results suggest that abnormal expression of FUS mutant is 
widely involved in the morphological, electrophysiological synapse 
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1.1. Pathophysiology and neurodegenerative disease 
Neurodegenerative disease refers to the progressive condition that neurons 
losses their functions and results in neuronal degeneration or death. This 
progression is accompanied by atrophy or lesions in various brain or central 
nervous system (CNS) regions and causes significant clinical phenotypes.  
In the most cases, neurodegenerative diseases are symptomized to be 
dementia and motor neuron diseases, such as Alzheimer’s disease (AD), 
Parkinson’s disease (PD), frontotemporal dementia (FTD, or frontotemporal 
lobar degeneration (FTLD)) and amyotrophic lateral sclerosis (ALS). These 
diseases damage the abilities to memorise, think, behave, move and 
eventually, ruin the everyday life. Briefly introducing each disease, AD is 
known to present atrophy in wide range of cortex, thought to be affected from 
medial temporal lobe in the early stage and accompanied by cognitive 
impairment, PD shows neuronal loss in substantia nigra and mainly impairs 
motor and non-motor functions. FTD expressed with neuronal loss in 
frontotemporal lobe and alteration of behaviour and dysfunction of language 
skills, ALS is characterised by loss of motor neurons and showing 
dysfunction of voluntary muscles. 
They are mainly regarded and expressed to be age-dependent, however, 
environments, genetic mutations, lifestyle or various factors also have been 
identified and/or expected to trigger early onset form of the diseases 
(Erkkinen et al., 2019). Accurate understanding of those factors will make 
early and accurate diagnoses easier and give clues for therapeutic or 
preventive approaches toward those diseases. Considering the progression 
of those diseases are slow and accumulative than acute, the number of 
patients is exponentially growing to result in high demand of social care 
resources and it gives burdens to the responsible family members. Therefore, 
early and accurate diagnosis of the diseases gaining attentions worldwide 
and the importance of them are growing. 
The most dominant neurodegenerative disease, AD, takes about 60-80 % of 
dementia worldwide, estimated to be 24 million (Mayeux and Stern, 2012). 
 
 






The prevalence of AD was 701 cases per 100,000 in 2016 (Nichols et al., 
2019). PD is the second common neurodegenerative disease and comes 
with the motor symptoms. The prevalence of PD is generally known to be 
100-200 cases per 100,000 (Von Campenhausen et al., 2005) and 
prevalence of dementia within PD cases is thought to be 30 % (Hely et al., 
2008). FTD is also one of the major dementia and it is mostly expressed to 
be early onset, takes 12 % of dementia before 65 years and 2 % of dementia 
from 65 years and older cases (Van Der Flier and Scheltens, 2005). The 
prevalence of FTD is estimated for 0.01-4.6 cases per 1000 people (Hogan 
et al., 2016). And ALS is the most common motor neuron disease and the 
prevalence is about 6 cases per 100,000 (Talbott et al., 2016). Overall, these 
diseases are expressed in the older age groups and the population of aged 
group is increasing, therefore, the worldwide economic cost of dementia was 
reported to be $1 trillion (USD) in 2018, according to the world Alzheimer 
report 2018.  
The progression of diseases primarily damage distinct neural areas, for 
instance, cerebral cortex is affected in AD and FTD, basal ganglia and 
thalamus are affected in AD, PD and FTD, hippocampus is affected in AD, 
brain stem and spinal cord are affected in ALS  (Gan et al., 2018). When 
those neural regions are damaged, then, clinical phenotypes appear such as 
behavioural, cognitive, primary motor, extrapyramidal symptoms and 
metabolism and they are overlapped in AD, FTD, ALS and PD (Ahmed et al., 
2016). For instance, behavioural symptoms and metabolism issues are 
expressed in all 4 different diseases, whereas cognitive symptoms are 
prominent in AD and FTD, motor (primary motor, extrapyramidal) symptoms 
are expressed in ALS, PD and FTD. Because of that heterogeneity in the 
clinical phenotypes, there were efforts to find the connections between 
neurodegeneration and molecular pathology (or proteinopathy) (Golde and 











1.2. Proteinopathies – distinct diseases with shared pathophysiology 
Proteinopathy (or proteopathy) is a category of disease with malfunction of 
proteins. Common mechanism of proteinopathy is generally characterised by 
misfolding of certain proteins that can act as seeding molecules to recruit 
multiple functioning proteins and form bigger complexes (widely referred as 
oligomers, inclusions or aggregates), which in turn, disrupt cellular functions 
and cause cell death. This concept has been applied to neuronal 
degenerations to explain progression of the diseases (Jucker and Walker, 
2011). 
As the known molecules in the inclusions or aggregates of the proteinopathy, 
amyloid β (Aβ) and Tau are mainly identified in AD, α-synuclein in PD, TAR 
DNA-binding protein 43 (TDP-43) and fused in sarcoma (FUS) are mainly 
found in FTD and ALS (Fu et al., 2018). These proteins are normally 
expressed in the various range of cells in the healthy conditions and have 
their basic roles. However, in the pathological condition, those molecules are 
prone to aggregate like prion protein (Goedert et al., 2010). The aggregates 
are known to be misfolded into β-sheet structure and propagate by seeding 
to recruit other proteins into the aggregates (Soto and Estrada, 2008). These 
aggregates are deposited in the wide range area of the brain and CNS 
regions and interfere the neuronal functions and induce neurodegenerations. 
Interestingly, each protein has the predominant area that is deposited and 
induces neuronal toxicity, therefore, it results in the distinct neuronal 
degeneration patterns and likely correlates with the clinically affected brain 
regions as mentioned above (Gan et al., 2018). 
For the further aspects to the neural dysfunctions and clinical phenotypes, 
those pathologies also have been investigated in the further smaller level, 
neurons. Therefore, neurodegeneration is also referred to be a series of 
phenomena that describes the progressive loss of neuronal structure and 
function (Haass and Selkoe, 2007). In that sense, those proteinopathy is not 
just neural region-specific, but also neuron-specific and gene-specific that 
contribute the selective vulnerability of the neurons (Fu et al., 2018). 
 
 






Obviously, the mutations on the genes of the main pathological proteins (e.g. 
Aβ, α-synuclein, TDP-43 and FUS) in each neurodegenerative disease and 
the other genes that accelerate the neuronal pathologies are largely involved. 
Mentioning few major genes for each disease, APP, PSEN1 and PSEN2 are 
involved in AD pathology, SNCA, LRRK2 are involved in the PD pathology, 
TARDBP, superoxide dismutase 1 (SOD1), FUS are involved in ALS 
pathology, GRN, microtubule-associated protein Tau (MAPT) are involved in 
FTD and C9orf72 is involved in both ALS and FTD (Fu et al., 2018). These 
pathogenic gene and protein expression result in the alterations of neuronal 
homeostasis (Gan et al., 2018). For instance, protein quality control 
mechanism and autophagy and lysosome pathway are dysregulated, 
therefore, it accelerates accumulation of misfolded proteins (Gomez-Pastor 
et al., 2017; Taylor et al., 2016). In addition, adenosine triphosphate (ATP) 
production of mitochondria can be also less efficient by aging and eventually 
impaired by neurodegenerative diseases (Golpich et al., 2017). And adding 
up to those disruption of neuronal homeostasis, those pathogenic proteins 
can propagate to the other adjacent neurons via seeding (Braak and Braak, 
1991; Luk et al., 2012) or interfere the normal function of stress granules 
(Aulas and Velde, 2015) to spread out the neuronal toxicity intracellular or 
cell-to-cell manner. Overall, neurodegenerative diseases can cause the 
alteration of neuronal dynamics and result in neuronal death eventually. 
 
1.3. Memory as a cognitive function 
The brain is a key organ for learning and memory that consists of the 
neuronal dynamics through connections among nerve cells. The brain 
receives sensory inputs from the environment and coordinates various 
information through different brain regions. As described previously, various 
neurodegenerative diseases damage different compartments of the brain, 
therefore, disable their normal functions. Since the functionality of learning 
and memory is widely affected from synaptic level, it has been monitored in 
many neurodegenerative diseases. Although it is distinct in certain disease, 
 
 






brain region, neuron and major pathogenic protein types, however, the 
principle neuronal dynamics of learning and memory is shared throughout 
CNS. In addition, the proteinopathy of neurodegenerative diseases not just 
stay in the main area of disease, but also spread through CNS, therefore, 
those well-characterised neuronal models for learning and memory also can 
be utilised to study diverse range of neurodegenerative diseases, such as 
ALS and FTD. To understand the function of memory, the most common 
theory postulated was Hebb’s rule “neurons fire together and wire together” 
(Hebb, 1949) and this theory was previously suggested by Cajal (Cajal, 
1894). Therefore, neuronal activity and neuronal circuit from various brain 
regions process information and store the encoded information as a memory 
(Squire, 2009). 
 
1.3.1. Definitions of memory 
Memory has long been thought of as a process in which sensory information 
is encoded, stored and made accessible for retrieval (Nadel and Hardt, 2011). 
It has long been established (Waugh and Norman, 1965) that memory does 
not occur via a single process but various subtypes.  Broadly, there are three 
different types of memory; sensory memory, short-term memory and long-
term memory depend on the duration of the memory and how the memory is 
produced and processed. The memory types are drawn as a diagram in Fig. 
1-1. 
Sensory memory refers to the sensed information from the outside world 
such as iconic memory from visual stimuli, echoic memory from auditory 
stimuli and haptic memory from tactile stimuli. Among them, iconic memory 
is dominantly used and to be relied on (Atkinson and Shiffrin, 1968). For the 
formation of the memory, visual stimuli need to be processed by retinal 
receptors and cells and occipital lobes (Camina and Güell, 2017). For the 
further conversion and consolidation, the information goes through ventral 
route to inferior temporal cortex (Camina and Güell, 2017).  
 
 







Short-term memory (working memory) is the processed information for a 
short period of time (Baddeley and Hitch, 1974), therefore, short-term 
memory can work as an independent memory or work as a prior stage of 
long-term memory to be processed. The first example of short-term memory 
can be seen from Miller’s 1956 study in which participants were required to 
study a sheet of numbers and subsequently list them without refereeing to 
the original reference. The information processing capacity (or working 
memory) of the participant can be proposed from the amount of correct 
 
Figure 1-1 Classification of memory types. 







































numbers repeated. It has been suggested that working memory has the 
central executive, visuospatial sketchpad, phonological buffer, episodic 
buffering components, all of which interact each other (Baddeley and Hitch, 
1974). The central executive has roles to focus on attention, to separate 
attention from multiple tasks, to access to long-term memory (Baddeley and 
Hitch, 1974) and requires frontal lobe activity. Visuospatial sketchpad is 
specialised to the formation and maintenance of the visual and spatial 
contents of short-term memory. It has been suggested to be mainly held in 
the right hemisphere of the brain. Phonological buffer (or phonological loop) 
is specialised to the formation and maintenance of the auditory information 
by storing short-term acoustic contents and rehearsing subvocal articulatory 
contents. This has found to be on the left hemisphere of the posterior 
superior temporal gyrus (Buchsbaum et al., 2001). Episodic buffer is able 
to store memories in a short-term and can integrate information from different 
sources (Baddeley, 2000). There are no specific brain area(s) proven to do 
this role, thus, episodic buffer is often hypothesised as short-term memory 
(Baddeley, 2000). Overall, working memory can give attention and integrate 
information to form short-term information for the further consolidation of the 
memory to be stored. 
Long-term memory is the information to be stored for long and/or 
permanent period of time and can be recalled. It is categorised into two 
different types; declarative memory and non-declarative (procedural) 
memory. 
Declarative memory is the information which can be recalled consciously. 
It was further categorised to episodic memory and semantic memory by 
Tulving in 1972 (Tulving, 1972). Episodic memory represents the information 
about personal experiences or specific events related to the time and place. 
Therefore, these declarative memory forms are important for the cognitive 
functions of the brain. This type of memories is known to be processed 
mainly in the hippocampus and cortices near hippocampus (Allen and Fortin, 
2013; Irish and Piguet, 2013). Episodic memory is unique as it consists of 
 
 






personal experiences in terms of temporal and spatial context. Episodic 
memory has been thought to be one of the major neurocognitive memory 
systems (Schacter and Tulving, 1994). Episodic memory is thought to be 
exclusive for the humans because it is difficult to define and convert the 
concept of the personal experience to the nonhuman species (Templer and 
Hampton, 2013). But there are still approaches to define episodic-like 
memory from animal studies (Clayton and Dickinson, 1998; Easton et al., 
2012). In addition, episodic memory is more vulnerable to the neuronal 
dysfunction compared to the other memory systems (Tulving, 2002). 
Hippocampus and adjacent cortices participate in the process of episodic 
memory. Semantic memory represents the understandings and thinking of 
the common knowledge and concepts. The exact brain regions required for 
semantic memory are still debated but temporal and inferior parietal lobes 
are known to be broadly related  (Binder and Desai, 2011). However, two 
main hypotheses exist, 1) memory is processed in the temporal lobe and 
hippocampal formation as episodic memory, 2) memory can be associated 
with the wide-range of sensory and motor cortices and converged in the 
inferior parietal lobe and temporal lobe in the brain (Binder and Desai, 2011).  
Non-declarative memory is commonly explained as the memory of skill 
learning, where on has the ability to repeatedly complete a motor task (e.g. 
tying shoelaces) that is recalled unconsciously. Non-declarative memory is 
further categorised to procedural memory, associative memory, non-
associative memory and priming (Camina and Güell, 2017). Procedural 
memory is related to physical skills and habits. This still requires the 
conscious learning process to be associated, but once acquired, it becomes 
automated and does not require conscious thinking. For the acquisition, the 
striatum of the basal ganglia is required and for the execution, motor 
neuronal regions such as cerebellum are needed. Associative memory is a 
process that storing and retrieving information to associate multiple different 
types of the information. Or, this process can do simply associating the 
existing information than generating new information (classical conditioning) 
(Pavlov, 1927) or association of information to affect positively or negatively 
 
 






to the further behaviour (operant conditioning) (Skinner, 1938). Non-
associative memory represents alterations of the responses toward the 
repetitive stimulations that result in either decreased response (habituation) 
or increased response (sensitisation) (Kandel, 1976). This is process in the 
reflex pathways and related to acetylcholine and serotonin. Priming is the 
process that certain stimulation affects the responses towards other 
stimulations in the future. This is known to be related to neocortex (Baars et 
al., 2010). Overall, these different long-term memory types have different 
functions and associated with the different brain regions.  
 
1.3.2. Neuroanatomy of memory  
Then how are memories are obtained, processed and stored? At the 
beginning, information from outside world needs to be received via sensory 
organs and then converted via sensory cortices as sensory memory. Sensory 
memory is delivered to association areas such as frontal, temporal and 
parietal lobes and processed to the short-term memory. At this stage, spatial 
type (potential episodic memory) and non-spatial type memories (potential 
semantic memory) are handled separately. And both types of the memories 
enter the parahippocampal region but go through the different sub regions. 
Spatial type memories mainly go through parahippocampal cortex and 
postrhinal cortex and then they are transferred to medial entorhinal cortex. 
Meanwhile, non-spatial type memories go through perirhinal cortex and then 
transferred to lateral entorhinal cortex. Both spatial and non-spatial type 
memories enter the hippocampus for the consolidation process and the 
process can be done either separately or associatively. Then, the memories 
are encoded to declarative memory, either episodic memory or semantic 
memory and amygdala can add emotional context for the episodic memory. 
Those encoded memories are thought to be stored in the associative cortices 
and when the memories are needed to be retrieved or executed, prefrontal 
cortex receives the information and then delivers it to the relevant cortices or 
regions of the brain to take actions. Overall, these connected compartments 
 
 






for the memory circuit are all necessary, however, for the declarative long-
term memory, hippocampus conducts the core process of the consolidation. 
In that context, many studies have been done with the hippocampus to 
dissect the process of learning and memory and it has been reported that the 
deficit of hippocampal functionality caused cognitive impairment and deficit 
in learning and memory (Broadbent et al., 2004; Eichenbaum, 2004; Jarrard, 
1993). Therefore, it is important to know the basic structure and what is 
happening in the hippocampus during the learning and memory process. 
Hippocampus is known to consist of dentate gyrus, cornu Ammonis 
(CA)1~3 and subiculum (Fig. 1-2). These brain regions form the neural circuit 
to receive the information from x, process and forward to y. CA1 is 
considered as the main spot of the memory circuit in the hippocampus. Each 
CA1 pyramidal neuron has two distinct dendritic branches (e.g., apical 
dendrite and basal dendrite) and receives distinct inputs from different brain 
regions. The layers of CA1 area match with the dendritic region and soma of 
each CA1 neuron; proximal apical dendrite in stratum radiatum (SR), distal 
apical dendrite in stratum lacunosum moleculare (SLM), basal dendrite in 
stratum oriens (SO) and soma in stratum pyramidale (SP). The main 
excitatory input CA1 neurons receive is via the Schaffer-collateral pathway 
that originates at CA3 neurons and terminates at proximal apical dendrite of 
CA1 (Masurkar, 2018). Proceeded this, the dentate gyrus receives input from 
entorhinal cortex, process it, then gives input to CA3, which is mossy fibre 
pathway. CA1 can also receive direct input from entorhinal cortex to distal 
apical dendrite. And distal apical dendrite also receives inputs from prefrontal 
cortex via nucleus reunions of thalamus. Meanwhile, basal dendrite receives 
input from CA2 directly and also contralateral CA3 gives input to the region 
(associational commissural pathway) (Masurkar, 2018). CA1 itself has 
different functions and neuronal features dependent on the anatomical 
location within the hippocampus. CA1 neurons can be located either in the 
dorsal or ventral area, proximal or distal area and deep or superficial area of 
the hippocampus. The main area of the CA1 responsible for processing 
spatial declarative memory is proximal area in dorsal hippocampus 
 
 






(Henriksen et al., 2010; Jung et al., 1994). The ventral area has broader roles 
related to anxiety, motivation, fear and others (Okuyama et al., 2016; Zhu et 
al., 2014). The inhibitory drive within the CA1 is mainly provided by GABA 
(γ-aminobutyric acid)-ergic interneurons which deliver inputs in the dynamic 
manner (Klausberger and Somogyi, 2008). 
 
In addition to the hippocampus itself, the input from entorhinal cortex also 
has major roles for the formation of the declarative memory, especially 
spatial memory (Parron et al., 2006), and consolidation of the memory 
(Takehara-Nishiuchi, 2014). The entorhinal cortex basically works as a 
bridge between neocortex and hippocampus closely communicate with 
hippocampus. The entorhinal neurons process spatial context by forming 
hexagonal grid patterns (known as grid cells) as the response to the 
surrounding spatial environment. And then, grid cells deliver the information 
to the place cells in the hippocampus for the further process to generate the 
spatial memory, which is a type of episodic memory (Moser et al., 2015).  
 
Figure 1-2 Hippocampal circuitry. 
The basic circuitry of hippocampus was illustrated. Entorhinal cortex delivers inputs 
to the granule cells dentate gyrus (DG) via performant pathway. Axons of granule 
cells deliver the signal to cornu Ammonis (CA)3 pyramidal cells via mossy fibre 
pathway. And axons of CA3 delivers signal to CA1 pyramidal cells via Schaffer-
collateral pathway. Those 3 pathways also referred as trysynaptic circuit. The 


















In short, the hippocampus has a highly aligned and organised circuit that can 
perform dynamic process of the memory in the coordination with the adjacent 
brain regions such as entorhinal cortex. However, the studies on this process 
have been further dissected to the smaller level; synapse and 
neurotransmission.  
 
1.4. Molecular mechanisms of memory 
1.4.1. The synapse 
Neuronal circuits described above coordinate the information and the store 
memory through the creation and strengthening of synapses (Südhof and 
Malenka, 2008). A synapse is the junction between cells and transfers 
signals from the presynaptic neurons to the postsynaptic neurons. Once a 
presynaptic neuron is excited enough to deliver action potentials, the 
intracellular Ca2+ level is increased and resulting in synaptic vesicles release 
via exocytosis into the synaptic cleft. These synaptic vesicles are filled with 
neurotransmitter. The postsynaptic neuron then detects the 
neurotransmitters with the diverse postsynaptic receptors. Upon, 
neurotransmitter binding the receptors either open the ion channels 
themselves to allow the flow of ions into the neuron or activate G proteins to 
send further intracellular signal cascades. Generally, especially in the case 
of ion channels, binding of neurotransmitters causes either excitatory and/or 
inhibitory function of neuron by allowing ions to flow through the channels. If 
Na+ flows into the cell via ion channels, then, the cell is depolarised and 
shows excitatory postsynaptic response, on the other hand, if Cl- flows into 
the cell or K+ flows out via ion channels, then, the cell is hyperpolarised and 
shows inhibitory postsynaptic response. Thus, summation of those 
responses decides whether the signal would be delivered further or stopped 
and not to be sent. 
Synaptic transmission can be categorised by the neurotransmitters that are 
involved in either excitatory and/or inhibitory function of neuron. There are 
 
 






plenty of chemical molecule species capable of neurotransmission, for 
example, amino acids, amines and peptides. Among them, the most 
abundant molecules in the brain are two amino acid types, one is glutamate 
for the excitatory synapses and the other one is GABA for the inhibitory 
synapses. Furthermore, glutamatergic receptors have been intensively 
studied and put the importance on the roles in learning and memory and also 
involved in the synaptic changes (or synaptic plasticity) (Bliss and 
Collingridge, 1993). Due to the importance and predominance, glutamatergic 
receptors have been targeted as the main parameters for studying neuronal 
or synaptic changes by neurodegenerative diseases (Sheldon and Robinson, 
2007). 
 
1.4.2. Excitatory ionotropic glutamate receptors 
Glutamate receptors are mainly expressed in the synaptic region of the 
neurons and have main roles in the glutamatergic neurotransmission of 
excitatory neurons. There are ionotropic glutamate receptors (iGluRs) and 
G-protein coupled metabotropic glutamate receptors (mGluRs). iGluRs are 
ligand gated ion channels which permit the influx of Na and Ca ions (See 
Traynelis et al., 2010 for review). On the other hand, metabotropic glutamate 
receptors are activated via G-protein coupled signal cascades and regulate 
neuronal function. In general, iGluRs are more likely participate in the fast 
responses and mGluRs is relatively slower response than iGluRs. The 
subtypes of glutamate receptors are displayed in the Fig. 1-3.  
 
 







There are 3 different ionotropic receptor groups, each of them has high 
affinity with specific agonists such as α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA), N-methyl-D-aspartate (NMDA) and/or 
kainate, respectively. Those receptors are named as AMPA receptors, 
NMDA receptors and kainate receptors, since they were selectively bound 
with each agonist and activated in the pharmacologically analysis. AMPA 
receptors (AMPARs) and NMDA receptors (NMDARs) are the predominant 
types of the excitatory neurons in the brain and have main roles for synaptic 
transmission and are involved in learning and memory (Citri and Malenka, 
2008). 
Activation of AMPARs causes the major component of fast excitatory 
synaptic transmission in the brain. AMPARs bind with glutamate (or other 
antagonists such as AMPA and 5-Fluorowillardiine) to allow the influx of Na+ 
and efflux of K+ and also influx of Ca2+ in some occasions (Zieglgänsberger 
et al., 2005). An important feature of AMPARs, is they can regulate synaptic 
efficacy through postsynaptic signalling cascades, which cause AMPARs to 
 
Figure 1-3 Classification of glutamate receptors and subunits. 
Glutamate receptors are mainly classified to ionotropic and metabotropic receptors 
and further divided into AMPAR, KAR, NMDAR and group I, II, III mGluR. The 










































be either recruited or removed from synaptic surface. AMPARs have 4 
subunit types, which are GluA1, GluA2, GluA3 and GluA4 and form tetramers 
to make AMPARs functional (Greger et al., 2017). The combination and 
status of subunits make the different functionalities of AMPARs. Most of 
AMPARs are composed of 2 dimers and in the most cases, a dimer of GluA2 
combined with a dimer of either GluA1, GluA3 or GluA4. Since GluA2 is 
included in almost all the AMPARs, the diverse functionality is usually 
determined by the status of GluA2. The mRNA of GluA2 usually goes through 
post-transcriptional modification at 607th residue by adenosine deaminase 
type 2 (ADAR2) and this change is related to Q/R editing site of GluA2 




Figure 1-4 Calcium permeability of AMPARs. 
Calcium permeability of AMPARs is mainly defined by the status of GluA2 subunit. 
If AMPAR is lacking GluA2 (left) or Q/R editing of GluA2 (centre), then, AMPAR is 
calcium permeable. However, predominant AMPARs contain Q/R-edited GluA2 
subunit and they are calcium impermeable (right). 














The Q/R site of GluA2 is predominantly edited to R and AMPARs are mostly 
impermeable to Ca2+. Non-edited Q variant and GluA2-lacking AMPARs are 
Ca2+-permeable, thus conductance is higher than that of R variant GluA2-
containing AMPARs (Swanson et al., 1997). Considering the combination of 
those factors, AMPARs can be referred as either Ca2+-permeable AMPARs 
(CP-AMPARs) or Ca2+-impermeable AMPARs (CI-AMPARs) depends on the 
permeability of Ca2+ ions. Due to that difference, CP-AMPARs and CI-
AMPARs have different current–voltage characteristics (or I-V curve). Since 
CP-AMPARs are not only permeable to Na+ and K+ but also Ca2+, this causes 
stronger inward rectification of I-V curve (Bowie and Mayer, 1995; Washburn 
et al., 1997). Therefore, abnormal expression of Q variant and/or GluA2-
lacking AMPARs are frequently found and implied in the neuronal 
pathologies, specifically those related to excitotoxicity (Kwak and Weiss, 
2006; Liu et al., 2006, 2004; Noh et al., 2005). In addition to Q/R editing, 
other variation of AMPAR subunits can be edited in the different ways to 
change the kinetics of AMPARs (Dingledine et al., 1999). mRNAs of GluA2, 
GluA3, GluA4 also go through R/G editing to change the speed of recovery 
from non-conducting and desensitised state (Wright and Vissel, 2012). The 
other variation is FLIP/FLOP alternative splicing of all the GluA subunits to 
change the speed of desensitisation (Dingledine et al., 1999). 
NMDARs also have important roles in synaptic plasticity, learning and 
memory (Collingridge, 1987). At the resting status, Mg2+ blocks the ion pore, 
therefore, no ion can pass through the NMDAR channel. Depolarisation of 
neuron (mainly by AMPAR) removes Mg2+ from the pore and allow the influx 
of Na+ and Ca2+, efflux of K+. NMDARs have various subunits, which are 
GluN1, GluN2A~D and GluN3A~B. The combination of subunits can be 
either di-heteromer or tri-heteromer and always forms tetramer. Di-
heteromeric NMDARs are composed of two dimers, one GluN1 dimer and 
either one of GluN2A, GluN2B, GluN2C, GluN2D or GluN3A. Tri-heteromeric 
NMDARs are composed of two GluN1 and GluN2A/2B, GluN2A/2C, 
GluN2B/2D and GluN2B/3A. GluN2 subunits bind to glutamate and GluN1 
and GluN3 can bind to glycine. The main combination of NMDAR subunits is 
 
 






GluN1 and GluN2 (Predominantly GluN2A and 2B) di-heteromer (McKay et 
al., 2018; Miglio et al., 2005; Sanz-Clemente et al., 2013). Since GluN2B has 
longer deactivation time compared to GluN2A (Paoletti et al., 2013), the ratio 
of GluN2B is usually found to be higher when the neuron is more exciting 
condition such as in early developmental brain or under excitotoxic 
environment (Martel et al., 2009, 2012). 
 
1.4.3. Synaptic plasticity in the hippocampus 
The connectivity of synapses can be either strengthened or weakened, a 
process which highly depends on the patterns of the synaptic input and/or 
experience. This change of synaptic connective strength (or efficiency) is 
called synaptic plasticity and it is considered to be a key component of the 
cellular and molecular mechanism of learning and memory (Bliss and 
Collingridge, 1993). This concept was initially suggested by Donald Hebb, 
who stated “neurons fire together and wire together” (Hebb, 1949). If one 
cell’s axon is close to the other cell’s dendrites and can excite, then the 
repetitive stimulation can induce metabolic change of those cells and 
strengthen the connectivity to form neuronal assembly (or engram). Addition 
to that neuronal assembly, there was a closely-related idea that 
morphological changes at synaptic region is the substrate for the learning 
(Konorski, 1948). To prove the concept, it was demonstrated by application 
of high-frequency electric stimulation in the rabbit’s hippocampus that 
induced the stable and persistent potentiation of the neuronal responses 
(Bliss and Lomo, 1973), later named long-term potentiation (LTP) (Douglas 
and Goddard, 1975). The molecular profile underpinning the synaptic 
changes was discovered with the great advance in the development of 
selective agonists and antagonists for the receptors on the synaptic 
membranes of neurons (Watkins and Jane, 2006). The NMDAR was 
revealed as a key component as NMDAR-mediated synaptic plasticity was 
discovered and is important for the learning and memory process (Morris et 
al., 1986), which is sensitive to hippocampus (Bliss and Collingridge, 2013; 
 
 






Morris et al., 1982). Therefore, synaptic plasticity happens between neurons 
to store information in the brain, which is basically learning and memory, and 
this concept has been postulated, demonstrated and proven for centuries 
and greatly improved in several decades with the advanced devices and 
techniques.  
The diversity of synaptic plasticity has been discovered and it is not clear that 
how many types of synaptic plasticity exist and their potential relationship 
(Südhof and Malenka, 2008). However, the main types of synaptic plasticity 
can be categorised in terms of the tendency of either potentiating or 
depressing, time span either long or short, molecular or cellular specificity 
and so forth. Broadly, these are categorised into short-term synaptic plasticity 
(lasts several minutes or less) and long-term synaptic plasticity (few hours, 
days or more) by the length of the maintained time (Cowan, 2008). In most 
cases, short-term plasticity only requires the trafficking of synaptic 
components, while long-term plasticity requires changes in the molecular 
profile and also accompanied by translation of the synaptic structural proteins 
to sustain the altered synaptic strength and morphology of the dendritic 
spines (Mayford et al., 2012). 
Short-term synaptic plasticity is transient changes that lasts very short 
period of time. It occurs predominantly at pre-synaptic neuron and is related 
to the change of the presynaptic level of Ca2+ to modify the dynamics of the 
release of synaptic vesicles (Zucker and Regehr, 2002). Paired-pulse 
facilitation (PPF) and depression (PPD) occurs when 2 pulses are delivered 
at short (less than 20 ms for PPD) or slightly long intervals (20~500 ms for 
PPF) (Citri and Malenka, 2008). This is mainly due to the probability (or 
readiness) of the release of synaptic vesicles from the presynaptic region. 
Trains of stimulations also induce longer transient changes (several seconds 
to minutes) such as augmentation, post-tetanic potentiation (PTP) and post-
tetanic depression (PTD) that are also related to the probability of the 
synaptic vesicles in addition to the sensitivity of the ligand-gated receptors 
(Zucker and Regehr, 2002). The occupancy of the presynaptic receptors or 
 
 






retrograde messengers also modulate the short-term synaptic plasticity, as 
well. Overall, short-term synaptic plasticity is mainly modulated by probability 
of synaptic vesicles, thus, this work as filter of high or low frequency input. 
Long-term synaptic plasticity is characterised by sustained changes that 
lasts for long period as the activity dependent response. This change is often 
accompanied by morphological changes of spines and background 
molecular profiles at synapse (Ho et al., 2011). LTP has been studied in the 
various way, as mentioned earlier, by postulating concepts, proving the 
concept with electrophysiology, pharmacology, molecular biology, behaviour 
test and other methods. NMDAR-dependent LTP is the most studied type of 
synaptic plasticity and has numerous evidences that are demonstrated in the 
CA1 region of the hippocampus of various mammalian models (Martin et al., 
2000; Zola-Morgan et al., 1993). 
As stated earlier, NMDAR-dependent LTP first requires activation of 
AMPARs to depolarise the post-synaptic region, removing the Mg2+ block 
from NMDAR to open and allow the influx of Ca2+. Once the concentration of 
Ca2+ increases to certain point by application of high-frequency stimulation 
(HFS), an intracellular cascade is triggered, and it is known to include 
Ca2+/calmodulin-dependent protein kinase II (CaMKII) (Park et al., 2014). 
This cascade is mainly composed of protein kinases and eventually triggers 
AMPAR trafficking to the post-synaptic membrane and results in the 
increased synaptic transmission efficiency (Lüscher and Malenka, 2012). In 
addition to the recruitment of AMPAR to the synaptic membrane, LTP needs 
further process to maintain the potentiation. Local translation of synaptic and 
structural proteins and trafficking of mRNAs to dendrites often suggested as 
the requirements to sustain LTP. This process eventually enlarges the active 
synaptic region of both pre- and post-synaptic neuron and strengthen the 
synaptic transmission (Loebel et al., 2013). On the other hand, NMDAR-
dependent long-term depression (LTD) also has been studied massively in 
the CA1 hippocampal neurons and known to be a counterpart of LTP in terms 
of the modulation of synaptic strength. NMDAR-Dependent LTD is typically 
 
 






induced by application of low-frequency stimulation (LFS). Similar to LTP, 
this LTD requires depolarisation and increase of Ca2+ level in post-synaptic 
region but in the moderate level. In this case, this Ca2+ triggers different 
cascade that includes calcineurin and other phosphatases (Mulkey et al., 
1994). This cascade results in the removal of AMPARs from synaptic region 
and decreases the efficiency of synaptic transmission and the size reduction 
or removal of synapse (Wiegert and Oertner, 2013). In addition to the post-
synaptic changes in NMDAR-dependent LTP or LTD, presynaptic region can 
also undergo synaptic plasticity. Presynaptic LTP is often suggested as 
triggered by massive action potentials and increase of Ca2+ level in pre-
synaptic region. These changes cause the increased release of 
neurotransmitter. There are several more different types of long-term 
synaptic plasticity types such as metabotropic glutamate receptor-dependent 
LTD, endocannabinoid-mediated LTD, metaplasticity, synaptic scaling and 
this is not the whole list of them (Citri and Malenka, 2008). Overall, these 
long-term plasticity types are activity-dependent and bidirectional regulation 
of the synaptic strength. Therefore, these activity-dependent synaptic 
changes are considered as the underlying mechanisms of encoding and 
saving of the information in the brain, which are implied in memory formation.  
Then how important is the hippocampus for studying synaptic plasticity? The 
early findings of LTP and other forms of synaptic plasticity were mainly found 
and studied in the hippocampus and for the decades, connection between 
synaptic plasticity in the hippocampus and functionality of learning and 
memory have been repetitively proven and reviewed (Bliss et al., 2018; 
Lynch, 2004; Nicoll, 2017). Patients with deficit in the hippocampus have 
been reported to have memory deficits (Boyer et al., 2007; Nagy et al., 1996; 
Penfield and Milner, 1958) and in the rodent models (Altemus and Almli, 
1997; Gallagher, 1997), inhibition of the major components of the 
hippocampal synaptic plasticity such as NMDAR has proven to damage the 
learning ability (Newcomer et al., 2000) and also, it was demonstrated that 
learning task could generate the activity patterns of hippocampal CA1 neuron 
and LTP (Whitlock et al., 2006). Therefore, the hippocampus became the 
 
 






most important, well-established tool to study synaptic plasticity, thus, the 
hippocampus can be utilised for seeking either pathologies or therapies that 
are closely connected to the memory function of the brain. 
 
1.4.4. Molecular mechanisms and protein interactions in synaptic plasticity 
As described in the session 1.4.3., main components of synaptic plasticity 
are receptors of neurotransmitters and their trafficking is critical to reflect the 
efficiency of neurotransmission. Therefore, molecular and protein 
interactions mediating the trafficking and sustaining the altered state of those 
receptors also have critical roles in synaptic plasticity. This topic has been 
relatively well studied in Schaffer-Collateral pathway between hippocampal 
CA3 and CA1 neurons. 
AMPAR is a main component of LTP and LTD studies and it has been known 
to be a major target of trafficking and expression in and out of the synaptic 
surface during synaptic plasticity (Collingridge et al., 2004). Basically, 
trafficking of AMPARs is categorised to exocytosis, endocytosis and lateral 
diffusion and many molecules are involved to mediate the trafficking. When 
AMPARs are on the synaptic membrane, GluA2 subunit is anchored to PDZ 
proteins such as AMPAR binding protein (ABP) and glutamate receptor-
interacting protein (GRIP) (Dong et al., 1997; Osten et al., 2000). In addition, 
GluA2 is needed to be bound with N-ethylmaleimide-sensitive factor (NSF) 
to maintain AMPARs staying in the synaptic region (Nishimune et al., 1998). 
GluA2 subunit also can bind with protein interacting with C-kinase (PICK1) 
after phosphorylation at Serine 880 by protein kinase Cα (PKCα) to be 
dissociated from ABP/GRIP and become available for later diffusion (Hee 
Jung Chung et al., 2000; Perez et al., 2001). Or NSF can be substituted by 
AP2 adaptor complex and this causes the endocytosis of AMPARs (Lee et 
al., 2002). The endocytosed AMPARs can be recycled with the binding of 
GluA1 subunits to synapse-associated protein 97 (SAP97) and myosin-VI 
(Wu et al., 2002). Again, AMPARs can laterally diffuse and then once reach 
to the synaptic region, AMPARs can bind with postsynaptic density protein 
 
 






95 (PSD-95) and this aids the anchoring at the synapse (Bredt and Nicoll, 
2003). 
In addition to the trafficking of AMPARs, the dynamics of cytoskeletons is 
also important for the changes on dendritic spines where synaptic plasticity 
happens. Mainly cytoskeletons in the dendritic spines are consist of actin 
proteins and highly dynamic during synaptic plasticity (Borovac et al., 2018), 
therefore, regulating their dynamics is important for the structural alteration 
of dendritic spines. The dynamics of actin proteins is often described as a 
balance between globular (G)-actin (monomer) and filamentous (F)-actin 
(polymer). F-actin is the functioning component of cytoskeleton to support 
the spine structure, thus, bundled F-actin is stabilised in the basal state 
(Hotulainen and Hoogenraad, 2010). Induction of synaptic plasticity (e.g. 
LTP), active CaMKII detaches F-actin bundles and then Cofilin/actin 
depolymerizing factor (ADF) dissociates F-actins into free F-actins and G-
actins (Bamburg and Bernstein, 2010). Afterwards, Aip1 and Arp2/3 bind to 
F-actin and mediate F-actin assembly, which results in the growth of the 
spines (Ichetovkin et al., 2002; Okreglak and Drubin, 2010). Finally, Drebrin, 
α-actinin and inactivated CaMKII stabilise the newly formed F-actin bundles 
and maintain the structure (Djinovic-Carugo et al., 1999; Koganezawa et al., 
2017; Okamoto et al., 2007). 
Overall, these molecular mechanisms and protein interactions are involved 
in the synaptic plasticity and interruption or dysfunction of those molecular 
mechanism can be important starting point of studying neurodegenerative 
diseases. 
 
1.4.5. Synaptic dysfunction and neurodegeneration 
As articulated in the previous sections, synapse is the very fundamental 
element that comprises neuronal activity, memory and cognition. Therefore, 
synapse has been suggested to be highly vulnerable and sensitive when it 
comes to the neurodegeneration. Synapses are often reported to be altered 
 
 






before expression of symptoms or neuronal degeneration (Wishart et al., 
2006). Therefore, a loss or impairment of neuronal regulatory dynamics for 
the connectivity in synapses can be the origin or the initiative mechanism of 
pathophysiology of neurodegenerative diseases. This pathological process 
is widely involved in the synaptic plasticity, which is a change in synaptic 
communication weight between neurons and thought to be  a cellular 
mechanism of learning and memory (Neves et al., 2008). Therefore, its main 
categories, LTP and LTD, have been studied in the context of 
neurodegenerations and/or aging whether they are actually affected or not 
during the progression of the diseases. To investigate the changes, the 
efficiency of neurotransmission can be monitored by checking the population 
and activity of those glutamate receptors. As mentioned in the section 1.1.4., 
AMPA receptor is one of the most dominant and dynamic glutamate receptor 
in excitatory neurons (Bredt and Nicoll, 2003) and it is widely accepted that 
AMPA receptor internalisation from synaptic region is an underlying 
molecular mechanism of LTD (Beattie et al., 2000) and vice versa for LTP 
(Bliss and Collingridge, 2013). Among the disease model, AD was widely 
investigated to understand the dysfunction of those synaptic plasticity 
process. For instance, application of Aβ has been shown to induce rapid 
recruitment of AMPARs (Whitcomb et al., 2015) and inhibit the induction of 
NMDAR-mediated LTP (Palop and Mucke, 2010). Tau was also found to be 
hyperphosphorylated during AD pathology (Kosik and Finch, 1987), 
especially post synaptic region in the neurodegenerative condition where 
LTD-like pathways mainly occur (Tai et al., 2012). These synaptic changes 
are highly dependent on Ca2+ homeostasis of the neurons and its 
dysregulation in the neurodegenerative diseases is also known to contribute 
the neuronal vulnerability (Morrison et al., 1998). In addition, FUS-related 
diseases are also shown to have altered status of Ca2+ homeostasis (Leal 
and Gomes, 2015; Machamer et al., 2018; Tischbein et al., 2019) and the 
involvement to the regulation of AMPAR (Udagawa et al., 2015), it would be 










1.5. Proteinopathy and synaptic dysfunction: the role of Fused in 
sarcoma (FUS) 
1.5.1. Structure and function of FUS 
FUS is a DNA/RNA-binding protein in which mutations or abnormal 
expression have been implicated in the pathogenesis of ALS and FTLD 
patients (Kwiatkowski et al., 2009; Neumann et al., 2009). FUS is thought to 
modulate the expression of genes by association with a wide range of 
transcription-related factors in different types of neurons in the nucleus 
and/or cytosol (Dormann and Haass, 2013; Fujioka et al., 2013). However, 
the pathological mechanisms of mutated FUS on neuronal physiology are 
not well understood. 
FUS is expressed on chromosome 16 and is a part of FET-family (or FET 
proteins), a group of DNA/RNA-binding proteins that include FUS, EWSR1 
and TAF15 (FET) (Crozat et al., 1993; Law et al., 2006). These proteins have 
common structural domains, which include N-terminal low-complexity (LC) 
domain, Arg-Gly-Gly (RGG) domains, a zinc finger (ZnF) domain, RNA 
recognition motif (RRM) and nuclear localisation signal (NLS) (Schwartz et 
al., 2015). Each domain has specific roles (Sama et al., 2014): RRM is an 
RNA binding site; RGG and ZnF contribute to FET-RNA binding and diversify 
binding RNA partners; LC and RGG domains promote self-assembly of FET 
proteins; NLS contributes to the localisation of FUS into nucleus (Fig. 1-5). 
 
 







The major role of FUS is thought to be DNA/RNA processes such as DNA 
repair, transcription, miRNA processing, splicing, RNA transport and local 
translation (Dormann and Haass, 2013; Lagier-Tourenne et al., 2010). These 
regulatory roles are known to be done with direct binding with DNA/RNA or 
indirect interaction through intermediate molecules. For DNA repair, FUS is 
recruited to DNA double-strand breaks and interact with histone deacetylase 
1 (HDAC1) or poly-ADP-ribose polymerase (PARP) (Mastrocola et al., 2013; 
Wang et al., 2013). For the transcription of RNA, FUS binds to the C-terminal 
domain of RNA polymerase II and RNA is thought to assist that binding 
(Kwon et al., 2013; Schwartz et al., 2012). FUS is also involved in RNA 
splicing by directly/indirectly binding with pre-mRNA or being a part of the 
spliceosome machinery (Kameoka et al., 2004; Wu and Green, 1997; Zhou 
et al., 2002). Relationship with miRNA is also indirectly done by binding with 
a protein, which is involved in miRNA maturation (Gregory et al., 2004). RNA 
transport and local translation has been suggested to be dependent on 
various neuronal activity and its mechanism has been proposed as the 
binding of FUS with RNA and transported via microtubule proteins (Belly et 
al., 2005; Fujii et al., 2005; Kanai et al., 2004). Although FUS has some 
preferences for binding with certain sequence or motifs of DNA/RNA, 
 
Figure 1-5 Schematic structure of FUS protein.  
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however, binding tendency depends more likely on overall affinity than well-
defined specificity of the sequence (Wang et al., 2015). 
 
1.5.2. Potential roles of FUS in neurons 
The distribution of FUS in either the nucleus or cytoplasm differs from cell 
type to type (Andersson et al., 2008). In neurons, FUS is mainly located in 
the nucleus and it can move between nucleus and cytoplasm by nucleo-
cytoplasmic shuttling (Zinszner et al., 1997). The intracellular trafficking of 
FUS was further discussed in the section 3.1.1., Chapter 3. This trafficking 
of FUS is known to be involved in the transportation of various essential 
mRNAs to the synaptic region and possibly mediated and accelerated by 
mGluR5 activation (Fujii and Takumi, 2005). Those target mRNAs are related 
to the components of the synapse such as actin-related proteins, therefore, 
knock out of FUS caused abnormal morphology of dendritic spines (Fujii and 
Takumi, 2005), indicating FUS activity is related to synaptic morphology, as 
well. The roles of cytosolic FUS in the morphologic changes were further 
discussed in the section 3.1.2., Chapter 3. In addition, FUS is involved in 
various RNA processing and regulation, such as, RNA splicing and 
polyadenylation (Fujioka et al., 2013; Masuda et al., 2016) and local 
translation in the soma and neurites like axons and dendritic branches 
(Kamelgarn et al., 2018; López-Erauskin et al., 2018; Yasuda et al., 2013). 
In the postsynaptic dendrites and spines, FUS stabilises mRNA of GluA1 to 
regulate AMPAR function (Udagawa et al., 2015) and also associates with 
NMDAR to regulate the expression of the other mRNAs (Belly et al., 2005), 
thus, synaptic activity can be affected by FUS. Also, FUS can directly bind to 
Tau RNA and get involved in the alternative splicing of the mRNA and 
expression of the protein (Ishigaki et al., 2017). Knockdown of FUS increased 
the expression of Tau exon 3 and 10, which in turn, increase of the longest 
isoform of Tau 2N4R that is more likely to be aggregated in Alzheimer’s 
disease pathology compared to the other isoforms of Tau (Orozco et al., 
2012). Therefore, it can be suggested that FUS might have roles in dendritic 
 
 






spine dynamics by transporting and processing of RNAs at the dendritic 
spines which in turn, affect the stability and the morphology of dendritic 
spines. These dynamic, morphological, structural and translational changes 
at dendritic spines by FUS can be related to the synaptic plasticity, but it 
needs to be investigated further. 
FUS is assembled to form either homogenous or heterogeneous aggregates 
to respond to cellular changes (Fig. 1-6). In cellular stress conditions (e.g. 
Osmotic stress, irradiation) cytoplasmic FUS protein is recruited into stress 
granules (SGs) (Higelin et al., 2016; Sama et al., 2013). The roles of SGs 
are not clearly understood, but thought to be related to the protection of 
mRNAs against cellular stress by storing mRNAs into the granules, 
processing, splicing and translation of RNA by recruiting RNA and RNA-
binding proteins (RBPs) (Nover et al., 1989; Protter and Parker, 2016; 
Schwartz et al., 2015). After the stress is resolved, these granules are 
disassembled and FUS protein can return to be transportable between 
cytoplasm and nucleus (Deng et al., 2014; Niu et al., 2012). This kind of SGs 
or SG-like aggregates consist of various RBPs (e.g. FUS, TDP-43, TIA1) 
(Lagier-Tourenne et al., 2010; Wolozin, 2012) to form hydrogel-like 
structures, which is stable and reversible in the cells (Murakami et al., 2015). 
The concentration of FUS in the cytoplasm also affects the formation of SGs 
and high cytoplasmic concentration by either overexpression or NLS 
mutation can increase the formation of SGs in the presence of stress 
conditions (Andersson et al., 2008; Li et al., 2013; Sama et al., 2013). In 
addition, increased cytosolic FUS and cation-π interaction between FUS 
proteins also involved in FUS condensations and phase separations and it is 
regulated by post-translational methylation of arginine residues in FUS 
(Dormann et al., 2012; Rappsilber et al., 2003). The FUS-FUS interaction 
and the relationship between hypomethylation and enhanced cation-π 
interaction were further discussed in the section 5.1.1. and 5.1.2., Chapter 5. 
Overall, FUS can translocate from nucleus to cytoplasm and dendritic spines 
with the abilities to bind to various RNA and ribonucleoprotein particle (RNP) 
 
 






targets to form granules. If these mechanisms have disrupted or overdriven 
by mutations in FUS, deleterious pathology will be initiated. 
 
1.5.3. Mutations in FUS and neurodegenerative diseases 
Several mutant forms of FUS were found in subtypes of ALS and FTLD cases, 
accompanying deposition of insoluble FUS in motor neurons and 
neurodegeneration (Deng et al., 2014; Higelin et al., 2016). The effects of the 
mutations were dependent on the domain of the sites. The mutations at LC 
domain abolishes binding of transcription factors or impairs the assembly of 
FUS, either abolition of reversible hydrogel formation or acceleration of 
fibrilisation (Murakami et al., 2015). The mutations at NLS impairs the 
 
Figure 1-6 Schematic model of the FUS pathology through the formation of 
stress granule. 
FUS is predominantly localised in the nucleus and shuttles between cytosol and 
nucleus. In the cytosol, FUS can be recruited to stress granules (SGs) as a part of 
cellular response to the cellular stress. Mutations on FUS inhibit the nuclear 





















localisation of FUS into the nucleus and enhances the accumulation of FUS 
in the cytoplasm (Dormann et al., 2010; Higelin et al., 2016). The mutations 
in RGG2, ZnF, RGG3 domains can impair the affinity of FUS towards RNAs 
or SGs, formed in response to cellular stress (Schwartz et al., 2015). As a 
whole, mutations of FUS could result in accumulation of cytoplasmic portion 
of FUS proteins and make them recruited into SGs, SG-like aggregates or 
irreversible fibrils. Eventually, those cytoplasmic FUS induce DNA damage, 
impair DNA-repairing and apoptosis (Higelin et al., 2016; Scekic-Zahirovic et 
al., 2016). Therefore, the mutations in FUS gene cause either gain of function 
or loss of function. 
As stated above, the concentration of cytosolic FUS is related to the 
increased formation of SG and mutation at NLS domain promotes the 
accumulation of FUS in cytoplasm. In other words, FUS-containing 
irreversible aggregates or SGs were found in FUS-ALS or FUS-FTLD 
patients (Mackenzie et al., 2010a; Vance et al., 2013) and FUS with NLS 
mutant accelerated the pathologies in the neuronal cytoplasm (Deng et al., 
2010; Kwiatkowski et al., 2009). Thus, cytoplasmic aggregates of FUS, 
especially NLS mutant forms, have been investigated to find out the 
mechanisms of FUS pathology (Blokhuis et al., 2013; Vance et al., 2013). 
 
1.5.4. Implied mechanism and importance of FUS 
ALS (also known as Lou Gehrig’s disease) is a neurodegenerative disease 
that characterised by the loss of motor neurons in the cerebral cortex, brain 
stem and spinal cord (Van Langenhove et al., 2012; Ling et al., 2013). This 
neuronal loss causes atrophy and dysfunction of voluntary muscles and most 
patients die within few years from the onset of the first symptom. The causes 
of the disease are still being characterised, though mutations in C9orf72, 
SOD1, TARDBP and FUS/TLS genes have been found in ALS patients, 
along with pathological inclusions of TDP-43, SOD1 and FUS proteins (Ling 
et al., 2013). 
 
 






FTLD (or referred as FTD in clinical practice) is another neurodegenerative 
disease that neuronal loss happens in the frontal and temporal lobe (Van 
Langenhove et al., 2012; Ling et al., 2013). This leads to behavioural change 
and dysfunction of language skills. From FTLD patients, mutations of MAPT 
and progranulin (PGRN) were mainly found and TDP-43, Tau, FUS and 
ubiquitin-proteasome system (UPS) pathologies were also found (Ling et al., 
2013). 
Both ALS and FTLD share several pathologies related to RNA processing 
and protein regulatory dynamics especially, such as TDP-43 and FUS 
DNA/RNA binding proteins (Lagier-Tourenne et al., 2010; Ling et al., 2013). 
Mutations or aggregations of TDP-43 and FUS can develop DNA/RNA and 
protein dynamics-related pathologies for example, malfunction of DNA 
repairing mechanism, alternative splicing and abnormal changes of mRNA 
expression to protein, which will cause disruption of cellular homeostasis and 
degeneration, eventually. Therefore, investigating common pathologies of 
FUS or TDP-43 would be needed to find the shared pathophysiological 
changes in both ALS and FTLD in addition to the other major targets from 
other neurodegenerative diseases. 
 
1.6. Aims and summary 
As articulated, FUS has the various roles to regulate the dynamics of 
DNA/RNA and also involved in the deleterious pathologies of ALS/FTLD. 
Since both ALS and FTLD includes neurodegeneration, the synapse 
weakening process might be done prior to the neuronal death. However, 
there are many missing gaps and mechanisms not well explained. The aim 
of this thesis is to investigate the early physiological and morphological 
alterations by the abnormal expression of FUS that eventually forms cytosolic 
inclusions throughout the dendrites. By biolistically transfecting 2 different 
mutant forms, 2 major pathologies found in the FUS-opathy were tested in 
the organotypic hippocampal slices model to utilise well-characterised 
neuronal circuit of neurotransmission and synaptic plasticity.  
 
 






First, cytosolic accumulation of FUS was investigated using FUS-P525L 
mutant form, which has mutation on NLS region that is required for nuclear 
internalisation of FUS. In the Chapter 3, the intracellular trafficking and 
morphological changes by FUS-P525L expressions were discussed. FUS-
P525L was shown to have quicker translocation though the dendrites than 
that of FUS-WT and this difference resulted in the reduction of spine density 
in the distal part of the apical dendrites in FUS-P525L neurons. In the 
Chapter 4, the electrophysiological changes by FUS-P525L expressions 
were discussed. FUS-P525L was shown to have increased synaptic 
conductance and intrinsic excitability and the excitability was returned to the 
control level when CP-AMPAR blocker IEM-1460 was applied. And had 
decreased basal synaptic transmission and inhibited induction of both LTP 
and LTD. 
Second, FUS mutant with enhanced cation-π interaction was investigated by 
using FUS-16R mutant form, which has 16 additional arginine residues 
therefore increases the affinity between FUS proteins to form inclusions in 
the cytosol. In the Chapter 5, both morphological and electrophysiological 
changes by FUS-16R were discussed. The spine density of FUS-16R cells 
were shown to be reduced in both basal and apical dendrites compared to 
FUS-WT cells. In addition, intrinsic excitability and basal synaptic 
transmissions were reduced in FUS-16R cells.  
Together, the results suggest that abnormal expression of FUS mutant is 
widely involved in the morphological, electrophysiological synapse 
weakening and it is related to the neuronal activity and excitability.  
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2.1. Animal-derived materials 
2.1.1. Animals 
All procedures involving animals were performed in accordance with the UK 
Scientific Procedures Act, 1986. Male Wistar Han rats of postnatal 6-8 days 
(P6-P8) were used to prepare organotypic slice culture on the day of delivery.  
 
2.1.2. Organotypic hippocampal slice culture preparation 
Animals were sacrificed by cervical dislocation (Schedule 1) and then 
decapitated. The upper skin and then the skull of the head was cut sagittally 
from the middle back of the head. Frontal bone was cut coronally and the 
upper skull was opened with forceps. The whole brain of rat was quickly 
transferred to the ice-cold cutting solution (238 mM sucrose, 2.5 mM KCl, 26 
mM NaHCO3, 1 mM NaH2PO4, 11 mM D-glucose, 5 mM MgCl2 and 1 mM 
CaCl2). Hippocampi were dissected and cut into 350 µm coronal slices with 
McIlwain tissue chopper. The hippocampi were transferred to culture 
medium (78.8% minimum essential medium (MEM), 20% horse serum (heat-
inactivated), 30 mM HEPES, 26 mM D-glucose, 5.8 mM NaHCO3, 2 mM 
CaCl2, 2 mM MgSO4, 70 μM Ascorbic Acid, 0.1% 1 mg/ml Insulin, pH 7.3 and 
320–330 mOsm) and separated into individual slices. Hippocampal slices 
were washed by transferring slices into the 35 ml petri dishes with fresh 
culture medium for 4 times. The washed slices were placed onto a semi-
permeable membrane inserts (Millipore, PICM0RG50) in a 6-well plate with 
culture medium. The slices were stored in an incubator at 35 ⁰C 5% CO2 and 
medium was changed every 2-3 days. 
 
2.2. Biolistic transfection 
2.2.1. Genes of interest 
Neurons were transfected with plasmids that contain gene of interest. 
Plasmid DNA constructs were kindly provided from Professor Peter St 
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George-Hyslop (Clinical neurosciences, Cambridge Institute for Medical 
Research, UK). Information of the plasmid constructs were shown as a Table 
2-1. For the mutations, FUS-P525L has only mutation of P525L, on the other 
hand, FUS-16R mutation has mutations on G167R, G170R, G173R, G202R, 
S205R, S221R, G225R, G228R, G230R, M254R, G379R, N381G, 
insert387G, G398R, G401R, S402G, G404R, G456R, M464R, therefore, 
FUS-16R has 16 additional arginine residues. 
FUS genes were loaded to 2 different types of plasmid vectors to tag either 
EYFP or mCherry as displayed in Fig. 2-1. Later for the transfection, those 
plasmid DNA constructs were loaded to gold microcarriers with the amount 
as shown on Table 2-1 and the procedure is explained in the chapter 2.2.4. 
Venus, mCherry and TdTomato are types of structural fluorescence marker 
protein and Venus is further used as transfection control. 
 









YFP Kanamycin 20 
YFP_FUS-FL-
WT peYFP-C1 FUS Human 
N-term 










C1 FUS Human 
N-term 








mCherry Kanamycin 20 or 40 
Venus - - Jellyfish - Ampicillin 10 
mCherry - - Discosoma - Ampicillin 60 
TdTomato - - Discosoma - Ampicillin 10 
 
Table 2-1 Information of DNA plasmid constructs used in the study. 
Basic information of DNA genes of interest and used amount were displayed. 
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2.2.2. Plasmid amplification 
The whole process of this amplification takes 3 consecutive days. DH5α 
(Invitrogen, 18265-017) E.coli strain was used for the amplification of the 
plasmids.  
 
Figure 2-1 Plasmid vectors used for tagging FUS proteins. 
Plasmid vectors were utilised to add either EYFP or mCherry at the N-terminus of 
FUS proteins. (a) peYFP-C1 vector was used and as a result, N-terminus of each 
type of FUS protein was tagged. (b) pmCherry-C1 vector was used and as a result, 
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First day was to transform DH5α with the target plasmid. 50 µl of DH5α 
(expected to yield >1 x 106 transformants / µg) was aliquoted to a 1.5 ml tube 
from thawed stock on the ice. 1-10 ng of target plasmid was added and gently 
mixed, then, incubated on ice for 30 minutes. Next, 20 seconds of heat shock 
at 42 °C was applied on a heat block and then placed on ice for 2 minutes. 
950 μl of SOC medium (Invitrogen, 15544-034) was added to maximise the 
transformation efficiency of the plasmid and then the tube was incubated in 
the 37 °C shaker for 1 hour. 120 µl of media with transformed E.coli was 
plated on the premade agarose gel plate with the antibiotics either 50 µg/ml 
of kanamycin (Sigma-Aldrich, K0254) or 100 µg/ml ampicillin (Sigma-Aldrich, 
A9518) for the target plasmid. After 10 minutes, the agarose plate was 
incubated overnight in the 37 °C oven. 
Second day was to prepare for the starter culture. The agarose plate was 
checked whether transformed E.coli with target plasmid formed colonies. 
One of the colonies was transferred into a 1.5 ml tube with 1ml of LB Broth 
and 1 µl of appropriate antibiotic. The tube was incubated in the 37 °C shaker 
for 6-7 hours as the starter culture. The starter culture was transferred into 
an autoclaved glass flask with 80ml LB broth and 80 µl of appropriate 
antibiotic and then incubated overnight in the 37 °C shaker. 
Third day was to purify the target plasmids with Plasmid midi kit (QIAGEN, 
12943) and it was conducted based on the product manual with few minor 
variations. The incubated flask from the previous day was checked whether 
the broth was cloudy, indicating amplified E.coli cells. The broth was split into 
two 50 ml falcon tubes, then, centrifuged at 2800 rpm for 15 min. The 
supernatant was discarded. 2 ml of buffer P1 was added into each tube to 
resuspend the pellets and then the contents were mixed into one tube. 4 ml 
of buffer P2 was added, gently mixed and then incubated at RT for 3 minutes 
to lyse the E.coli cells. 4 ml of buffer S3 was added and mixed to precipitate 
cell debris. The mixture was centrifuged at 2800 rpm for 5 minutes and 
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filtered into a new tube to remove precipitant. 2 ml of buffer BB (binding buffer) 
was added and gently mixed together. To separate the target plasmid, the 
mixed buffer was gone through the QIAGEN plasmid plus midi spin column 
with suction from a vacuum pump. The column with target plasmid was 
washed with 0.7 ml of buffer ETR by centrifuging at 13,000 rpm for 45 
seconds and the flow-through was discarded. The washing step was 
repeated for twice with 0.7 ml of buffer PE. Further spinning at 10,000 rpm 
for 2 minutes to remove the remaining buffer. Then, the column was placed 
on the new 1.5 ml tube. 110 µl of buffer EB buffer (elution buffer) was added 
on the column and incubated at RT for 3 minutes and then, the column and 
the tube were spun at 13,000 rpm for 45 seconds. The flow-through was 
transferred again on the column and incubated at RT for 2 minutes, then, 
they were spun at 13,000 rpm for 1 minute. The flow-through was again, 
transferred on the column and incubated for 1 minutes, it then, spun at 
13,000 rpm for 1 minute. The concentration of the eluted plasmid was defined 
by using NanoPhotometer (Implen, P300). 
 
2.2.3. Concept of biolistic transfection: Gene gun 
Biolistic transfection (biological and ballistic transfection) is a technique to 
deliver DNA into target cells by using small-sized carriers such as gold 
particles. This is mechanical method, therefore, versatile and simple to be 
used on diverse kinds of cells and tissues that includes hippocampal 
organotypic culture slices. The big advantage of biolistic transfection is that 
this method physically delivers genes, therefore, it can be reliably applied to 
a variety of neuron and tissue types with higher success rate and less 
limitations compared to the other transfection methods (McAllister, 2000). In 
addition, it is also easy to combine and deliver few different DNAs together, 
thus, easier to express target genes with different visual markers (e.g. 
fluorescence proteins). The core component of this technic is gene gun, 
which is designed to release pressurised inert gas flow to shoot DNA-
containing carrier particles into the cells. Those carrier particles are usually 
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prepared to be bound with target genes using spermidine, then, loaded in the 
plastic Tefzel cartridge, so called bullets. Once carrier particles are shot from 
the gene gun, then, the particles penetrate through the tissues and cell 
membranes and release plasmid that contains target gene to be expressed. 
The concept summary of biolistic transfection is shown in Fig. 2-2. 
 
 
2.2.4. Microcarrier preparation 
Tefzel tubing (Bio-Rad, 1652441) was inserted into the tubing prep station 
(Bio-Rad) and dried with nitrogen gas, while rotating, for minimum 30 minutes. 
To prepare the DNA/RNA construct solutions, constructs of interest were 
mixed at the desired ratio (total volume 100 μl, maximum DNA/RNA content 
100 μg). A 100 μl of 50 mM spermidine was added to 10 mg of gold 
microcarriers (1.6 μm) (Bio-Rad, 1652264), vortexed for 10 seconds and 
then bath-sonicated for 10 seconds. Then DNA/RNA construct solution was 
  
Figure 2-2 Biolistic transfection. 
Organotypic hippocampal slices were biolistically transfected by using Helios gene 
gun system (Bio-Rad). Gold microcarriers were coated with gene of interest (DNA 
plasmids), loaded on gene gun and pressurised helium gas propels microcarriers 
just enough to penetrate cell membrane and transfect the cell. Usually, target genes 








(Coated with gene of interest)
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added and the mixture was vortexed together for 10 seconds. Calcium 
chloride (100 μl of 1 M) was added dropwise while the mixture was gently 
vortexed. The mixture was left at RT for 10 minutes to precipitate the solution. 
The mixture was mini-centrifuged for -15 seconds and then supernatant was 
removed. The pellet was resuspended and washed with 1 ml of 100 % 
ethanol for 3 times (mini-centrifuged for 5 seconds and the supernatants 
removed every time). After the last wash, the supernatant was removed and 
remaining gold microcarrier mixture was resuspended and mixed with 3 ml 
20 µg/ml polyvinylpyrrolidone in 100 % ethanol. The mixture was aspirated 
into 10 ml syringe with 3-5 cm silicone tubing attachment. The aspirated 
mixture was loaded into the Tefzel tubing on the prep station and held in 
place for 2 minutes. The solution was slowly aspirated, and the tubing was 
turned 180º and left for 30 seconds. The tubing was rotated for 1 minute 
followed by, an additional 5 minutes of rotation with a nitrogen gas flow to dry 
out the remaining liquids inside the tubing. The tubing was cut into 0.5’’ 
cartridge (gene gun bullets), desiccated and stored for the further 
experiments. 
 
2.2.5. Gene transfection 
Hippocampal neurons were transfected with a gene gun (Helios gene gun 
system, Bio-Rad). Each gene gun bullet cartridge contains DNA/RNA 
constructs bound to 1.6 μm gold microcarriers. To shoot the gene gun, bullets 
were loaded into the cartridge holder and assembled to the gene gun. The 
gene gun was connected to the helium cylinder at the pressure of 140-180 
psi. Once gene gun was ready, 6-well culture plates with hippocampal slices 
were taken out of the incubator. The culture membranes were aimed with the 
gene gun (distance between the front tip of the gene gun’s barrel liner and 
the membrane was 1 cm), then the gene gun was triggered to shoot the gold 
microcarriers to the culture tissues. Once the process was done, the culture 
plates were returned to the incubator. 
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Transfection was done at Day In Vitro (DIV) 3-5 to let organotypic 
hippocampal slices stabilise on the membrane before the transfection 
process. Once the transfection was done, hippocampal slices were left in the 
incubator for Day After Transfection (DAT) 2-7 depends on the experiment 
type. For the electrophysiology experiments, DAT 3-4 time window was used 
for early stage, DAT 5-7 time window was used for late stage. The summary 
of the timetable is shown in Table 2-2. DAT 5-7 time window was mainly 
selected to make sure the pathogenic inclusions translocated through 
dendrites, which will be described in the results chapters. To be clear, these 
different time windows represent the progression of pathology, however, they 
are relatively early progression before neuronal death, therefore, those time 
points are not directly matched with early onset or late onset of the real 




2.3.1. Electrophysiology rig setup 
The recording chamber for the electrophysiology experiments (Warner 
Instruments, RC-26G) was attached on a glass coverslip (Warner 
Instruments, CS-22/40) with the sealing of vacuum grease (Dow Corning). 
Day In Vitro (DIV) 0 1 2 3 4 5 6 7 8 9 10 
Day After 
Transfection (DAT)    0 1 2 3 4 5 6 7 
Slice culture 
preparation            
Transfection            
Experiments (Early)            
Experiments (Late)            
 
Table 2-2 Summary of transfection timetable. 
Time course of Days in vitro (DIV) and Day After Transfection (DAT) were displayed 
with the critical steps of the experiments with blue boxes.
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Perfusion of artificial cerebrospinal fluid (ACSF) (119 mM NaCl, 2.5 mM KCl, 
26 mM NaHCO3, 1 mM NaH2PO4, 11 mM D-glucose, 4 mM CaCl2, 4 mM 
MgCl2, 0.02 mM picrotoxin, 0.01 mM 2-chloroadenosine) was supplied from 
a glass bottle with 95 % O2 / 5 % CO2, perfused by peristaltic pump (Watson-
Marlow, 323S/D) at about the flow rate of 2-3 ml / min through polythene 
tubing (Fisher Scientific, 800/100/460), Norprene tubing (Cole-Parmer, 
06410-01) and PTFE tubing (Cole-Parmer, 06417-31). The bottle with ACSF 
was heated to 37 °C in a water bath (Nickel-Electro, Clifton NE1-4) and 
perfusion tubing was heated with a pen heater (ALA Scientific Instruments, 
HPT-2A) and a control unit (npi electronic, TC-10) to adjust the temperature 
to 28-30 °C when the perfusion enters the recording chamber. A syringe 
needle with a suction pump (Charles Austen, Dymax 5) was placed to 
remove the excessive ACSF from the recording chamber. To visualise the 
recording chamber, a microscope (Nikon, Eclipse E600FN) and a camera 
(Hitachi, KP-M1AP) were used. The X-, Y- movement of the table was 
adjusted by an in-house built X-, Y-plate and Z- movement was adjusted by 
automated motor unit (Prior, Optiscan) attached to the microscope. To 
reduce the recording noise from vibrations, the whole microscope and X-, Y-
plate were placed on the air table (Newport, VH3036W-OPT) and the air was 
supplied by an air compressor (Bambi, 35 / 20). An in-house built Faraday 
cage was used to cover the whole unit above the air table and to shield the 
inside from electrical fields. For the stimulation, two-strand-twisted Nickel80 
/ Cromium20 wire (Advent Research Materials, NI653514) and the wire was 
inserted through a glass capillary and fixed and it was prepared as a pair of 
stimulating electrodes. The pair of stimulating electrodes were held by a pair 
of manipulators (Scientifica, LBM-7). The end of the wire was soldered to 
general electric wires and connected to a pair of constant voltage isolated 
stimulators (Digitimer, DS2A – Mk.II) that generate 0.1 ms square-wave 
constant voltage pulses as triggered by commands. For making recording 
glass electrodes, Flaming/Brown micropipette puller (Sutter Instruments, P-
1000) was used to pull the glass capillaries (Harvard Apparatus, 30-0057) to 
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the pipette resistance of 4-7 MΩ (Ideally about 5.5 MΩ). The electrodes were 
then filled with internal filling solution (see chapter 2.3.2.) and fixed to an 
electrode holder (Molecular Devices, 1-HL-U) that is connected to a 
headstage (Molecular Devices, CV-7B) and the headstage was connected 
to an amplifier (Molecular Devices, Axon multiclamp 700B). A 0.2 mm silver 
wire (Advent Research Materials, AG548815) was coated with chloride in 
advance and fixed to the electrode holder to touch the filling solution inside 
the glass electrodes. The back of the headstage was connected to another 
long silver wire, which was also coated with chloride in advance and then the 
coated part was submerged inside the recording chamber to be a ground 
reference. The whole electrode on headstage unit was mounted on the 
automated micromanipulator (Scientifica, PatchStar). 
The data acquisition was done at 20 kHz with Multiclamp 700B amplifier and 
a CA-1000 data acquisition device (National Instruments) and filtered at 2 
kHz. For the recording and saving of the data from electrophysiology 
experiments, WinLTP version 2.10 software (Anderson and Collingridge, 
2007) was used. 
A cultured hippocampal slice was placed in the recording chamber and an 
in-house built mesh net was placed to surround the slice and prevent the 
movement by the flow of ACSF. For the experiments requiring preincubation, 
cultured hippocampal slices were placed in 5 ml of ACSF (room temperature, 
bubbled with 95 % O2 / 5 % CO2) with the drugs of interest (e.g. IEM-1460). 
Concentration and incubation time are described in the results chapters as 
the drugs used. The preincubated slice was transferred to the recording 
chamber perfused with ACSF containing the same drugs. 
 
2.3.2. Whole-cell patch and recording 
For whole-cell patch clamp, hippocampal slice was placed in the recording 
chamber with ACSF perfusion of the consistent flow rate and temperature as 
described in the chapter 2.3.1. One each stimulating electrode was placed 
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on the Schaffer-collateral pathway (experimental pathway) and subiculum-
CA1 pathway (reference pathway) when required. 
For voltage clamp experiments, the recording electrode was filled with Cs 
methanesulfonate filling solution (130 mM Cs methanesulfonate, 10 mM 
HEPES, 0.5 mM EGTA, 4 mM Mg-ATP, 0.3 mM Na-GTP, 6 mM QX-314 
chloride, 8 mM NaCl, pH 7.2 and 285-290 mOsm). For current clamp 
experiments, K-Gluconate filling solution (135 mM K-Gluconate, 10 mM 
HEPES, 0.5 mM EGTA, 2 mM Mg-ATP, 0.3 mM Na-GTP, 8 mM NaCl, pH 
7.2 and 275-290 mOsm) was used. 
The recording electrode was positively pressurised to prevent blockage of 
the tip of the electrode by using a 1 ml syringe connected to the electrode 
holder via Tygon lab tube (RS components, ACF00002-C). Once the 
electrode pipette dipped into the solution in the recording chamber, the 
resultant current through the tip was set to zero by using the software 
Multiclamp 700B. Pipette resistance was also checked whether that was 
within the ideal range (4-7 MΩ) with WinLTP by applying 10 mV square-wave 
pulse of 100 ms through the headstage. Target CA1 cell in the pyramidal cell 
layer was identified by Venus or YFP (yellow fluorescence protein) 
fluorescence with a blue light source (CoolLED, pE-300) for the transfected 
cells or in-built bright-field of the microscope for untransfected cells. Once 
target cell was identified, the tip of the electrode was approached carefully. 
When the tip of the electrode was close enough to show a dent on the target 
cell by the positive pressure from the tip, the pressure was released (and 
gentle negative pressure applied if needed) to make a giga-seal (GΩ) 
between pipette tip and the membrane of the cell body. Once giga-seal was 
accomplished, holding voltage was set to -30 mV and gradually changed to 
-70 mV. Then, capacitive transient of pipette was compensated. Negative 
pressure was applied to break the cell membrane between pipette internal 
solution and cytosol of the cell. If the patch was successful, test pulse 
(generated by 10 mV square-wave) on WinLTP should show capacitive 
transient pattern that the peak would be calculated to the series resistance 
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(Rs) and current difference would be calculated to the membrane resistance 
(Rm) (Fig. 2-3). For Rs, only patched cells under 23 MΩ with the change of 
max 20 % were used for analysis not to record signals with blockage of the 
recording pipette. For Rm, only cells over 50 MΩ were further recorded and 
used to ensure stable attachment of the tip on the cellular membrane without 
rupturing excessively (Finkel et al., 2006; Ionescu-Zanetti et al., 2005). 
 
After each cell was patched, resting membrane potential (RMP) was also 
checked by temporarily removing voltage holding of the recording pipette. 
Only cells with RMP hyperpolarised than -40 mV because less polarised cells 
easily showed epilepsy upon electric stimulations. These passive properties 
of patched cells (Rs, Rm and RMP) are supposed to evaluate the quality of 
the whole-cell patch. Therefore, once the passive properties of the patched 
cells met the proper condition as stated above, difference between groups 
should not significantly influence the actual data sets of the 
electrophysiological recordings. To confirm the quality of the whole-cell patch 
recording, example passive properties from each major transfection groups 
 
Figure 2-3 Parameters of whole-cell patch recording. 
An example single trace of whole-cell recording. Series resistance (Rs), membrane 
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were plotted as a supplementary data (Fig. 2-4). The recorded data sets are 
part of AMPA/NMDA current tests in Chapter 4 and 5. From each cell, RMP 
values were acquired right after whole-cell patch and for Rs and Rm values, 
10 sweeps of test pulses per 30 seconds were recorded and averaged. Most 
of transfected cells were paired with untransfected cells, thus n-number of 
untransfected cell group is bigger than other FUS transfected cell groups. 
The data set was shown as Mean ± SEM. From multiple neurons from 
different groups (Untransfected: 49 cells, FUS-WT: 12 cells, FUS-P525L: 15 
cells, FUS-16R: 15 cells), recorded RMP (Untransfected: -58.65 ± 1.03 mV, 
FUS-WT: -61.42 ± 2.91 mV, FUS-P525L: -56.67 ± 1.08 mV, FUS-16R: -63.68 
± 1.60 mV, F = 3.378, p = 0.0217), Rs (Untransfected: 14.45 ± 0.45 MΩ, 
FUS-WT: 17.08 ± 1.07 MΩ, FUS-P525L: 16.19 ± 0.87 MΩ, FUS-16R: 14.64 
± 0.76 MΩ, F = 2.727, p = 0.0486) and Rm (Untransfected: 177.45 ± 10.10 
MΩ, FUS-WT: 158.40 ± 25.20 MΩ, FUS-P525L: 237.58 ± 40.27 MΩ, FUS-
16R: 101.12 ± 9.40 MΩ, F = 7.117, p = 0.0002) distributed within the proper 
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Excitatory postsynaptic currents (EPSCs) were generated by stimulating 
electrodes previously placed on Schaffer-collateral pathway (experimental 
 
Figure 2-4 Example passive properties of neurons during whole-cell patch 
recording. 
Passive properties were recorded to confirm the quality of whole-cell patch. (a) 
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pathway) and subiculum-CA1 pathway (reference pathway) at a holding 
voltage of -70 mV. Two pathways were stimulated alternately at 15 seconds 
interval. Only cells show fast rise / decay kinetics with monosynaptic 
responses were used. The peak amplitude was used for the parameter of the 
synaptic efficacy. For EPSCNMDA, the peak at 90-100 ms after stimulation 
artefact was measured. Rm, Rs, DC were also measured to monitor the 
quality of the whole-cell patch. 
For AMPA/NMDA current tests, 10 EPSCAMPA recorded at -70 mV voltage 
and changed to +40 mV voltage holding, waited for > 2 minutes and further 
10 EPSCNMDA were recorded. Total 20 EPSC per one experiment were 
recorded. One transfected cell and the other untransfected cell in one slice 
were always recorded as a pair. 
 
2.3.2.2. mEPSCs 
For miniature EPSCs (mEPSCs) experiments, target cells were voltage 
clamped at -70 mV, then, ACSF with 500 nM tetrodotoxin, 50 μM D-AP5 and 
20 μM bicuculline was perfused for 7 minutes. The perfusion was to remove 
the EPSCs induced by excitation of presynaptic neuron. Therefore, this 
procedure makes the presynaptic neurons to release neurotransmitters 
without any contamination of action potential-mediated release of synaptic 
vesicles. After the perfusion, then mEPSCs were continuously recorded 
without any electrical stimulation for 6 minutes. 
 
2.3.2.3. LTP / LTD 
For the baseline recording, two stimulating electrodes were alternately 
delivered stimulations every 15 seconds. For LTP experiments, a stable 
baseline was recorded for 5 minutes and then, 200 pulses of 2 Hz stimulation 
at the holding voltage of 0 mV (Kullmann and Nicoll, 1992; Malinow and Tsien, 
1990) were delivered to the Schaffer-collateral pathway. EPSCs were further 
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recorded for 35 minutes at the holding voltage of -70 mV. For LTD 
experiments, a stable baseline was recorded for 10 minutes and then, 200 
pulses of 1 Hz stimulation at the holding voltage of -40 mV (Hjelmstad et al., 
1997; Lüthi et al., 1999) were delivered to the Schaffer-collateral pathway. 
EPSCs were further recorded for 40 minutes at the holding voltage of -70 mV. 
Only one cell per hippocampal slice was recorded due to the irreversible 
stimulations were applied, therefore, transfected cells and untransfected 
cells were recorded from separated slices. To increase the comparability 
between control vs transfected cells, always one cell from each group was 
recorded from same animal and same preparation. 
 
2.3.2.4. Firing activities 
For firing activity experiments, target cells were current clamped, then 500 
ms of square-wave current was injected to the cells from -50 to 450 pA in 50 
pA steps. Between each step, the interval was 15-20 seconds to avoid 
overstimulation. 
 
2.3.3. Data analysis and statistics 
For the EPSCs, those measured peak amplitude, Rm, Rs and DC were used 
for the analysis as acquired from WinLTP. For mEPSCs, single trace files 
were imported to Clampfit 10.7 (Molecular Devices) and EPSC events over 
15 pA from baseline were detected to exclude contamination from the 
baseline noise and then, peak amplitude, rise time 10% to 90% and decay 
time 90% to 10% were measured from each event. All the peaks were 
manually checked and false events were rejected. For firing activity 
experiments, single trace files were imported to Clampfit and number of firing 
events were counted with the threshold of 20 mV. And the frequency was 
calculated from inter-event interval. 
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For AMPA/NMDA experiments, the mean values of 10 AMPA EPSCs and 10 
NMDA EPSCs were used for the unpaired t-test comparison between 
transfected and untransfected cells.  
For LTP / LTD experiments, each time point was normalised with the average 
of the baseline (all the time points before LTP / LTD induction protocols) 
therefore, baseline was converted to 100 %. The change by LTP / LTD 
induction protocols was calculated by comparing the 5 time points prior to 
the induction protocol and 5 time points at the end of recording. Initially, to 
verify the magnitude of LTP / LTD from each neuron, a paired t-test was used 
to compare the pre- and post-induction protocols. An unpaired t-test was 
applied to analyse differences between groups. 
For mEPSC experiments, rise time and decay time were compared between 
transfected and untransfected cells via the Mann-Whitney test, due to a 
none-standard distribution. However, due to a standard distribution, the 
mEPSC event frequency of transfected and untransfected cells was 
compared using an unpaired t-test. 
For firing activity experiments, the frequency and the number of firing events 
were compared at each excitatory input point by using an unpaired t-test. 
The difference between groups were compared with a repeated measures 
analysis of variance (RM-ANOVA). 
The data sets were analysed with Sigmaplot 12 software (Systat Software) 
and displayed as the mean value ± standard error of the mean (SEM). 
Significant difference between groups indicates a p-value of less than 0.05 
(p < 0.05) for all the statistical tests. 
 
2.4. Multi-photon and confocal imaging 
2.4.1. Optic parameters 
Multi-photon imaging was performed in either the Wolfson Bioimaging 
Facility (WBFLM) of University of Bristol or Wohl Cellular Imaging Centre 
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(WCIC) of King’s College London. In WBFLM, Leica Application Suite X (LAS 
X) software with SP8 AOBS (Leica) confocal laser scanning microscope 
mounted on dm6000 (Leica) microscope was operated with 25X HC Fluotar 
water dipping objective (Working distance: 2.5 mm, Numeric aperture: 0.95). 
In WCIC, NIS-Elements software on A1R Multiphoton system (Nikon) was 
operated with 25X CFI75 Apochromat 25XC water dipping objective 
(Working distance: 2.0 mm, Numeric aperture: 1.10) was used. Additional 
digital magnification (0.75X-6X) was applied depending on the experiment. 
Spinning disk confocal imaging was performed from Prof. Kei Cho’s lab in 
King’s College London Dementia Research Institute (KCL-DRI). In KCL-DRI, 
NIS-Elements software on A1R Multiphoton system (Nikon) was operated 
with Plan 100X/1.10 W water dipping objective (Working distance: 2.5 mm, 
Numeric aperture: 1.10) was used. 
Transfected hippocampal slices were placed in a 35 ml petri dish, containing 
HEPES buffer (30 mM glucose, 25 mM HEPES, 5 mM KCl, 119 mM NaCl, 
500 nM picrotoxin, 1μM glycine, 2 mM MgCl2, 2 mM CaCl2). For the filters, I3 
(Excitation: 450-490 nm, Emission: 515 nm) (for Venus) and/or N21 
(Excitation: 515-560 nm, Emission: 590 nm) (for mCherry) filters were used 
for each target protein. Image were acquired as z-stacks with 1 µm intervals 
with 3 averages at each plane. 
 
2.4.2. Image process and assay parameters 
Taken images from section 2.4.3. were further processed and analysed with 
ImageJ software. Regions of interest (ROIs) are categorised into 3 groups 
(apical dendrites at 0-100 μm and 100-200 μm, basal dendrites at 0-100 μm) 
and some groups were not taken if it was not available to find any secondary, 
tertiary or more branched dendrites and/or bright ROIs in that area. Within 
the categories, 15 μm X 15 μm sized 3 ROIs were randomly picked and 
cropped among dendrites with spines. Since morphological analysis was part 
of broad screening of neuronal change by FUS rather than heavily focused 
 
 
Chapter 2  





on morphology, 2D analysis was utilised over 3D analysis to make the 
analysis simple, quick and no requirement of specialised paid software, 
though, 2D slightly sacrifices accuracy. The cropped ROI images were z-
projected (Max brightness), converted to 8-bit and the contrast and 
brightness were optimised. Within the ROIs, spine densities were manually 
counted only when the spine has neck where spine head can be defined and 
the length of the whole spine was shorter than 5 µm to exclude filopodia. 
Since manual analysis can be easily biased without blinding and 
randomisation, those multiple data sets were crosschecked with other lab 
members to confirm that the tendency to be same. By drawing straight line 
with measuring function of ImageJ, spine head widths, spine head lengths, 
spine neck width and spine length were measured within ROIs and then, 
spine head / neck width ratio and spine head area were calculated from 
measured values. Based on the measured values, spines were categorised 
to 3 different shapes (stubby, thin, and mushroom) according to the length, 
head / neck width ratio. Stubby spines were defined as length < 1 µm and 
head width / neck width ratio < 1.5. Thin spines were defined as length 1 – 5 
µm and head width / neck width ratio < 1.5. Mushroom spines were defined 
as length < 5 µm and head width/neck width ratio > 1.5. If a spine length was 
longer than 5 µm, the spine was regarded as filopodium and not used for the 
analysis. The parameters and criteria for analysing dendritic spines are 
summarised in the Fig. 2-5. 
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2.4.3. Data analysis and statistics 
For all the morphology analyses, basal dendrites or apical dendrites were 
separately analysed, thus, they were not directly compared with any 
statistical analysis. 
For the spine density comparisons, measured values of different groups were 
compared by using unpaired t-test. 
For the shape of the dendritic spines, the ratio of spines in different shapes 
was calculated per each cell and then, those ratios of each shape type were 
pooled together. Within each shape type, the differences between groups 
were compared by using unpaired t-test. 
Those backup parameters (spine head width, spine head length, spine neck 
width, spine length, Spine head width / spine neck width, Spine head area) 
were plotted and compared by using unpaired t-test. 
The data sets were analysed with Sigmaplot 12 software (Systat Software) 
and displayed as the mean value ± SEM. Significant difference between 
 
Figure 2-5 Parameters of spine morphology classification. 
(a) Parameters of spine morphology were measured as displayed. (b) Based on the 
measured parameters, shapes of dendritic spines were categorised into filopodia, 
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groups indicates a p-value of less than 0.05 (p < 0.05) for all the statistical 
tests. 
 
2.5. Pharmacological reagents 













ab120037 10 μM ddH2O 
Bicuculline GABAAR antagonist 
Abcam 
ab120107 20 μM DMSO 
D-AP5 NMDAR antagonist 
Abcam 
ab120003 50 μM ddH2O 
IEM-1460 CP-AMPAR antagonist 
Abcam 
ab141507 50-100 μM DMSO 
Picrotoxin GABAAR antagonist 
Abcam 







ab120054 500 nM ddH2O 
 
Table 2-3 Pharmacological reagents used in the study.  
Information of the reagents and the usage of them were shown. 
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3.1.1. Imbalance of trafficking of FUS in neurodegenerative disease 
FUS is nuclear protein and dominantly localised in the nucleus about 90 % 
or more (Hock et al., 2018), however, many cases from ALS, FTLD and other 
neurodegenerative diseases found mutation of FUS caused an imbalance of 
FUS level between nucleus and cytosol (Deng et al., 2010; Neumann et al., 
2009; Svetoni et al., 2016). This imbalance of FUS trafficking was often 
suggested to be the cause of either/both the depletion of FUS in the nucleus 
and/or accumulation of cytosolic FUS (Ederle and Dormann, 2017; Ishigaki 
and Sobue, 2018). This different degree of the formation of FUS inclusions 
is suggested to be potentially due to the environmental differences between 
the nucleus and the cytosol such as different pool of DNA/RNAs (Chen, 2009; 
Yang et al., 2015) and proteins (Burke et al., 2015; Hofweber et al., 2018) 
that can interact with FUS either in the nucleus or in the cytosol. Those 
interaction may accelerate the formation of inclusions in the cytosol by 
recruiting FUS proteins into the aggregates (e.g. abnormally long mRNA can 
bind with multiple FUS proteins to accelerate cytosolic localisation of FUS 
(Tyzack et al., 2019)) or dissociate the FUS inclusions into individual FUS 
proteins by chaperoning the conformation of FUS to be less aggregative and 
import FUS into the nucleus (Guo et al., 2018). The depletion of FUS in the 
nucleus is often considered as loss-of-function because FUS is known to 
regulate the dynamics of DNA/RNA in the nucleus. Therefore, reduced 
expression or knockdown of FUS resulted in the decreased viability, impaired 
cellular proliferation and increased histone H3 phosphorylation (mitotic 
arrest), altered gene expression (either up or downregulation), loss of Gems 
(compact protein structure in the nucleus) that form complex with survival 
motor neuron (SMN) proteins and regulate small nuclear RNPs (snRNPs) for 
the splicing of RNAs, and so on (Kino et al., 2015; Ward et al., 2014; 
Yamazaki et al., 2012). While, the accumulation of FUS in the cytosol is 
frequently considered as gain-of-function because high level of cytosolic 
FUS can propagate from soma to dendrites, forms inclusions, which can 
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either accelerate or block the normal function of FUS (Kryndushkin et al., 
2011; Shelkovnikova et al., 2014) and induce neurodegeneration (Dormann 
and Haass, 2011; Naumann et al., 2018). Both depletion of FUS and 
cytosolic accumulation of FUS alter and interfere the normal roles of FUS, 
however, cytosolic accumulation of FUS is thought to be more deleterious to 
the neurons (Dormann, 2016; Scekic-Zahirovic et al., 2016) and cellular 
stress (e.g. hyperosmolar stress, irradiation and thermal stress) has been 
demonstrated to boost the effect (Higelin et al., 2016; Murakami et al., 2012). 
Then what can cause the imbalance of FUS trafficking? There are several 
possibilities but the well-characterised cause of the FUS mislocalisation is 
the mutation on the NLS domain. FUS mutations are mainly clustered in the 
NLS domain where nuclear-trafficking protein Transportin-1 (TRN-1) binds to 
(Dormann et al., 2012; Mackenzie et al., 2010b). Since FUS protein is initially 
translated in the cytoplasm, thus, once nuclear localisation mechanism is 
inhibited by NLS domain mutation, then, FUS accumulates in the cytosolic 
area and subject to form increased SG or non-SG inclusions. Therefore, 
patients with NLS mutations often show young-onset progressive clinical 
phenotypes (Shang and Huang, 2016) and NLS mutants of FUS have well-
characterised pathologic progression (e.g. mislocalisation) than the other 
mutants (Ederle and Dormann, 2017; Mackenzie et al., 2010b), therefore, 
frequently utilised as experimental models of FUS pathology. Simply, 
neuronal aging (Higelin et al., 2016) or overexpression of FUS (Mitchell et 
al., 2013) can also cause cytosolic FUS and FUS inclusions. Or, expression 
of RNAs with abnormally extended introns can also alter the normal nucleo-
cytosolic balance of FUS (Tyzack et al., 2019) as FUS can translocate from 
nucleus to the cytosol when bound with RNA (Zinszner et al., 1997). In that 
aspect, if the binding affinity between FUS and RNA is abnormally high or if 
RNA can be bound with multiple FUS proteins due to the expression of 
abnormal RNA species (e.g. mutation or abnormally increased expression), 
then FUS can be accumulated in the cytosol together with RNA. Overall, any 
mechanism that causes mislocalisation and cytosolic aggregation of FUS 
can have similar pathologic progression in the neurons. 
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3.1.2. Cytosolic FUS and morphologic changes of neurons 
Propagation and imbalanced level of cytosolic FUS will be problematic, in 
addition, FUS also has roles in the neuronal trajectories such as dendrites 
and axons. Therefore, the roles of FUS in both physiological and pathological 
situations need to be discussed. 
Even though FUS is predominantly nuclear protein, FUS is also located in 
the cytosolic space, mainly bound with mRNA, and propagate through 
dendrites and axons in the physiological conditions (Belly et al., 2005; 
Schoen et al., 2016; Yasuda et al., 2013). Therefore, FUS functions as cargo 
ship for mRNAs in the cytosolic area and through neurites (Fujii et al., 2005; 
Sahoo et al., 2018). In addition, FUS is involved in the stability of mRNAs 
(Colombrita et al., 2012) and the local translation of proteins in the axonal 
and dendritic region (López-Erauskin et al., 2018; Sahoo et al., 2018; 
Shiihashi et al., 2017). This local translation includes the essential structural 
and synaptic proteins (Fujii and Takumi, 2005; Udagawa et al., 2015; Yokoi 
et al., 2017), therefore, FUS is closely related to the neuronal morphology.  
Then, what happens to the neuronal morphology when FUS expression is 
altered? Overexpression of both wildtype and NLS mutant forms of FUS can 
cause dendritic morphologies to be less branches and spines and abnormal 
branching of axon. Overexpression of wildtype FUS and Caz (homolog of 
FUS in Drosophila), NLS mutants FUS-P525L and Caz-P398L  caused 
simplified dendritic branching and altered axonal and synaptic transport 
(Machamer et al., 2018). Mice model with FUS-R521C overexpression 
reduced dendritic spine number, maturity and dendritic length, which were 
also moderately impaired in wildtype FUS overexpression (Qiu et al., 2014). 
In other transgenic mice model with ΔNLS-FUS had phenotypes of reduced 
dendritic spines and synaptic marker proteins such as postsynaptic density 
95 (PSD95) and vesicular glutamate transporter 1 (VGLUT1) (Shiihashi et 
al., 2017). Expression of FUS-H517D and FUS-P525L mutants in human-
induced pluripotent stem cell (hiPSCs)-derived motor neurons showed 
abnormal axon branching (Akiyama et al., 2019) and reduced neurite length 
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(Ichiyanagi et al., 2016). In other study, overexpression of wildtype FUS 
doesn’t show morphological changes from transgenic mice while FUS-
R521G mice showed dendritic defects (Sephton et al., 2014), therefore, 
cytosolic FUS level is more important than total FUS regardless of FUS 
variants. In addition, depletion or knockout of FUS in the mice model also 
caused deleterious effects to the morphology such as the reduced number 
of total spines and mature spines in the dendrites (Yokoi et al., 2017), 
outlength of neurite was reduced (Ishigaki et al., 2017). Therefore, cytosolic 
level of FUS needs to be maintained to the optimal range to sustain the 
normal morphology of neurites. 
 
3.1.3. NLS mutant FUS-P525L as a tool to investigate cytosolic FUS 
FUS protein is composed of total 526 amino acids and FUS-P525L (Proline 
at 525 is substituted to Leucine) is a type of NLS mutant at C-terminus of 
FUS protein that impairs the internalisation of FUS proteins into the nucleus 
by interfering the binding between nuclear transport receptor Transportin-1 
(TRN-1) and FUS (Dormann et al., 2010). NLS mutants are dominant among 
FUS mutants that causes ALS and FUS-P525L mutation has been found and 
identified from ALS patients (Deng et al., 2014; Naumann et al., 2019). In a 
cohort study showed that among ALS cases, the percentage of FUS-P525L 
cases was 1.37 % but when it comes to the cases within FUS mutant group, 
FUS-P525L cases took about 8.44 %, therefore, it is one of the most common 
form of FUS-NLS mutants together with FUS-R521 mutants (Shang and 
Huang, 2016). The cases have been reported to express very progressive 
and early onset ALS phenotypes compared to the other FUS mutants 
(Lattante et al., 2012; Naumann et al., 2019), reported to be found more from 
female patients (Huang et al., 2010; Mochizuki et al., 2012). 
Because of this fast progression of pathology, FUS-P525L has been utilised 
and studied to investigate the mechanisms of abnormal trafficking / 
accumulation of FUS in the cytosolic compartment of neurons and 
consequential pathologies. For instance, FUS-P525L was demonstrated to 
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show abnormally reduced interaction with TRN-1 and mislocalisation of FUS 
(Neumann et al., 2012), association with stress granules (Lenzi et al., 2015), 
increased tendency to form aggregates and irreversible hydrogels (Marrone 
et al., 2020; Murakami et al., 2015), abnormal fission of mitochondria (Deng 
et al., 2015), impaired DNA damage response and repair (Wang et al., 2013) 
and altered synaptic calcium transients (Machamer et al., 2018). Like other 
FUS mutant forms, FUS-P525L doesn’t seem to be investigated intensively 
for synaptic physiology or morphology and most of studies were conducted 
with motor neurons since ALS is basically motor neurons disease. Therefore, 
it would be useful to combine FUS-P525L and hippocampal neurons to 
investigate how FUS can alter the synaptic physiology and dynamics. 
Considering previous studies, abnormal FUS translocation will alter the 
physiology of the neurons from the synapse level in the early stage before 
the neuron is progressed to cell death and this pathologic process does not 
necessarily require the alteration of FUS in the nucleus. Thus, by utilising 
NLS mutant FUS-P525L, morphology of dendritic spines was investigated to 
check the translocation pattern of cytosolic FUS through the dendrites and 
affects the morphology of dendritic spines. 
 
3.2. Results 
3.2.1. FUS-P525L mutant causes cytosolic inclusions 
As articulated previously, the NLS mutant FUS (FUS-P525L) has impaired 
trafficking ability and accumulates in the cytosolic area (Vance et al., 2013). 
To confirm that this mislocalisation of FUS occurs in our model, YFP-tagged 
wildtype FUS (FUS-WT) and FUS-P525L were overexpressed in the 
hippocampal CA1 neurons and imaged on the multiphoton microscope 
system (Fig. 3-1). FUS-WT was predominantly localised in the somatic area 
(thought to be locked in the nucleus) at 5 days after transfection (Fig. 3-1a), 
whereas FUS-P525L propagated through the dendrites and formed 
inclusions in the somatic cytosol and dendritic cytosols at 5 days after 
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transfection, which is the minimum stabilising time point after using biolistic 
transfection method (Fig. 3-1b). 
 
Propagation of FUS-P525L at different time points after transfection were 
also observed with FUS-P525L transfected CA1 neurons (Fig. 3-2). This was 
to investigate how quickly FUS-P525L can translocate from soma to the 
dendrites, therefore, electrophysiological changes can be compared and 
crosschecked in the later chapters. Two days after transfection (Fig. 3-2a), 
FUS-P525L already accumulated in somatic cytosol and formed inclusions. 
Comparing with the different cells at the same time point (Fig. 3-1b), dendritic 
propagation of FUS-P525L was variable at this stage. FUS-P525L inclusions 
(Fig. 3-2b) were formed in soma and widespread through the dendrites 
around three days after transfection, a trend that was at five (Fig. 3-2c) and 
six days (Fig. 3-2d) post transfection. In brief, cytosolic propagation of FUS-
P525L inclusions occurs at very early time point of transfection (2 days). In 
 
Figure 3-1 Confocal images of CA1 neurons with FUS-WT and FUS-P525L 
transfection. 
Each YFP-tagged FUS was imaged at DAT5 with red fluorescence structural marker, 
TdTomato on confocal spinning disk. (a) YFP-tagged FUS-WT was predominantly 
locked in the somatic region. (b) YFP-tagged FUS-P525L translocated through 
dendrites and multiple inclusions were found. The spinning disk confocal images 
were acquired from Prof. Kei Cho’s lab in King’s College London Dementia Research 
Institute (KCL-DRI). 
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contrast to FUS-P525L mutation, no FUS-WT was visible in the cytosol as it 
was still locked in the nucleus (Fig. 3-1a). 
 
Overall, within the time window for the optimal biolistic transfection method, 
FUS-WT was confined in the nucleus whereas FUS-P525L caused cytosolic 
inclusions. Due to the variability of cytosolic expression at early post 
transfection days, 5-7 days post transfection was selected further 
experiments. This post transfection time point will ensure that FUS-P525L 
propagation is consistent and saturated, while, FUS-WT is predominantly 
 
Figure 3-2 Translocation of FUS-P525L in different time points through 
dendrites. 
Multiphoton images of FUS-P525L were taken at (a) DAT2, (b) DAT3, (c) DAT5, (d) 
DAT6. From DAT2 to DAT6, YFP-tagged FUS-P525L proteins were all highly 
expressed in the cytosolic area and translocated through dendrites with significant 
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confined in the nucleus. Therefore, FUS-P525L and FUS-WT would show 
the maximised differential phenotypes of pathophysiology in terms of 
different FUS distribution. 
 
3.2.2. Dendritic spine density is reduced in FUS-P525L expressing neurons 
Since overexpression of cytosolic FUS was suggested to reduce the dendritic 
spines by trapping essential mRNAs needed for maintaining the structure of 
dendritic spines (Machamer et al., 2018; Shiihashi et al., 2017), it was 
needed to be investigated whether FUS inclusions affect the synapse 
morphology. Especially, spine density of neurons represents the connectivity 
between neurons and efficiency of synaptic transmission, therefore, spine 
density was thought to be decreased if cytosolic FUS weakens or destroys 
the synaptic connections. 
Hippocampal CA1 neurons were transfected with Venus (FUS negative), 
FUS-WT (wildtype overexpression) and FUS-P525L either with Venus or 
mCherry co-transfection, then dendritic spine density was measured from 
both basal or apical dendrites of CA1 neurons (Fig. 3-3 and Table 3-1). Due 
to the different circuitry between basal and apical dendrites as articulated in 
the section 1.3.2. (Masurkar, 2018), they were analysed separately. The data 
set was shown as Mean ± Standard Error of Mean (SEM). Hippocampal 
slices from 6 animals for Venus, 5 animals for FUS-WT and 7 animals for 
FUS-P525L were used for the results in Chapter 3 dendritic spine analysis. 
The spine density of the basal dendrites was not affected by either FUS-
P525L or FUS-WT expression (Fig. 3-3a). However, at apical dendritic 
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Figure 3-3 Spine density of apical dendrites was reduced in FUS-P525L 
expressing neurons. 
CA1 cells were transfected with Venus, FUS-WT and FUS-P525L and the dendritic 
spines were imaged at DAT5-7. Example ROI (15 μm x 15 μm) images were taken 
from each group. (a) In the basal dendritic region, spine densities did not show 
significant differences between groups. (b) Also in the apical dendritic region, spine 
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Basal dendrites Venus (V) FUS-WT (W) FUS-P525L (P) 
n-number (Cell) 12 12 10 
Spine density 
(15 µm-1) 7.27 ± 0.95 5.80 ± 0.50 7.10 ± 0.61 
p-value 
ANOVA, (W vs P), 
(V vs W), (V vs P) 
0.3027 0.4487 
0.3251 0.9849 
    
Apical dendrites Venus (V) FUS-WT (W) FUS-P525L (P) 
n-number (Cell) 18 12 10 
Spine density 
(15 µm-1) 7.25 ± 0.62 6.51 ± 0.58 5.29 ± 0.83 
p-value 
ANOVA, (W vs P), 




Overall, FUS-P525L transfection specifically reduced the number of spines 
in the apical dendrites, not in the basal dendrites whereas FUS-WT did not 
alter significant dendritic spine numbers in either region. Therefore, this data 
suggests that cytosolic inclusion of FUS induces a synapse weakening 
process through the reduction of available synapses and this may be variable 
to the different regions of dendrites. 
 
3.2.3. Effects of FUS-P525L on dendritic spine morphology 
Neuronal morphology, in particular the shape of dendritic spine is highly 
coupled to function (Bourne and Harris, 2008). The morphology of a spine 
represents the maturation, health and strength of the spines, in a manner 
governed by neuronal activity, and therefore it indicates the fate of the 
synapse (Bourne and Harris, 2008; Tønnesen and Nägerl, 2016). The most 
popular and common categories of spine morphology are filopodia, stubby, 
thin and mushroom shapes (Hering and Sheng, 2001; Rochefort and 
 
Table 3-1 Statistical summary of spine density of basal and apical dendrites in 
Venus, FUS-WT and FUS-P525L expressing neurons. 
Statistics of Fig. 3-3 was summarised as tables. 
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Konnerth, 2012). With the idea, it was of interest that whether expression of 
mutant FUS can alter the morphology of the dendritic spines because FUS 
is required for the maturation of the spines (Yokoi et al., 2017).  
The standard morphological categorisation was used as the criteria for this 
study except for the filopodia because it is often considered as immature, 
non-functional spine and was therefore excluded from the analysis. The 
mushroom shaped spines are considered to be most mature, followed by thin 
shaped and then stubby shaped spines (Ebrahimi and Okabe, 2014; 
Rochefort and Konnerth, 2012). Representative ROIs (15 μm in length) were 
extracted from basal and apical dendrites and all the spines found were 
categorised into stubby, thin and mushroom based on the length and width 
ratio (see section 2.4.2. for the criteria), then, the percentage was calculated 
for each neuron (Fig. 3-4 and Table 3-2). And measured parameters for the 
spine shape categorisation (Spine head width, Spine head length, Spine 
neck width, Spine length, Spine head width / spine head length and Spine 
head area) were also displayed as the supplementary data for basal (Fig. 3-
5 and Table 3-3) and apical (Fig. 3-6 and Table 3-4) dendritic spines. The 
data set was shown as Mean ± SEM. 
In the basal dendrites (Fig 3-4a), the percentage of stubby spines were 
higher in FUS-WT, whereas thin spines and mushroom spines did not show 
any significant differences. In apical dendrites (Fig. 3-4b), stubby spines and 
thin spines did not show significant differences but in mushroom shape, FUS-
WT was lesser than the other groups. 
Overall, although FUS-P525L expressing neurons exhibit a general 
reduction in spine density (see section 3.2.2.), they did not exhibit a change 
in the distribution of spine morphology. Surprisingly, the FUS-WT expressing 
cells had an increased percentage of stubby basal dendritic spines and 
decreased mushroom apical dendritic spines. Therefore, overall maturation 
level of dendritic spines is reduced in FUS-WT expressing cells. 
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Figure 3-4 Dendritic spine shape was not altered in FUS expressing neurons. 
(a) In basal dendrites, the ratio of different shapes of spines was not altered by FUS 
transfected neurons compared to Venus transfected neurons. (b) In apical dendrites, 
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Basal dendrites Venus (V) FUS-WT (W) FUS-P525L (P) 
n-number (Cell) 12 12 10 
Stubby 
(% Spines) 35.29 ± 3.28 45.31 ± 3.55 32.37 ± 4.32 % 
p-value 
ANOVA, (W vs P), 
(V vs W), (V vs P) 
0.0464 (F = 3.396) 0.0530 
0.1347 0.8475 
Thin 
(% Spines) 20.82 ± 2.32 14.79 ± 3.26 23.40 ± 4.55 
p-value 
ANOVA, (W vs P), 
(V vs W), (V vs P) 
0.1973 (F = 1.711) 0.1945 
0.4041 0.8560 
Mushroom 
(% Spines) 43.88 ± 2.69 39.89 ± 4.59 44.22 ± 6.02 
p-value 
ANOVA, (W vs P), 
(V vs W), (V vs P) 
0.7461 (F = 0.296) 0.7817 
0.7939 0.9985 
  
Apical dendrites Venus (V) FUS-WT (W) FUS-P525L (P) 
n-number (Cell) 18 12 10 
Stubby 
(% Spines) 36.47 ± 2.67 42.18 ± 2.79 35.77 ± 3.30 
p-value 
ANOVA, (W vs P), 
(V vs W), (V vs P) 
0.2779 (F = 1.326) 0.3491 
0.3331 0.9847 
Thin 
(% Spines) 17.01 ± 1.80 20.81 ± 4.42 20.87 ± 1.88 
p-value 
ANOVA, (W vs P), 
(V vs W), (V vs P) 
0.5074 (F = 0.6910) 0.9999 
0.5844 0.6092 
Mushroom 
(% Spines) 46.51 ± 2.94 37.01 ± 4.19 43.36 ± 3.12 
p-value 
ANOVA, (W vs P), 
(V vs W), (V vs P) 





Table 3-2 Statistical summary of dendritic spine shape of basal and apical 
dendrites in Venus, FUS-WT and FUS-P525L expressing neurons. 
Statistics of Fig. 3-4 was summarised as tables. 
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Figure 3-5 Parameters of the spine shapes were measured in basal dendritic 
spines. 
(a) Spine head width was all similar between groups. (b) Spine head length was 
similar between groups. (c) Spine neck width was similar between groups. (d) Spine 
length was longer in FUS-P525L cells. (e) Spine head width / spine neck width ratio 
did not show any difference between groups. (f) Spine head area also did not show 
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Basal dendrites Venus (V) FUS-WT (W) FUS-P525L (P) 
n-number (Cell) 12 12 10 









ANOVA, (W vs P), 
(V vs W), (V vs P) 
0.4297 (F = 0.8681) 0.9359 
0.4153 0.6592 









ANOVA, (W vs P), 
(V vs W), (V vs P) 
0.4360 (F = 0.8528) 0.6505 
0.9094 0.4132 









ANOVA, (W vs P), 
(V vs W), (V vs P) 











ANOVA, (W vs P), 
(V vs W), (V vs P) 
0.0298 (F = 3.941) 0.0253 
0.6631 0.1467 
Spine head width / 








ANOVA, (W vs P), 
(V vs W), (V vs P) 
0.7661 (F = 0.2688) 0.8811 
0.7560 0.9777 









ANOVA, (W vs P), 
(V vs W), (V vs P) 




Table 3-3 Statistical summary of parameters measured for the differentiation 
of basal dendritic spine shapes in Venus, FUS-WT and FUS-P525L expressing 
neurons. 
Statistics of Fig. 3-5 was summarised as a table. 
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Figure 3-6 Parameters of the spine shapes were measured in apical dendritic 
spines. 
(a) Spine head width was wider in FUS-WT and FUS-P525L cells. (b) Spine head 
length was longer in FUS-P525L cells. (c) Spine neck width was wider in FUS-WT 
cells. (d) Spine length was all similar between groups. (e) Spine head width / spine 
neck width ratio did not show any difference between groups. (f) Spine head area 
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Apical dendrites Venus (V) FUS-WT (W) FUS-P525L (P) 
n-number (Cell) 18 12 10 









ANOVA, (W vs P), 
(V vs W), (V vs P) 
0.0017 (F = 7.611) 0.8267 
0.0026 0.0238 









ANOVA, (W vs P), 
(V vs W), (V vs P) 
0.0174 (F = 4.531) 0.7651 
0.0972 0.0229 









ANOVA, (W vs P), 
(V vs W), (V vs P) 











ANOVA, (W vs P), 
(V vs W), (V vs P) 
0.3681 (F = 1.027) 0.6579 
0.8678 0.3349 
Spine head width / 








ANOVA, (W vs P), 
(V vs W), (V vs P) 
0.5675 (F = 0.5753) 0.8013 
0.5391 0.9454 









ANOVA, (W vs P), 
(V vs W), (V vs P) 






Table 3-4 Statistical summary of parameters measured for the differentiation 
of apical dendritic spine shapes in Venus, FUS-WT and FUS-P525L expressing 
neurons. 
Statistics of Fig. 3-6 was summarised as a table. 
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3.2.4. Local vulnerability of apical dendritic spines in FUS-P525L expressing 
neurons 
Overall spine density and shape of either basal or apical dendrites were not 
different between groups but FUS (FUS-WT and FUS-P525L) transfected 
neurons had bigger head width and area only in apical dendrites, therefore, 
still there is a possibility that spine dynamics has been locally altered in apical 
region. Due to the complex and branched structure of dendrites, they have 
difference (or gradient) of molecular and ionic dynamics between proximal 
vs distal dendrites from where dendritic branch starts (Weber et al., 2016). 
This difference may cause different degree of vulnerability caused by FUS 
expression, thus, it was of interest to further investigate whether proximal vs 
distal dendrites have different spine density upon FUS transfections. 
Raw images for spine density assay (Fig. 3-3, randomly selected ROIs) were 
re-cropped from proximal and distal part of same dendrites as pairs to 
investigate the possible local synaptic changes (Fig. 3-7 and Table 3-5). 
Counted spine density of proximal and distal dendrites were compared within 
group (Fig. 3-7a~c) and the ratio of either distal / proximal or proximal / distal 
dendritic spine density from all three groups were compared (Fig. 3-7d, e). 
The data set was shown as Mean ± SEM. 
The comparisons of proximal vs distal spines did not show any difference 
from Venus (Fig. 3-7a) and FUS-WT (Fig. 3-7b) transfected neurons, 
whereas, FUS-P525L neurons (Fig. 3-7c) showed the reduction of spine 
density in distal part. As FUS-P525L has difference between proximal vs 
distal spine density, the ratio of that also showed different trends compared 
to Venus and FUS-WT (Fig. 3-7d, e). Within ANOVA comparison (multiple 
comparison), only proximal / distal showed significance and it was not quite 
significant in distal / proximal ratio, however, T-test comparison between 
Venus vs FUS-P525L showed significance (p = 0.0407, Power: 0.552). This 
is possibly due to the relatively small size of n-number of each group. 
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Figure 3-7 Spine density and the ratio of proximal vs distal apical dendrites 
were altered in FUS-P525L expressing neurons. 
Dendritic spine images from Fig. 3-3 were re-cropped from proximal vs distal region. 
Example ROI (15 μm x 15 μm) images were taken from each group. (a) Venus 
neurons had similar number of proximal and distal dendritic spines. (b) FUS-WT 
neurons also had similar number of proximal and distal dendritic spines. (c) FUS-
P525L neurons had reduced distal dendritic spines than proximal dendrites. (d) 
Distal / Proximal ratio was slightly reduced in FUS-P525L neurons. (e) Proximal / 
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 Venus (V) FUS-WT (W) FUS-P525L (P) 
n-number (Cell) 11 11 7 
Proximal S.D.  
(15 µm-1) 9.43 ± 0.60 6.55 ± 0.68 8.35 ± 1.26 
Distal S.D.  
(15 µm-1) 8.60 ± 0.57 5.77 ± 0.79 5.00 ± 0.46 
p-value (T-test) 
(Proximal vs Distal) 0.330 0.466 
0.0284  
(Power: 0.628) 
Distal / Proximal 
Ratio 0.93 ± 0.07 0.91 ± 0.09 0.66 ± 0.11 
p-value 
ANOVA, (W vs P), 
(V vs W), (V vs P) 
0.1045 (F = 2.466) 0.1564 
0.9828 0.1170 
Proximal / Distal 
Ratio 1.12 ± 0.07 1.23 ± 0.13 1.74 ± 0.24 
p-value 
ANOVA, (W vs P), 
(V vs W), (V vs P) 
0.0188 (F = 4.650) 0.0543 
0.8445 0.0182 
 
Overall, only FUS-P525L (not FUS-WT) transfection caused local reduction 
of spine density in distal part of dendrites rather than proximal dendritic 
spines. As discussed in the session 3.2.2., this reduction was not found when 
whole dendritic spine density was compared. Therefore, cytosolic 
accumulation of FUS inclusion may cause more deleterious results to the 
distal dendrites and make distal synapses more vulnerable. 
  
 
Table 3-5 Statistical summary of spine density of proximal and distal region of 
apical dendrites in Venus, FUS-WT and FUS-P525L expressing neurons. 
Statistics of Fig. 3-7 was summarised as a table. 
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3.3.1. FUS-P525L is a proper experimental tool to investigate progressive 
cytosolic FUS proteinopathy 
This chapter investigated the effect of FUS inclusions on the morphology of 
dendritic spines of CA1 neurons. As demonstrated, NLS mutant FUS formed 
inclusions in the cytosol and fully translocated from soma to the tip of the 
dendrites at the early stage of the transfection (2 days) and it did not show 
significant difference with the spreading patterns at 4, 5 days after 
transfection. DAT 2 (2 days after transfection) is earlier than the general use 
of transfected hippocampal neurons for the electrophysiology experiments, 
which usually requires more than 2 days of stabilisation of cells and 
expression of the target genes after biolistic transfection of organotypic 
hippocampal culture slices. This progressive feature of FUS-P525L is 
consistent with the early and progressive clinical phenotypes from familiar 
patients with the NLS FUS mutants (Shang and Huang, 2016). This massive 
cytosolic translocation was not observed from FUS-WT expressing CA1 
neurons. FUS pathology is mainly defined by FUS containing inclusions in 
the neurons and these inclusions are predominantly localised in the cytosol, 
in FUS mutations both with and without the NLS mutants. Therefore, utilising 
the NLS mutant FUS (FUS-P525L) is a good tool for investigating the 
downstream pathology of cytosolic FUS inclusions. 
 
3.3.2. Different vulnerability of dendritic spines against FUS-P525L 
expression in different compartment of dendrites of CA1 neurons 
Expression of FUS-P525L did not induce massive alterations of spines on 
both basal and apical dendrites, however, it did reduce the spine density at 
the distal part of the apical dendrites. In addition, overall apical dendritic 
spine density of FUS-P525L neurons were reduced if individual ROIs were 
not averaged (data not shown). Then, why and how do FUS inclusions cause 
a region dependent pathology even though FUS inclusions are present in all 
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the way through the dendrites? The difference between apical and basal 
dendrites in terms of changes in spine density may arise from physiological 
consequences. For instance, apical dendrites receive the major excitatory 
input to CA1 neurons via the Schaffer-collateral pathway (Jarsky et al., 2005), 
which is ipsilateral pathway from CA3 neurons, whereas basal dendrites 
mainly receive inputs from CA2 in this hippocampal slice model. In addition, 
majority of excitatory inputs to CA1 are delivered to apical dendrites, whereas 
inhibitory inputs to CA1 are mainly delivered to basal dendrites (Olypher et 
al., 2012). Therefore, more excitatory input can accelerate neural activity of 
apical dendrites (rather than basal dendrites) and may affect the pathology 
of dendritic FUS inclusions (Tischbein et al., 2019). Furthermore, FUS 
inclusion may interfere molecule trafficking (Soo et al., 2015; 
Sundaramoorthy et al., 2015), therefore, FUS can trap the essential 
molecular resources (e.g. structural mRNAs, proteins), required to sustain 
the spine structure and activity, not to be delivered to the dendritic spines 
and eventually destroy the spines by stopping the synaptic dynamics and 
depletion of resources. In addition, the reduction of spines is very distinct in 
the distal area compared to the proximal area of dendrites. This might be 
closely related to the translocation of FUS because translocation of RNP is 
thought to depend on the microtubule mediated (Fujii and Takumi, 2005). 
The direction of RNP movement via microtubule is either unipolar or bipolar 
and it is bipolar in proximal, unipolar in distal dendrites (Hirokawa and 
Takemura, 2005), therefore, this polarity might have contributed the 
accumulation of FUS in the distal dendrites rather than proximal dendrites. 
Due to the complex nature of neurons, it is likely that all the hypothesis 
described above may play a synergistic part in exacerbating the pathology, 
and thereby warrant further investigation of the mechanism and clarification 
of the cause of the spine reduction whether it is due to the inhibition of spine 
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3.3.3. Abnormal expression of FUS is involved in the morphological alteration 
of dendritic spines 
FUS-P525L expressing neurons did not exhibit any change in spine shape 
compared to Venus expressing cells. This means cytosolic FUS did not 
significantly altered the overall maturity of the spines. Although, the head size 
of apical dendritic spines was bigger in both FUS-WT and FUS-P525L, thus, 
overexpression of FUS in general seem to affect dynamics of dendritic spines 
in some way. And FUS-P525L transfected cells showed distal vulnerability, 
still there is marginal chance for cytosolic FUS-P525L to translocate to distal 
part of apical dendrites and accelerate the overall growth of the spine size. If 
this growth of spine size is a part of maturation, this might have caused the 
increase of postsynaptic excitatory receptors, resulted in excitotoxicity to be 
destroyed from distal dendrites eventually. However, the major changes in 
the dendritic spine would be much complicated than it actually looks like. 
FUS is basically RNA binding protein, therefore, NLS variants (or mutants) 
of FUS can cause the alteration of the dynamics of mRNAs related to the 
spine morphology. Expression of NLS-truncated FUS (ΔNLS-FUS) showed 
the decrease of spine density in cortical neurons and also had no change of 
the portion of mature spines (Shiihashi et al., 2017), the tendency is 
consistent with this thesis study. Further investigation in that study also 
demonstrated the expression of ΔNLS-FUS reduced the expression of 
AMPA receptor subunits, trapped other mRNAs and RNPs and reduced local 
translation in the dendrites. In addition, in other study with FUS-R521C 
mutant showed that expression of that NLS mutant FUS exhibited the 
interference of DNA damage repair and reduced expression of brain-derived 
neurotrophic factor (BDNF), which is related to the generation and 
maintenance of synapses and dendrites (Qiu et al., 2014). Therefore, this 
reduced spine density can be started with the interruption of the spinogenesis 
and then co-progression with the degeneration of existing spines without 
changing the ratio of mature spines. On the other hand, overall dendritic 
spine size of FUS-WT expressing cells was increased without changing the 
number of spines. Considering the normal function of cytosolic FUS that is 
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required for the maturation of dendritic spines (Fujii and Takumi, 2005; 
Udagawa et al., 2015; Yokoi et al., 2017), FUS-WT may have slightly boosted 
the function. However, overexpressed FUS-WT was predominantly locked in 
the nucleus, the pathologic mechanism is more likely started from the inside 
of the nucleus. In addition, endogenous FUS was not knocked out, therefore, 
it is possible that FUS-WT could have boosted the leakage of FUS into the 
cytosol and caused the moderate effect similar to FUS-P525L. However, 
there is a possibility that overexpression of FUS-WT can cause opposite  
effects like autoregulation of the mRNA level of FUS, reducing the total level 
of endogenous FUS (Zhou et al., 2013). Though, the morphology of dendritic 
spines are highly dynamic and transient (Hering and Sheng, 2001), it needs 
to be careful to tell the actual status of the spines and further study would be 
required. 
In summary, NLS mutant form FUS-P525L rapidly propagated to cytosol, 
formed dendritic FUS inclusions and cause synapse weakening in the distal 
part of the apical dendrites in CA1 neurons. To investigate the further 
pathophysiological alterations of cytosolic FUS, electrophysiological 
changes were also monitored in the further studies in the next chapter.  
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4.1.1. Physiological alteration in the neurons with cytosolic FUS 
By utilising NLS mutant FUS, Chapter 3 found that propagation of cytosolic 
FUS caused weakening of synapse structure in CA1 neurons. Therefore, it 
is of interest whether the aberrant inclusions of FUS result in functional 
modifications. As articulated in the Chapter 1, it is known that FUS plays a 
key role in neuronal homeostasis, synaptic regulation of dendritic spine 
(Higelin et al., 2016). Both gain- and loss-of-function are associated with 
FUS-mediated pathologies in terms of cellular and neurophysiological 
aspects, such as alteration of gene expression, alternative splicing that are 
critical for the viability of neurons (Ishigaki and Sobue, 2018; Scekic-
Zahirovic et al., 2016). In addition, NLS mutants of FUS are also involved in 
the dysregulation of intracellular transport of essential molecules (e.g. mRNA) 
through dendrites, organelle interaction (e.g. endoplasmic reticulum (ER)-
mitochondria interaction) and maintenance of dendritic spines of the cell 
(Farg et al., 2013; Shiihashi et al., 2017; Zinszner et al., 1997). The NLS 
mutant also results in a disruption of ER-mitochondria tethering and Ca2+ 
exchange between them (Stoica et al., 2016) to perturb ATP production and 
activate GSK-3β. The activation of GSK-3β is involved in neurodegenerative 
pathologies such as Tau phosphorylation in AD pathology (Regan et al., 
2017) and the activity of GSK-3β is also increased by mutant TDP-43 
(Ambegaokar and Jackson, 2011), therefore, it suggests that FUS pathology 
shares common pathway with the other neurodegenerative pathologies 
(Stoica et al., 2016). Collectively, suggesting that cytoplasmic FUS 
aberrantly regulate cellular homeostasis, Ca2+ signalling, axonal trafficking, 
neurophysiological function. It is notable that the link between Ca2+ and 
neurodegenerative diseases has been suggested because Ca2+ is one of the 
most versatile and universal secondary messenger that participate in very 
basic functions of cells, such as growth, survival, apoptosis and regulation of 
excitability of cells (Mattson, 2007). Therefore, it is important to know how 
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dysregulation of Ca2+ kills the neurons as a significant risk factor in the 
neurodegenerative diseases (Pchitskaya et al., 2018). 
 
4.1.2. Excitotoxicity in FUS pathology  
Some evidences suggest that alteration of neuronal excitability could be the 
part of the pathophysiology during neurodegeneration (e.g. increased 
excitability can induce excitotoxicity). Specifically, dysregulation of calcium 
ion (Ca2+) in both ALS and FTLD was found to exhibit abnormal increase of 
Ca2+ permeability or decreased buffering ability of Ca2+ (Imamura et al., 2016; 
Leal and Gomes, 2015). It has been suggested that Ca2+ permeability profile 
of AMPARs can be altered in the ALS cases by the altered mRNA expression 
(Hideyama and Kwak, 2011). For instance, the NLS mutant FUS was shown 
to downregulate Gria2 (gene of GluA2) in the rodent stem cell model 
(Capauto et al., 2018), therefore, it was assumed that the overall composition 
of the AMPAR will be altered (e.g. less GluA2). The GluA2 subunit of AMPAR 
is important because it regulates the Ca2+-permeability of AMPARs (Geiger 
et al., 1995; Jonas and Burnashev, 1995; Washburn et al., 1997). The GluA2 
subunit is Ca2+-impermeable (Pachernegg et al., 2015) and included in the 
most of AMPARs (about 95% in CA1 neurons) (Lu et al., 2009). However, 
absence of the GluA2 subunit leads AMPARs which are Ca2+-permeable 
AMPARs (CP-AMPARs). In addition to the GluA2-lacking AMPARs, 
reduction of post-transcription modification of GluA2 (Q/R editing site) also 
causes the increase of CP-AMPARs (Isaac et al., 2007). Therefore, changed 
AMPAR subtypes by FUS NLS mutation could alter the intrinsic excitability 
of the neuron and induced excitotoxicity, ultimately leading to cell death. 
As articulated above, NLS mutant FUS has been reported to induce the 
excitotoxicity and neuronal death. Then, we also need to know how synapses 
are changed by NLS FUS in the cytosol before the neuron undergoes 
degeneration. The reason to investigate the electrophysiology is that these 
tools are sensitive enough to measure the electric responses from synapses, 
therefore, small alteration of the ion channel profile (e.g. ratio of subtypes or 
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number of AMPARs) on the neuronal membranes can be detected. In 
addition, the functionality of dendritic spines (e.g. local translation or 
trafficking of neurotransmitter receptors) can be tested by induction of 
synaptic plasticity (e.g. LTP and LTD). Thus, it was of interest that the 
electrophysiological patterns of synaptic changes caused by cytosolic NLS 
mutant FUS (FUS-P525L). 
 
4.2. Results 
4.2.1. Expression of FUS-P525L mutant regulates the kinetics of mEPSCs  
mEPSC represent a type of spontaneous responses caused by the release 
of a neurotransmitter vesicles from the presynaptic region (in the absence of 
action potential) and responses by receiving the neurotransmitters at the 
post-synaptic neurotransmitter receptors. Assays of mEPSC can determine 
modification of pre- and/or postsynaptic function. 
In this section, mEPSCs from FUS-P525L and FUS-WT were compared with 
those from untransfected cells to investigate whether presynaptic release of 
neurotransmitter vesicles and the profile of postsynaptic receptors was 
changed by overexpression of wildtype and/or cytosolic FUS. To monitor the 
presynaptic profile, number of mEPSC event (inter-event interval) was 
counted and to monitor the postsynaptic profile, peak amplitude, rise time 
(10% to 90% of the maximum amplitude) and decay time (90% to 10% of the 
maximum amplitude) so amount and kinetics of postsynaptic receptors can 
be calculated. Peak amplitude is strongly correlate with the number of 
synaptic neurotransmitter receptors, meanwhile, rise and decay times are 
likely to be changed by the traits or kinetic alteration of each receptor. 
Therefore, comparing peak amplitude of mEPSC with rise and decay time 
would be a good start to look at how number of receptors and kinetics are 
altered and have any correlation for those alterations. To do so, first, 
mEPSCs from each group were plotted for the comparison of peak amplitude 
vs rise time (Fig. 4-1) and peak amplitude vs decay time (Fig. 4-2) to get the 
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brief idea of the correlation between peak amplitude and the kinetics of 
mEPSC events. Hippocampal slices from 9 animals for Control, 3 animals for 
FUS-WT and 4 animals for FUS-P525L were used during the mEPSC 
experiments. 
The distribution of amplitude overlapped entire ranges of mEPSCs between 
untransfected control and FUS-P525L transfected neurons. However, FUS-
P525L expressing neurons were more widely distributed in terms of the rise 
time of mEPSCs (Fig. 4-1c) compared to untransfected (Fig. 4-1a) and FUS-
WT (Fig. 4-1b) groups. The trend was similar in the decay time of FUS-P525L 
(Fig. 4-2c) when compared to untransfected (Fig. 4-2a) and FUS-WT (Fig. 4-
2b) groups. These graphs did not show any no significant correlation 
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Figure 4-1 mEPSC comparison of peak amplitude vs rise time (10% to 90%) 
Peak amplitude vs rise time of mEPSC from (a) untransfected, (b) FUS-WT, (c) FUS-
P525L cells were plotted to check the difference of populated tendency. FUS-P525L 
showed notable decrease of rise time compared to the other groups.
Rise time 10% to 90% (ms)
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Figure 4-2 mEPSC comparison of peak amplitude vs decay time (90% to 10%) 
Peak amplitude vs decay time of mEPSC from (a) untransfected, (b) FUS-WT, (c) 
FUS-P525L cells were plotted to check the difference of populated tendency. FUS-
P525L showed notable decrease of decay time compared to the other groups.
Decay time 90% to 10%
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Next, those mEPSC events from Fig. 4-1 and Fig. 4-2 were statistically 
analysed for each parameter to investigate any alterations by FUS-P525L or 
FUS-WT expressions (Fig. 4-3, 4) (Untransfected: n = 1147 events, 20 cells, 
FUS-WT: n = 498 events, 12 cells, FUS-P525L: n = 651 events, 11 cells). 
Events from each cell were averaged for the comparison between groups. 
The data set was shown as Mean ± Standard Error of Mean (SEM). The 
amplitude of events from each group (Fig. 4-3b) did not show any statistic 
differences and distributions were similar in cumulative curves 
(Untransfected: 27.663 ± 1.217 -pA, FUS-WT: 26.612 ± 1.645 -pA, FUS-
P525L: 31.613 ± 2.327 -pA) (One-way ANOVA: p = 0.130, F = 2.148). The 
frequency of mEPSC (Fig. 4-3c) also had no statistical differences between 
groups (Untransfected: 1.1651 ± 0.2867 Hz, FUS-WT: 1.1836 ± 0.3248 Hz, 
FUS-P525L: 1.1304 ± 0.2897 Hz) (One-way ANOVA: p = 0.994, F = 0.00616). 
The rise time of mEPSC events (Fig. 4-4a) did not show any significant 
differences between groups (Untransfected: 1.337 ± 0.071 Hz, FUS-WT: 
1.315 ± 0.105 Hz, FUS-P525L: 1.269 ± 0.162 Hz) (One-way ANOVA: p = 
0.901, F = 0.104). The mEPSC event decay time (Fig. 4-4b), was also did 
not show statistical differences (Untransfected: 8.116 ± 0.307 ms, FUS-WT: 
8.275 ± 0.447 ms, FUS-P525L: 8.515 ± 0.752 ms) (One-way ANOVA: p = 
0.835, F = 0.181). Although there were no statistical differences in rise and 
decay time of mEPSC between groups, the cumulative curves with individual 
events showed shifted rise and decay time in FUS-P525L neurons that 
indicates the marginal chance of alteration by overexpression. Overall, FUS-
P525L overexpression did not show any alteration of the properties of 
mEPSC. This suggests that FUS-P525L expression did not alter the 
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Figure 4-3 Peak amplitude and frequency of mEPSC did not show statistical 
difference between untransfected and FUS-WT and FUS-P525L expressing 
neurons. 
mEPSC events from Fig. 4-1 and Fig. 4-2 were statistically compared. (a) Example 
recordings from untransfected (black), FUS-WT (blue) and FUS-P525L (red). 
Averaged mEPSC single traces were taken and the peak scale was fitted from each 
group’s one example cell. (b) Peak amplitude of mEPSC events did not show any 
statistic difference between groups. (c) Frequency of mEPSC events was not 
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4.2.2. Intrinsic excitability is increased in FUS-P525L expressing neurons 
The intrinsic excitability indicates how neurons are depolarised to fire action 
potentials. This property depends on the resting membrane potential and ion 
exchange through ion channels and receptor profile of the neuron. Therefore, 
 
Figure 4-4 Kinetics of mEPSC was faster in FUS-P525L expressing neurons. 
mEPSC events from Fig. 4-1 and Fig. 4-2 were statistically compared. (a) Cumulative 
comparison of the rise time (10% to 90%) was reduced in FUS-WT and the reduction 
was bigger in FUS-P525L cells, however, averaged values from each cell did not 
show any difference between groups. (b) Cumulative comparison of the decay time 
(90% to 10%) was significantly decreased in FUS-P525L cells, not in FUS-WT cells, 
however, averaged values from each cell did not show any difference between 
groups. Overall, FUS-P525L had events with decreased rise and decay time 
compared to untransfected and FUS-WT cells but it was not great enough to show 
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intrinsic excitability is related to the input-output of the neuron (Nelson and 
Turrigiano, 2008; Zhang and Linden, 2003). Since excitotoxicity has been 
reported in various ALS studies (Van Damme et al., 2005; King et al., 2016), 
it is important to investigate whether inclusions of FUS affect intrinsic 
excitability of the neuron. 
Firing activity experiments were conducted with CA1 neurons in the presence 
or absence of FUS-P525L or FUS-WT transfection. Transfected and 
adjacent untransfected neurons were recorded and analysed by a pair-wise 
assay within the same hippocampal slices. The main comparison parameters 
were frequency (calculated from inter-event interval) and number of firing 
activity events. The resting membrane potentials and threshold of action 
potentials were also measured for the additional profiles of cells. The data 
set was shown as Mean ± SEM for each X-axis point. Hippocampal slices 
from 7 animals for FUS-P525L, 9 animals for FUS-WT were used during the 
firing activity experiments. 
First, the intrinsic excitability of FUS-P525L expressing cells were compared 
with paired untransfected neurons (Fig. 4-5). FUS-P525L cells required a 
smaller current input (about 100 pA) to be fired when compared to the 
untransfected counterparts (about 200 pA) (Fig. 4-5a). In addition, FUS-
P525L cells had increased firing frequency overall (degree of freedom (DF) 
= 1, F = 6.141, p = 0.022, n = 22 cells each) (Fig. 4-5b) when compared with 
untransfected cells. The number of events increased until an input of 200 pA 
(DF = 1, F = 7.749, p = 0.011, n = 22 cells each) (Fig. 4-5c), when the input 
goes over 250 pA and higher, the number of events of FUS-P525L was 
saturated due to the desensitisation of the neurons and overtaken by that of 
untransfected cells, thus, overall comparison from -50 to 450 pA did not show 
the significant differences (DF = 1, F = 0.0101, p = 0.921, n = 22 cells each).  
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Next, the intrinsic excitability of FUS-WT cells was compared with 
untransfected neurons (Fig. 4-6). FUS-WT cells showed very similar firing 
pattern when compared to untransfected cells (Fig. 4-6a). Also, firing 
frequency (DF = 1, F = 2.457, p = 0.135, n = 18 cells each) (Fig. 4-6b) of 
FUS-WT showed no statistical differences from untransfected cells but the 
number of events were decreased (DF = 1, F = 5.642, p = 0.030, n = 18 cells 
each) (Fig. 4-6c). 
 
Figure 4-5 Intrinsic excitability was increased in FUS-P525L expressing 
neurons. 
(a) Example firing activity patterns by current injection of 100-450 pA in control 
neuron (black) and FUS-P525L neuron (red). (b) Frequency of firing activity in FUS-
P525L was higher at 50, 100, 150, 300, 350 pA injection and overall comparison with 
untransfected group also showed the increase of the frequency. (c) Number of firing 
event of firing activity was increased in FUS-P525L until the input of 200 pA, however, 
the number of the events was saturated from 250 pA injection, therefore, overall 
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Overall, FUS-P525L showed an increased intrinsic excitability however, 
FUS-WT did show no statistical differences in firing frequency when 
compared with untransfected counterpart but decrease in the number of 
events. This suggests that FUS can cause hyper-excitability and it leads the 
neuron to be more susceptible to the excitotoxicity in synapse. In addition, 
overexpression of wildtype FUS altered the intrinsic excitability but in the 





Figure 4-6 Intrinsic excitability was slightly decreased in FUS-WT expressing 
neurons. 
(a) Example firing activity patterns by current injection of 100-450 pA in control 
neuron (black) and FUS-WT neuron (blue). (b) Frequency of firing activity in FUS-
WT did not show any significant differences from untransfected group. (c) Number 
of firing event of firing activity was decreased at the current injection of 450 pA in 
FUS-WT cells and overall comparison with untransfected group reveals slight 
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4.2.3. Evoked basal synaptic transmission is reduced in FUS-P525L 
expressing neurons 
Evoked basal synaptic transmission to CA1 through Schaffer-collateral 
synapses are involved in cellular mechanism of learning and memory in the 
hippocampus. Since Chapter 3 showed a selective decrease of apical 
dendritic spines in FUS-P525L expressing neurons, it is of interest whether 
evoked basal synaptic transmission is affected by inclusions of FUS in CA1. 
Electrically evoked AMPAR and NMDAR-induced synaptic currents through 
Schaffer-collateral pathway were analysed to determine any alteration in the 
basal synaptic transmission of the pathway. This is essential as the AMPARs 
and NMDARs are the main synaptic components of the excitatory neurons 
in the pathway (SC to CA1). The data set was shown as Mean ± SEM. 
Hippocampal slices from 10 animals for FUS-P525L, 5 animals for FUS-WT 
were used for the basal synaptic transmission experiments. 
Both EPSCAMPA and EPSCNMDA of FUS-P525L and FUS-WT cells were paired 
and compared with adjacent untransfected cells (Fig 4-7). In the comparison 
of FUS-P525L vs untransfected cells (Fig. 4-7b, c), both EPSCAMPA (FUS-
P525L: -158.8 ± 13.0 pA, untransfected: -214.9 ± 13.5 pA, p = 0.004 (power: 
0.836), n = 25) and EPSCNMDA (FUS-P525L: 136.5 ± 16.8 pA, untransfected: 
254.8 ± 29.7 pA, p = 0.001 (power: 0.920), n = 18) were significantly reduced 
in FUS-P525L cells compared with control untransfected cells. However, in 
the FUS-WT vs untransfected cells (Fig. 4-7e, f), there were no statistical 
differences in terms of EPSCAMPA (FUS-WT: -151.0 ± 9.7 pA, untransfected: 
-187.8 ± 28.7 pA, p = 0.236, n = 13) and EPSCNMDA (FUS-WT: 128.5 ± 22.4 
pA, untransfected: 167.5 ± 31.8 pA, p = 0.327, n = 13).  
Overall, basal synaptic transmission was altered in FUS-P525L cells but not 
in FUS-WT cells. This means the postsynaptic profile of the main two 
excitatory glutamatergic receptors were altered, which may represent a 
change in the number and/or conductance of glutamate receptors.  
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Figure 4-7 Amplitudes of AMPAR and NMDAR mediated currents were smaller 
in FUS-P525L expressing neurons, not in FUS-WT expressing neurons. 
(a) Example single traces of AMPAR and NMDAR mediated currents from FUS-
P525L cell and a paired untransfected cell was displayed. (b) Average amplitudes of 
AMPAR mediated currents were smaller in FUS-P525L cells. (c) Average amplitudes 
of NMDAR mediated currents were smaller in FUS-P525L cells.  (d) Example single 
traces of AMPAR and NMDAR mediated currents from FUS-WT cell and a paired 
untransfected cell was displayed. (e) Average amplitudes of AMPAR mediated 
currents did not show any significant differences between FUS-WT cells and paired 
untransfected cells. (f) Average amplitudes of NMDAR mediated currents did not 
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4.2.4. CP-AMPAR blocker IEM-1460 attenuated the increased excitability of 
FUS-P525L mutant neurons 
The FUS-P525L induced alteration to the mEPSCs kinetics and firing activity 
suggested changes in postsynaptic function. Therefore, this chapter also 
investigates whether FUS-P525L expression dysregulates the postsynaptic 
receptor profile, specifically glutamate receptor. Since AMPAR are involved 
in generating the fast component of EPSC, a conductance change of AMPAR 
may regulate kinetics of mEPSC and increased intrinsic excitability. AMPAR 
conductance changes are mainly due to the Ca2+ permeability profile dictated 
by the GluA2 subunit (Swanson et al., 1997) (also see section 1.1.4). 
Furthermore, an increase in CP-AMPARs can directly cause increased 
neuronal excitability (Li et al., 2012). Therefore, this chapter investigated 
whether inclusion of FUS regulates CP-AMPAR and affect the intrinsic 
excitability of the neuron. The competitive, voltage-dependent open channel 
CP-AMPAR blocker IEM-1460, which blocks both GluA2-lacking and 
unedited GluA2 containing AMPARs (Schlesinger et al., 2005), was tested 
on firing activity experiments with FUS-P525L and FUS-WT transfected CA1 
cells (Fig. 4-8, 9). The data set was shown as Mean ± SEM for each X-axis 
point. Hippocampal slices from 7 animals for FUS-P525L, 5 animals for FUS-
WT were used for the firing activity experiments with IEM-1460. 
FUS-P525L cells with IEM treatment did not show the increased firing 
frequency (F = 3.296, p = 0.091, n = 15) (Fig. 4-8b) and number of events (F 
= 3.604, p = 0.078, n = 15) (Fig. 4-8c) when compared with IEM-treated 
untransfected cells. Crosschecking with FUS-WT with IEM treatment also did 
not show any alterations of firing frequency (F = 0.0216, p = 0.886, n = 12) 
(Fig. 4-9b) and number of events (F = 0.164, p = 0.694, n = 12) (Fig. 4-9c). 
Therefore, the increased intrinsic excitability caused by cytosolic FUS (FUS-
P525L) (Fig. 4-5) may have occurred due to the CP-AMPARs and this is 
consistent with the increased conductance of mEPSC (Fig. 4-1~4). However, 
it is not clear if the CP-AMPARs consist of GluA2-lacking AMPARs and/or 
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unedited GluA2-containing AMPARs, therefore, this requires further studies 




Figure 4-8 Increased intrinsic excitability in FUS-P525L expressing neurons 
was attenuated by CP-AMPAR blocker, IEM-1460. 
(a) Example firing activity patterns by current injection of 100-450 pA in control 
neuron (black) and FUS-P525L neuron (red). (b) Frequency of firing activity with 
IEM-1460 in FUS-P525L cells did not show any differences with untransfected 
counterparts. (c) Number of firing event of firing activity with IEM-1460 in FUS-P525L 
cells showed decrease at 400 pA current injection but overall comparison with 
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4.2.5. Induction of long-term synaptic plasticity was inhibited in FUS-P525L 
expressing neurons 
As articulated in the general introduction chapter 1, LTP and LTD are 
fundamental types of synaptic plasticity that regulate the efficacy of synaptic 
plasticity. For this process, neuronal input from the presynaptic neuron to the 
postsynaptic neuron needs to be delivered in the specific patterns, such as 
HFS for LTP and LFS for LTD. They are accompanied by the trafficking of 
postsynaptic surface AMPARs (Malenka and Bear, 2004). 
The experiments were performed 3-4 days after FUS-P525L transfection. 
The data set was shown as Mean ± SEM for the comparison of the post-
 
Figure 4-9 Intrinsic excitability did not show any difference between FUS-WT 
expressing neurons and untransfected neurons in the presence of CP-AMPAR 
blocker, IEM-1460. 
(a) Example firing activity patterns by current injection of 100-450 pA in control 
neuron (black) and FUS-WT neuron (blue). (b) Frequency of firing activity in FUS-
WT cells did not show any difference with untransfected counterparts. (c) Number of 
firing event of firing activity also did not show any significant difference between FUS-














● Untransfected (+IEM) (n = 12)
● FUS-WT (+IEM) (n = 12)
● Untransfected (+IEM) (n = 12)































Chapter 4  





LTP/LTD induction EPSC. Hippocampal slices from 7 animals for LTP, 11 
animals for LTD experiments were used. Induction of LTP (2 Hz, 200 pulses 
at 0 mV) (Conducted by Dr. Jee Hyun Yi) was inhibited in FUS-P525L 
transfected hippocampal CA1 cells (100.9 ± 9.4 %, n = 12) and it was 
significantly different (p = 0.00564 (power = 0.894)) from control CA1 cells 
(166.2 ± 17.5 %, n = 11) (Fig. 4-10). Induction of LTD (1 Hz, 200 pulses at -
40 mV) was inhibited in FUS-P525L transfected hippocampal CA1 cells 
(90.37 ± 7.46 %, n = 13) and it was significantly different (p = 0.00201 (power 
= 0.910)) from control CA1 cells (58.00 ± 5.93 %, n = 15) (Fig. 4-11). 
 
 
Figure 4-10 LTP induction was inhibited in FUS-P525L neurons. 
LTP was induced by 200 pulses of 2 Hz stimulation at the holding voltage of 0 mV. 
In FUS-P525L cells, LTP induction was inhibited, whereas untransfected cells 
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Overall, both LTP and LTD were inhibited by dendritic inclusions of FUS in 
CA1 neurons. This implies that pathology of cytosolic FUS is not biased to 
one direction of synaptic plasticity and it impairs the whole mechanism of 
synaptic plasticity possibly by interrupting local translation of proteins or 
mRNA trafficking into the dendrites or binding with machinery signalling 
proteins near dendritic spines, which will require further studies. This may 





Figure 4-11 LTD induction was inhibited in FUS-P525L neurons. 
LTD was induced by 200 pulses of 1 Hz stimulation at the holding voltage of -40 mV. 
In FUS-P525L cells, LTD induction was inhibited, whereas untransfected cells 
exhibited induction of LTD.  
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4.3.1. FUS-P525L alters neurophysiology of CA1 neurons  
In this chapter, physiological alterations of hippocampal neurons by NLS 
mutant form of FUS (FUS-P525L) were investigated in the comparison with 
FUS-WT. FUS-P525L expression did not alter the amplitude and frequency 
of mEPSC because single AMPAR current is about -7.2 pA (Amin et al., 2017) 
and the difference of averaged peak mEPSC amplitude from each synapse 
was only 1-2 pA, which is not enough to represent the altered number of 
AMPARs in each synapse. Rise time and decay time kinetics of mEPSC 
correlate with synaptic conductance and they were massively changed in the 
comparison of mEPSC events, however, when it comes to the averaged 
value of each cell, difference was not significant. Taking together, this would 
be more likely postsynaptic alteration of the composition of the 
neurotransmitter receptors than the total amount change of those receptors 
and these changes would be occurred only in the certain local population of 
the dendritic spines. This would be the reason why the reduction of dendritic 
spines did not correlate with the peak amplitude, frequency nor averaged 
values of synaptic kinetics. In addition, FUS-P525L expressing neurons had 
increased intrinsic excitability whereas FUS-WT neurons had decreased 
intrinsic excitability, which suggests the regulatory roles of FUS that cytosolic 
FUS boosts the excitability and nuclear FUS reduces the excitability. This 
can be multiple mechanisms but one possible scenario is the interaction 
between FUS-P525L and mitochondria that induces mitochondrial damage 
and ROS production (Deng et al., 2015) that causes the increased excitability 
of cells (Zsurka and Kunz, 2015). It is not clear how FUS-WT reduced the 
excitability but ALS mutant FUS can be related to the hypoexcitability by the 
imbalance of ion balance, specifically reduction of Na+/K+ ratio by increased 
expression of potassium channel subtypes and decreased expression of 
sodium channel subtypes (Naujock et al., 2016). It is because sodium 
channels are responsible for depolarisation to let neuron exhibit action 
potentials and then potassium channels are responsible for repolarisation to 
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let neurons to terminate the action potential and be ready for the next action 
potentials. However, further mechanism needs to be studied for more 
accurate explanations. Evoked basal synaptic transmission was decreased 
in FUS-P525L neurons and this represents the reduction of the total amount 
of AMPARs and NMDARs in the apical dendrites. Since apical dendrites of 
CA1 neuron are the main receiver of the input via Schaffer-collateral (Jarsky 
et al., 2005), these synaptic alterations by FUS-P525L expression would be 
site specific. The spine densities of overall basal or apical dendrites were not 
significantly different between FUS-P525L and other groups (Venus and 
FUS-WT), however, within apical dendrites of FUS-P525L neurons, there 
were lesser spines at the distal than proximal dendritic region. Distal 
components of dendrites are known to be more sensitive to synaptic Ca2+ 
signalling and synaptic plasticity compared to proximal dendrites (Weber et 
al., 2016), therefore, lesser spines in specific populations could be consistent 
with the reduced AMPAR- and NMDAR-mediated EPSC and it may not 
correlate with mEPSC, since mEPSC is coming from all different kinds of 
dendritic spines from proximal to distal, basal to apical dendrites. Then, 
collected data suggested the change of postsynaptic profile by cytosolic FUS 
and the relationship between FUS pathology and excitotoxicity has been 
reported in other studies (Aizawa et al., 2016; King et al., 2016; Tischbein et 
al., 2019), thus, the intrinsic excitability was examined again with CP-AMPAR 
blocker IEM-1460. As demonstrated, the increased excitability of FUS-P525L 
expressing neurons was attenuated by IEM-1460, indicating that this 
response originated from CP-AMPAR. Thus, FUS-P525L altered the 
receptor composition increasing the CP-AMPARs. And then, synaptic 
plasticity induction was tested and FUS-P525L neurons showed the inhibited 
LTP and LTD induction. As synaptic plasticity requires the local translation 
of new proteins (Costa-Mattioli et al., 2009), there would be possibilities that 
FUS-P525L may have interrupted the machinery. Or, FUS-P525L already 
could have boosted the maturation of dendritic spines by massively 
accelerating local translation of synaptic proteins such as GluA1 subunits, 
therefore, further induction of synaptic plasticity was not available. Still there 
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is a caveat that the transfection itself had slightly interfered those mechanism, 
thus, there is a room to further cross-confirm LTP and LTD results with FUS-
WT or Venus transfected neurons. 
Overall, the neurophysiology of CA1 cells, from the basal synaptic 
transmission to the intrinsic excitability and synaptic plasticity, were all 
altered by FUS-P525L expression. 
 
4.3.2. Increase of CP-AMPAR is part of FUS pathology 
It has previously been demonstrated that ALS related FUS mutation caused 
a decreased expression of Gria2 (Capauto et al., 2018). Thereby, implying a 
reduction of GluA2 subunit in total AMPARs, which would increase the 
proportion of AMPARs permeable to Ca2+. In addition, from sporadic ALS 
patients, mRNA of ADAR2 was downregulated and this caused decrease of 
GluA2 Q/R editing (target of ADAR2 activity) to increase the proportion of 
Ca2+-permeable GluA2-containing AMPARs (Yamashita and Kwak, 2014). 
The ADAR2 downregulation has been co-occurred with the fragmentation 
and aggregation of TDP-43 in TDP-43 pathology, thus, one of them could be 
considered as the upstream of the counterpart (Aizawa et al., 2010). Then, 
increase of Ca2+ by increased CP-AMPAR and the activation of a protease 
calpain were suggested as the upstream of TDP-43 cleavage and 
aggregation (Yamashita et al., 2012). Furthermore, an ALS patient with FUS 
mutant (P525L, in NLS region) showed deficiency of ADAR2 and GluA2 Q/R 
editing (Aizawa et al., 2016), therefore, FUS pathology can be closely linked 
to the increase of CP-AMPAR and Ca2+ dysregulation in the neurons. As 
articulated above, abnormal expression of FUS is responsible for the altered 
AMPAR profile by altering gene expression and/or modification of GluA2. 
This altered GluA2 expression in ALS has been suggested as one of the 
underlain mechanisms of motor neuron vulnerability, hyperexcitability and 
excitotoxicity of ALS neurons (King et al., 2016; Vandenberghe et al., 2000), 
therefore, altered ratio of AMPAR subtypes by FUS NLS mutation might have 
changed intrinsic excitability and induced excitotoxicity to cell death. 
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In addition to the roles in excitability, CP-AMPAR also has roles in other 
essential functions of neurons and possibly altered CP-AMPAR may cause 
the change of those functions during pathology. CP-AMPAR is known to 
participate in synaptic plasticity, which is different from conventional 
NMDAR-dependent LTP (Jia et al., 1996; Park et al., 2019). It has been 
shown to be involved in two steps, 1. activation of protein kinase A (PKA) for 
the phosphorylation of GluA1 at S845 to induce CP-AMPAR exocytosis and 
2. recruit peripheral CP-AMPARs into the synaptic region (Park et al., 2018). 
Step 2 is thought to be NMDAR-independent LTP and does not necessarily 
need to be consecutive to step 1 (Jia et al., 1996; Whitehead et al., 2013). 
These have been mainly demonstrated by GluA2 KO, antagonising GluA2 or 
inhibition of GluA2 editing (Okada et al., 2001). In addition, high calcium 
permeability of neuron is required for synaptogenesis and that mechanism is 
crucial during developmental period of immature brain, therefore, the 
composition of CP-AMPAR (mainly by regulating expression of GluA1:2 ratio) 
is increased during that period (Kumar et al., 2002). CP-AMPAR-mediated 
synaptic plasticity also has roles during rapid response to the neuronal 
condition such as acute stress and oligomeric Aβ treatment (Whitcomb et al., 
2015; Whitehead et al., 2013). 
Considering the roles of CP-AMPAR in the synaptic region, it would be 
plausible to think that the altered expression of CP-AMPAR by abnormal FUS 
expression would interfere synaptic plasticity. Still, this aspect requires 
further investigations and evidences to prove the direct mechanism between 
the expression of NLS mutant FUS and increased level of CP-AMPARs by 
increasing GluA2-lacking AMPARs, Q/R-unedited GluA2-containing 
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5.1.1. FUS-FUS protein interaction 
FUS and other RBPs are prone to be assembled into either heterogeneous 
SGs or non-SG aggregates that consist of predominantly FUS 
(Shelkovnikova et al., 2014). The molecular interactions of FUS are mediated 
by LC domain (Murakami et al., 2015; Murthy et al., 2019) and RGG-rich 
domains (Burke et al., 2015) and these interactions include very basic 
molecular interactions such as hydrogen bonding and hydrophobic 
interactions (Murthy et al., 2019) and also, cation-π interaction that 
modulated by arginine methylations (Fig. 5-1), which can affect the FUS-FUS 
protein interactions (Dormann et al., 2012; Rappsilber et al., 2003). This 
attractive interaction induces aggregation of FUS proteins to form liquid-
liquid phase separation (LLPS) that can constitute membrane-free 
organelles to participate in the cellular functions such as local translation or 
transport of RNA (Sephton and Yu, 2015; Weber and Brangwynne, 2012). 
Though LLPS is involved in the cellular functions, it can be an initiative 
process of FUS proteinopathy in the neurons (Murthy et al., 2019). LLPS 
state of FUS can be progressed to irreversible fibrils under certain conditions, 
such as low concentration of salt, low level of methylation (hypomethylation) 
on arginine residues (Qamar et al., 2018) or disease specific mutations on 
FUS (Murakami et al., 2015; Patel et al., 2015). And LLPS can be dissociated 
by interaction with TRN-1, ATP and single-stranded DNA (ssDNA) (Hofweber 
et al., 2018; Kang et al., 2019). Therefore, formation and dynamics of LLPS 
have been regarded as an important mechanism of FUS proteinopathy. 
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5.1.2. Pathology of hypomethylated FUS 
Aberrant aggregation of FUS, especially homogeneous self-aggregation 
caused by environmental stress or mutation on FUS itself is implicated in 
ALS, FTLD and other neurodegenerative diseases (Deng et al., 2014; Ling 
et al., 2013; Sun et al., 2011). There are similarities of FUS aggregation 
between different neurodegenerative diseases, the mechanism of 
 
Figure 5-1 Different arginine methylation species have different strength of 
cation-π interaction with tyrosine residues. 
The schematics was adapted from (Qamar et al., 2018). Cation-Α interaction 
between tyrosine and arginine residues is weak when it comes to (a) asymmetric 
dimethylated arginine (ADMA). Cation-Α interaction has intermediate interaction 
when it is (b) monomethylated arginine (MMA). Cation-Α interaction is strong when 
it is (c) unmethylated arginine (UMA). Therefore, increased number of arginine 
residues and hypomethylation of arginine residues cause stronger cation-Α 
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aggregation can be variable and excusive for the specific disease type. For 
instance, the hypomethethylation of arginine residues was found in FTLD-
FUS, which resulted in enhanced cation-π interaction, formation of LLPS and 
aggregation of FUS protein (Dormann et al., 2012; Neumann et al., 2012). 
This was further demonstrated by using the variant FUS proteins that have 
additional 6 to 21 arginine residues under the condition of hypomethylation 
(e.g. usage of arginine methyltransferase inhibitor), showing strengthened 
cation-π interaction between FUS proteins to enhanced the formation of 
hydrogel or fibrillary gel, which in turn, impaired the known functions of SGs 
(Qamar et al., 2018). Thus, it is of interest whether hypomethylated FUS 
without any mutation on NLS region results in synaptic dysfunction. 
This chapter investigated the effect of a FUS mutant (FUS-16R) with 
enhanced cation-π interaction (mimicking hypomethylating condition of FUS) 
on neuronal function and structure. With additional 16 arginine residues, 
FUS-16R may exhibit different pathological traits from FUS-P525L because 
FUS-P525L is predominantly localised in the cytosol and propagates through 
the neurites very quickly with the intact molecular interactions, on the other 
hand, FUS-16R can easily form inclusions and shows LLPS than FUS-P525L 
in both inside and outside of the nucleus (Qamar et al., 2018) and exhibits a 
slower nucleus-to-cytosol propagation speed than FUS-P525L, yet still much 
faster than FUS-WT. Therefore, FUS-16R will show the different aspects of 
FUS pathology especially focused on the LLPS nature of FUS. 
 
5.2. Results 
5.2.1. FUS-16R exhibits slow cytosolic translocation 
The translocation speed of FUS-16R was investigated to compare that with 
FUS-WT and/or FUS-P525L expression (Fig. 5-2). As FUS-16R has intact 
NLS region, FUS-16R at DAT5 still showed the predominant localisation in 
the somatic area (thought to be inside the nucleus), massively formed 
granules there with leakage into the cytosolic region through the dendrites. 
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Therefore, the granule size and the translocation speed of FUS-16R is 
possibly different from those of FUS-P525L. 
 
5.2.2. Dendritic spine density is reduced at dendrites of FUS-16R mutant 
neurons 
As articulated in the section 3.2.2., cytosolic FUS was suggested to reduce 
the dendritic spines by trapping essential mRNAs needed for maintaining the 
structure of dendritic spines (Machamer et al., 2018; Shiihashi et al., 2017). 
Since FUS-16R variant is more aggregative form compared to FUS-P525L, 
this trapping effect can be more deleterious. 
To investigate any alteration of synaptic connectivity between neurons, the 
number of dendritic spines was observed in FUS-16R expressing CA1 
neurons and compared with Venus and FUS-WT expressing neurons (Fig. 
5-3 and Table 5-1). FUS-16R cells showed lower spine density at basal 
dendrites when compared to Venus and FUS-WT cells (Fig. 5-3a). In addition, 
spine density in apical dendrites (Fig. 5-3b) also showed lower spine density 
 
Figure 5-2 Confocal images of CA1 neurons with FUS-WT and FUS-16R 
transfection. 
Each YFP-tagged FUS was imaged at DAT5 with red fluorescence structural marker, 
TdTomato on confocal spinning disk. (a) YFP-tagged FUS-WT was predominantly 
locked in the somatic region. (b) YFP-tagged FUS-16R formed granules in the 
somatic area and translocated through dendrites. The spinning disk confocal images 
were acquired from Prof. Kei Cho’s lab in King’s College London Dementia Research 
Institute (KCL-DRI). 
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in FUS-16R cells. The data set was shown as Mean ± Standard Error of 
Mean (SEM). Hippocampal slices from 6 animals for Venus, 5 animals for 
FUS-WT and 4 animals for FUS-16R were used for the results in Chapter 5 




Figure 5-3 Spine density of both basal and apical dendrites were reduced in 
FUS-16R expressing neurons. 
In addition to Venus and FUS-WT in Fig. 3-3, CA1 cells were also transfected with 
FUS-16R and the dendritic spines were imaged at DAT5-7. Example ROI (15 μm x 
15 μm) images were taken from each group. FUS-16R expressing neurons showed 
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Basal dendrites Venus (V) FUS-WT (W) FUS-16R (R) 
n-number (Cell) 12 12 13 
Spine density 
(15 µm-1) 7.27 ± 0.95 5.80 ± 0.50 3.260 ± 0.68 
p-value 
ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.0014 (F = 7.913) 0.0478 
0.3750 0.0012 
    
Apical dendrites Venus (V) FUS-WT (W) FUS-16R (R) 
n-number (Cell) 18 12 15 
Spine density 
(15 µm-1) 7.25 ± 0.62 6.51 ± 0.58 4.46 ± 0.38 
p-value 
ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.0058 (F = 5.844) 0.0719 
0.7162 0.0049 
 
Overall, spine density was reduced at both basal and apical dendrites of 
FUS-16R cells. This suggests that expression of FUS with enhanced cation-
π interaction (FUS-16R) induces synapse weakening process possibly by 
trapping essential mRNA molecules for the dendritic spine structure. 
 
5.2.3. Effects of FUS-16R mutant on dendritic spine morphology 
The shape of dendritic spine is related to the functionality and maturation 
status of the synapse as articulated in the section 3.2.3. To find out whether 
FUS with enhanced cation-π interaction would alter or inhibit the maturation 
of the spines or not, the shape of dendritic spine was compared among FUS-
16R, Venus and FUS-WT expressing neurons. As same as the previous 
chapters, the ROIs were separated into basal and apical dendrites and the 
spines were categorised into stubby, thin and mushroom then percentage 
was calculated for each neuron (Fig. 5-4 and Table 5-2) with the same 
method as used in the chapter 3. And measured parameters for the spine 
 
Table 5-1 Statistical summary of spine density of basal and apical dendrites in 
Venus, FUS-WT and FUS-16R expressing neurons. 
Statistics of Fig. 5-3 was summarised as tables. 
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shape categorisation (Spine head width, Spine head length, Spine neck 
width, Spine length, Spine head width / spine head length and Spine head 
area)  were also displayed as the supplementary data for basal (Fig. 5-5 and 
Table 5-3) and apical (Fig. 5-6 and Table 5-4) dendritic spines. The data set 
was shown as Mean ± SEM. 
 
In the basal dendrites (Fig 5-4a), the percentage of stubby spines were 
statistically similar in all the cell types and it was same for thin spines and 
mushroom spines that all did not show any significant differences between 
groups. 
In apical dendrites (Fig. 5-4b), stubby spines did not show significant 
differences but there were more thin shape spines in FUS-16R cells. And 
mushroom-shaped spines were lesser in FUS-WT and FUS-16R when 
compared to Venus cells. 
Overall, FUS-16R cells did not change the shape of the dendritic spines in 
basal dendrites but in apical dendrites, there were more thin spines and less 
mushroom spines. This data suggests that FUS with enhanced cation-π 
interaction (FUS-16R) interfered the maturation of spines possibly by 
 
Figure 5-4 Apical dendritic spine shape was altered in FUS-16R and FUS-WT 
expressing neurons. 
(a) In basal dendrites, the ratio of spine shapes did not show any alterations. (b) In 
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trapping mRNAs required for the expression of proteins for the spine 
structure. 
Basal dendrites Venus (V) FUS-WT (W) FUS-16R (R) 
n-number (Cell) 12 12 13 
Stubby 
(% Spines) 35.29 ± 3.28 45.31 ± 3.55 34.14 ± 6.66 
p-value 
ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.2244 (F = 1.562) 0.2497 
0.3377 0.9849 
Thin 
(% Spines) 20.82 ± 2.32 14.79 ± 3.26 21.30 ± 4.58 
p-value 
ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.3745 (F = 1.011) 0.4101 
0.4778 0.9950 
Mushroom 
(% Spines) 43.88 ± 2.69 39.89 ± 4.59 44.54 ± 6.79 
p-value 
ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.7874 (F = 0.2407) 0.7950 
0.8499 0.9953 
  
Apical dendrites Venus (V) FUS-WT (W) FUS-16R (R) 
n-number (Cell) 18 12 15 
Stubby 
(% Spines) 36.47 ± 2.67 42.18 ± 2.79 37.13 ± 3.32 
p-value 
ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.3808 (F = 0.9880) 0.4988 
0.3852 0.9852 
Thin 
(% Spines) 17.01 ± 1.80 20.81 ± 4.42 26.47 ± 2.77 
p-value 
ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.0617 (F = 2.979) 0.3940 
0.6320 0.0491 
Mushroom 
(% Spines) 46.51 ± 2.94 37.01 ± 4.19 36.38 ± 3.47 
p-value 
ANOVA, (W vs R), 
(V vs W), (V vs R) 




Table 5-2 Statistical summary of dendritic spine shape of basal and apical 
dendrites in Venus, FUS-WT and FUS-16R expressing neurons. 
Statistics of Fig. 5-4 was summarised as tables. 
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Figure 5-5 Parameters of the spine shapes were measured in basal dendritic 
spines. 
 (a) Spine head width was wider in FUS-16R cells. (b) Spine head length was longer 
in FUS-16R cells. (c) Spine neck width was wider in FUS-WT cells, the widest in 
FUS-16R cells. (d) Spine length did not show any difference between groups. (e) 
Spine head width / spine neck width ratio was not different between groups. (f) Spine 
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Basal dendrites Venus (V) FUS-WT (W) FUS-16R (R) 
n-number (Cell) 12 12 13 









ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.0055 (F = 6.094) 0.0834 
0.4643 0.0044 









ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.0194 (F = 4.438) 0.0607 
0.9323 0.0265 









ANOVA, (W vs R), 
(V vs W), (V vs R) 











ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.3835 (F = 0.9860) 0.3515 
0.7102 0.8247 
Spine head width / 








ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.3983 (F = 0.9460) 0.7917 
0.7604 0.3647 









ANOVA, (W vs R), 
(V vs W), (V vs R) 




Table 5-3 Statistical summary of parameters measured for the differentiation 
of basal dendritic spine shapes in Venus, FUS-WT and FUS-16R expressing 
neurons. 
Statistics of Fig. 5-5 was summarised as a table. 
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Figure 5-6 Parameters of the spine shapes were measured in apical dendritic 
spines. 
(a) Spine head width was wider in FUS-WT and FUS-16R cells. (b) Spine head 
length was longer in FUS-16R cells. (c) Spine neck width was wider in FUS-WT and 
FUS-16R cells. (d) Spine length was similar in all the 3 groups. (e) Spine head width 
/ spine neck width ratio was not different between groups. (f) Spine head area was 
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Apical dendrites Venus (V) FUS-WT (W) FUS-16R (R) 
n-number (Cell) 18 12 15 









ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.0006 (F = 9.015) 0.7764 
0.0114 0.0008 









ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.0026 (F = 6.876) 0.3052 
0.1481 0.0018 









ANOVA, (W vs R), 
(V vs W), (V vs R) 











ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.5375 (F = 0.6301) 0.9270 
0.7930 0.5164 
Spine head width / 








ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.5484 (F = 0.6095) 0.9613 
0.5629 0.7048 









ANOVA, (W vs R), 
(V vs W), (V vs R) 





Table 5-4 Statistical summary of parameters measured for the differentiation 
of apical dendritic spine shapes in Venus, FUS-WT and FUS-16R expressing 
neurons. 
Statistics of Fig. 5-6 was summarised as a table. 
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5.2.4. Apical dendritic spines in FUS-16R expressing neurons does not 
exhibit local vulnerability 
FUS-16R transfected neurons showed the reduction of spine density both in 
basal and apical dendrites and also showed bigger head area compared to 
other groups. Therefore, FUS-16R transfected neurons may exhibit much 
deleterious phenotypes compared to FUS-WT or even FUS-P525L. As 
cytosolic accumulation of FUS-P525L in the neurons showed local reduction 
of spine densities at the distal region, it could be worth to check whether 
stronger FUS-FUS interaction would exhibit similar patterns or not. With the 
same criteria, spines of proximal vs distal dendrites were investigated for 
FUS-16R transfected neurons. 
Raw images for spine density assay (Fig. 5-3, randomly selected ROIs) were 
re-cropped from proximal and distal part of same dendrites as pairs to 
investigate the possible local synaptic changes (Fig. 5-7 and Table 5-5). 
Counted spine density of proximal and distal dendrites were compared within 
group (Fig. 5-7a~c) and the ratio of either distal / proximal or proximal / distal 
dendritic spine density from all three groups were compared (Fig. 5-7d, e). 
The data set was shown as Mean ± SEM. 
The proximal vs distal spine density of FUS-16R expressing neurons (Fig. 5-
7c) did not show any difference but the distribution of data points were quite 
scattered to exhibit bigger error bars compared to Venus (Fig. 5-7a) and 
FUS-WT (Fig. 5-7b) neurons. The ratio of proximal vs distal spine density 
from FUS-16R also did not show any difference when compared to Venus 
and FUS-WT (Fig. 5-7d, e) by ANOVA tests. Those data points of FUS-16R 
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Figure 5-7 Spine density and the ratio of proximal vs distal dendrites were not 
altered in FUS-16R expressing neurons. 
Dendritic spine images from Fig. 5-3 were re-cropped from proximal vs distal region. 
Example ROI (15 μm x 15 μm) images were taken from each group. (a) Venus 
neurons had similar number of proximal and distal dendritic spines. (b) FUS-WT 
neurons also had similar number of proximal and distal dendritic spines. (c) FUS-
16R neurons also had similar number of proximal and distal dendritic spines. (d) 
Distal / Proximal ratio was all similar in all the groups. (e) Proximal / Distal ratio was 
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 Venus (V) FUS-WT (W) FUS-16R (R) 
n-number (Cell) 11 11 14 
Proximal S.D.  
(15 µm-1) 9.43 ± 0.60 6.55 ± 0.68 7.02 ± 1.19 
Distal S.D.  
(15 µm-1) 8.60 ± 0.57 5.77 ± 0.79 5.76 ± 1.19 
p-value (T-test) 
(Proximal vs Distal) 0.330 0.466 0.447 
Distal / Proximal 
Ratio 0.93 ± 0.07 0.91 ± 0.09 0.85 ± 0.11 
p-value 
ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.8235 (F = 0.1954) 0.8996 
0.9884 0.8249 
Proximal / Distal 
Ratio 1.12 ± 0.07 1.23 ± 0.13 1.71 ± 0.40 
p-value 
ANOVA, (W vs R), 
(V vs W), (V vs R) 
0.2804 (F = 1.322) 0.4420 
0.9674 0.3069 
 
Overall, FUS-16R expression did not induce local reduction of spine density, 
rather caused global reduction throughout the dendrites. The trend was 
relatively variable in FUS-16R, which indicates the effects might be acute 
than gradual pattern once deleterious mechanism is triggered by inclusions. 
Since FUS-FUS interaction is much stronger with FUS-16R than FUS-P525L, 
the nature of FUS-16R inclusions may cause more global dysfunction of 
neurons rather than infiltrate to the very local part of the dendrites. 
  
 
Table 5-5 Statistical summary of spine density of proximal and distal region of 
apical dendrites in Venus, FUS-WT and FUS-16R expressing neurons. 
Statistics of Fig. 5-7 was summarised as a table. 
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5.2.5. Intrinsic excitability is decreased in FUS-16R mutant neurons  
Intrinsic excitability was investigated by testing the input-output efficiency of 
neuron that is triggered by current injection and exhibited as action potentials 
as articulated in the section 4.2.2. To compare the intrinsic excitability of 
FUS-16R CA1 cells with untransfected control cells, firing activity 
experiments were conducted (Fig. 5-8). The data set was shown as Mean ± 
SEM for each X-axis point. Hippocampal slices from 7 animals for FUS-16R 
were used for the firing activity experiments. Firing pattern of FUS-16R cells 
generally required a similar current input to fire when compared to the 
untransfected counterpart but tend to fire slightly less with the higher current 
inputs (Fig. 5-8a). Firing frequency of FUS-16R cells were similar to 
untransfected cells (DF = 1, F = 2.975, p = 0.110, n = 13 cells each) (Fig. 5-
8b) but the number of events was fewer with the higher current input over 
250 pA (Fig. 5-8c) and there was significant differences in overall group 
comparison (DF = 1, F = 10.927, p = 0.006, n = 13 cells each) when 
compared with untransfected cells. 
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Overall, intrinsic excitability of FUS-16R cells was decreased in FUS-16R 
cells in the comparison with untransfected control cells. This suggests that 
the pathologic mechanism of FUS-16R would be more likely related to the 




Figure 5-8 Intrinsic excitability was decreased in FUS-16R expressing neurons. 
(a) Example firing activity patterns by current injection of 100-450 pA in control 
neuron (black) and FUS-16R neuron (orange). (b) Frequency of firing activity in FUS-
16R was slightly smaller at 300 pA injection but had no difference as a whole 
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5.2.6. Evoked basal synaptic transmission is reduced in FUS-16R 
expressing neurons 
Evoked basal synaptic transmission via AMPA/NMDA receptors is a 
parameter of synaptic efficacy through Schaffer-collateral pathway as 
articulated in the section 4.2.3. Therefore, to check the potential synaptic 
efficiency changes by FUS with enhanced cation-π interaction, AMPA and 
NMDA receptor mediated EPSCs were analysed in FUS-16R expressing 
neurons and compares with untransfected control neurons. The data set was 
shown as Mean ± SEM. Hippocampal slices from 9 animals for FUS-16R 
were used for the basal synaptic transmission experiments. Both EPSCAMPA 
and EPSCNMDA of FUS-16R cells were compared with paired untransfected 
cells (Fig. 5-9). When FUS-16R transfected cells and untransfected cells 
were compared in terms of EPSCAMPA (FUS-16R: - 164.5 ± 10.3 pA, 
untransfected: - 278.0 ± 37.6 pA, p = 0.006 (power: 0.807), n = 20) and 
EPSCNMDA (FUS-16R: 113.1 ± 12.8 pA, untransfected: 226.0 ± 42.0 pA, p = 
0.01 (power: 0.705), n = 20), both EPSCAMPA and EPSCNMDA were reduced 
in FUS-16R transfected cells. 
Overall, basal synaptic transmission was decreased in FUS-16R cells when 
compared to untransfected cells. This suggests that expression of FUS-16R 
weakened the synaptic strength of Schaffer-collateral pathway, which is 
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Figure 5-9 Amplitudes of AMPAR and NMDAR mediated currents were smaller 
in FUS-16R expressing neurons. 
(a) Example single traces of AMPAR and NMDAR mediated currents from FUS-16R 
cell and a paired untransfected cell was displayed. (b) Average amplitudes of 
AMPAR mediated currents were smaller in FUS-16R cells. (c) Average amplitudes 
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5.3.1. Enhanced cation-π interaction of FUS weakens the overall synaptic 
strength of CA1 neurons 
The FUS with enhanced cation-π interaction, FUS-16R, represents the 
enhanced cation-π interaction of FUS proteins by adding additional arginine 
residues to boost LLPS process as shown in the neurodegenerative diseases 
(Qamar et al., 2018). In terms of the expression of the FUS protein variant, 
FUS-16R did not show massive translocation through the dendrites as shown 
for the FUS-P525L in the section 3.2.1. This would be mainly due to the intact 
NLS region of FUS-16R. But still, FUS-16R shows more cytosolic diffusion 
compared to FUS-WT, which could be due to the milder impairment of 
nuclear localisation by interfering the interaction between FUS protein and 
TRN-1 with the hypomethylation (Hofweber et al., 2018). In terms of dendritic 
spine morphology and dynamics, FUS-16R CA1 cells showed a reduced 
spine density in both basal and apical dendrites and consistent with that, the 
glutamatergic receptor mediated basal synaptic transmission was reduced. 
As observed in the experiments, global reduction of spine density in FUS-
16R cells was different tendency from FUS-P525L cells that showed the local 
reduction of spines at the distal part of apical dendrites. Considering the 
aggregative nature of hypomethylated arginine residues, it is plausible that 
FUS-16R forms inclusions much quicker than FUS-P525L, therefore, 
average size of FUS-16R inclusions would be bigger than FUS-P525L 
inclusions that would slow down the speed of diffusion in the cytosol. In 
addition, NLS domain is intact in FUS-16R, therefore, it may start to form 
inclusions from the inside of the nucleus, disrupt the homeostasis of the 
neuron and affect the whole dendrites, rather than translocate to the 
dendrites, form the inclusions, then, alter the RNA/DNA and/or protein 
dynamics on-site as FUS-P525L would do. With the accordance to that, FUS-
16R may autoregulate the expression of endogenous FUS to reduce the total 
level of endogenous FUS and also aggregative nature of FUS-16R is more 
likely to trap other FUS proteins or essential mRNAs required for the spine 
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maturation. Thus, FUS-16R may have similar pathologic mechanism with the 
overexpression of FUS-WT but FUS-WT may exhibit much milder 
phenotypes than that of progressive FUS-16R proteins. 
 
5.3.2. FUS-16R alters neurophysiology of CA1 neurons 
In addition to the significant molecular dynamics and the alteration of the 
dendritic spine morphology, FUS-16R expressing neurons exhibited the 
altered neurophysiology of CA1 neurons. First, the glutamatergic receptor 
mediated basal synaptic transmission was reduced. Similar to FUS-P525L 
results (Fig. 4-7b, c), postsynaptic profile of main two excitatory 
glutamatergic receptors were altered and it was also consistent with the 
reduction of dendritic spine density of CA1 cells (Fig. 5-2). Those changes 
on the synapses are rely more on the FUS species with enhanced cation-π 
interaction than total level of FUS expression as FUS-WT did not alter the 
basal synaptic transmission (Fig. 4-7e, f). Therefore, NLS mutant FUS and 
FUS with enhanced cation-π interaction both has deleterious effects to the 
synapse. In addition, intrinsic excitability was rather decreased than 
increased. This could be the altered expression of sodium and potassium 
channels therefore Na+/K+ ratio was reduced and caused hypoexcitability as 
once mentioned in section 4.3.1. for the results of FUS-WT. 
Overall, these data suggest that both FUS-P525L, FUS-16R are deleterious 
to synaptic structure and function, however, the pathophysiological effects of 
the two FUS mutations likely occur via different a mechanism(s).  FUS-16R 
is mainly locked in the nucleus like FUS-WT at the early stage of transfection 
but FUS-16R forms inclusions in the nucleus and then comes out of the 
nucleus and starts to diffuse and form inclusions in the cytosols. Therefore, 
it can be suggested that FUS-16R may interrupt the normal transcription, 
alternative splicing, trafficking of mRNAs in and out of the nucleus, translation 
in the cytosol and potentially weaken both basal and apical dendrites and 
also morphological maturation of apical dendritic spines, as well. However, 
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this needs further fine investigation to know the molecular mechanism of 














6.1. The roles of FUS on synapse during the pathophysiology (Further 
discussion on findings) 
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6.1. The roles of FUS on synapse during the pathophysiology 
FUS was first identified as a novel RNA-binding protein in cancer pathology 
(Crozat et al., 1993; Rabbitts et al., 1993) and shown to be involved in the 
abnormal transcription. Furthermore, FUS is involved in the DNA repair 
(Hicks et al., 2000; Kuroda et al., 2000; Wang et al., 2013) and the gene 
expression by the association with diverse transcription factors (Riggi et al., 
2007) and related proteins such as RNA polymerase II (Bertolotti et al., 1996, 
1998). Arginine residues of FUS were reported to be dimethylated 
(Rappsilber et al., 2003) during post-translation modification and it has been 
implied to have regulatory function for FUS. 
Recent studies found that FUS emerged as an aberrantly regulated protein 
in neurodegenerative disease, especially ALS and FTLD (Kwiatkowski et al., 
2009; Lagier-Tourenne and Cleveland, 2009; Vance et al., 2009). The 
proceeding decade since its emergence, many roles of FUS in both 
physiological and pathological conditions have been found and articulated. 
Especially, FUS has been known to be recruited to the SG formation in the 
response to the diverse cellular stress such as hyperosmolar stress, heat 
shock stress, oxidative stress (Li et al., 2013; Wolozin, 2012). Since SGs are 
formed in the cytosol, NLS mutations of FUS were shown to accelerate the 
formation of cytosolic inclusions under stress conditions and disrupt normal 
functions of FUS as a DNA/RNA modulator and induce cellular toxicity. The 
NLS mutants were also demonstrated to impair fast axonal transport by 
phosphorylating and inhibiting kinesin-1 via activation of p38 mitogen-
activated protein kinases (p38 MAPK) (Sama et al., 2017). Therefore, this 
would be a part of morphological alterations by NLS mutant FUS. 
Furthermore, another RNA metabolism regulator ataxin-2 was shown to be 
co-localised with FUS in the intracellular organelles (e.g. ER-Golgi) to induce 
fragmentation of Golgi and trigger apoptosis (Farg et al., 2013). This 
apoptosis was reported from ALS patients and demonstrated to be boosted 
by NLS mutant FUS, therefore, interaction with ataxin-2 can be another 
background mechanism of the physiological alterations by NLS mutant FUS 
 
 






(Farg et al., 2013). Even though there are many interesting ideas have been 
reported, still it is difficult to draw a whole picture of the pathophysiology of 
NLS mutant FUS.  
In this PhD study, the nature and consequence of abnormal FUS variants 
were investigated in terms of the potential pathology that would be involved 
in ALS, FTLD and other possible neurodegenerative diseases. As articulated 
above, the main pathogenic factors of FUS (NLS mutation and 
hypomethylation) were utilised to investigate both morphological and 
physiological alterations by abnormal expression, propagation and 
aggregation of FUS in the neuronal cytosols. 
The key findings from the expression of NLS mutant cytosolic FUS (FUS-
P525L) can be summarised into few points. First, the translocation through 
the dendrites and the formation of inclusions were highly accelerated in the 
FUS-P525L expressing neurons. Therefore, FUS-P525L expression can 
more directly alter the dynamics of dendritic spines, locally. This will be 
involved in the alteration of the local translation in the spines to inhibit the 
induction of synaptic plasticity. Second, dendritic spine loss was exclusively 
shown in the distal part of apical dendrites rather than global loss. This 
suggests that FUS-mediated alterations make synapses vulnerable from 
distal end of the dendrites, which is possibly due to the translocation of FUS 
inclusions towards distal dendrites and accumulation at the end. In addition, 
AMPA/NMDA mediated EPSCs were decreased to be consistent with the 
reduced spines at distal part of the apical dendrites. This synapse weakening 
process can be linked to the faster conductance of synapse and increased 
intrinsic excitability in FUS-P525L neurons. Therefore, this shows the 
potential link to the excitotoxicity and increased proportion of CP-AMPAR as 
they are implied in the FUS pathology (King et al., 2016). Still the mechanism 
is not quite clear whether it is destruction of existing spines or inhibition of 
spinogenesis in the combination of excitotoxicity. However, there is a 
potential clue that synaptic plasticity in distal compartment is prone to form 
clustered spines with GluA1 subunits of AMPARs upon sensory experience 
 
 






while homeostatic enhancement (or scaling) by sensory deprivation is more 
likely global phenotype throughout the neuronal dendrites with GluA2 
subunits in layer 2/3 pyramidal neurons (Makino and Malinow, 2011). 
Therefore, it would be worthwhile to check the local alteration of the 
composition and subtypes of AMPAR than the change of the whole cell in 
the future. 
To further confirm the role(s) of dendritic inclusions of FUS on neuronal 
function, this study alternatively utilised abnormal expression of additional 
arginine mutant form FUS (FUS-16R). FUS-16R exhibited a similar but 
different pathological outcomes compared to FUS-P525L. FUS-16R was 
designed to investigate the effects of enhanced cation-π interaction and 
mimicked hypomethylation, therefore, it was mainly locked in the nucleus in 
the early stage of expression, and exhibits slower cytosolic translocation than 
that of FUS-P525L. However, FUS-16R formed inclusions quicker than FUS-
WT due to the enhanced cation-π interaction. Thus, FUS-16R likely formed 
inclusions in the nucleus before getting accumulated in the cytosol. Thus, 
FUS-16R inclusion in the nucleus might have trapped essential transcription 
factors required for the survival of the neuron to alter the profile of gene 
expression. Furthermore, this nuclear aggregation will be less likely to 
release free FUS into the dendritic region even though the inclusions can 
translocate through the dendrites. Dendritic FUS is important for the local 
translation of structural proteins (Fujii and Takumi, 2005; Yokoi et al., 2017) 
and stability of GluA1 subunits of AMPARs (Udagawa et al., 2015), thus, 
trapping free FUS may have caused the reduction of synaptic AMPARs, 
reductions of spines in both apical and basal dendrites. 
Overall, this study showed that both FUS-P525L and FUS-16R caused 
synaptic loss with the different alterations on the neuronal physiology. Still 
there would be molecular mechanisms to be discovered further to explain the 
pathology, this study demonstrated FUS can trigger either gain-of-toxicity or 
loss-of-function and both of them altered neuronal excitability and were able 
to cause the synapse weakening at the end. 
 
 






6.2. Caveats and limitations of the study 
The current PhD study found pathophysiological roles of FUS, but it also 
remains limitations to be address in the future. 
The main target FUS construct in this study, FUS-P525L, is one of the most 
popular mutant forms to investigate the pathology of ALS, FTLD and FUS 
related pathologies and it does exist in the real familiar patients. However, 
FUS-P525L represents a very rare (1.37 % of 947 cases) (Shang and Huang, 
2016) and progressive form of the disease, therefore, there would be 
possibilities that the pathologies won’t directly fit into the general forms of 
neurodegenerative diseases. However, the inclusion of FUS without NLS 
mutation has been associated with certain pathological progress in the brain 
(Aoki et al., 2012; Armstrong et al., 2011; Deng et al., 2010). This raises the 
question that FUS could be modified to be aggregated without any NLS or 
disease related mutations and subsequently affected synaptic function. 
Therefore, FUS-16R form represents an alternative experimental model. 
Overall, those FUS mutant forms are good for investigating the nature of FUS 
pathology in some aspects, but it may need further conceptual justification 
and translation into the disease model.  
Since FUS has various fundamental biological roles, I utilised an 
experimental approach to ‘overexpress the FUS mutants’ with endogenous 
FUS. Therefore, the main focus was the effects of cytosolic inclusions of FUS 
in CA1 neurons. The constructs in this study would be appropriate for 
investigating the effects of cytosolic FUS (FUS-P525L), FUS overexpression 
(FUS-WT) and enhanced FUS-FUS interactions (FUS-16R), as intended. 
Unfortunately, due to this design they won’t directly show the loss-of-function 
by nuclear depletion of FUS by NLS mutation because endogenous FUS will 
be localised in the nucleus and exhibit the normal functions. But still, there is 
a possibility of nuclear depletion even with endogenous FUS because NLS 
mutant FUS can trap those endogenous FUS by co-aggregation in the 
cytosolic area (Vance et al., 2013). 
 
 






The rodent hippocampal organotypic slice culture model is a well-established 
neuronal circuit model to investigate the physiology of neurons, however, the 
pathology of FUS is mainly exhibited in the motor neurons even though FUS 
pathology is also found in the hippocampal CA1 neurons (Armstrong et al., 
2011; MacKenzie et al., 2011). Therefore, it is good to investigate the general 
neuronal pathology of FUS in the presence of input via natural synaptic 
connections and neuronal activities and ALS/FTLD cases with cognitive 
impairments (Ishigaki and Sobue, 2018) but there can be some differences 
from the pathophysiology of motor neuronal aspects. 
 
6.3 Comparing with the other FUS mutant models and future 
possibilities 
Cytosolic mislocalisation and aggregation are the most prominent features 
of FUS-mediated pathology. Therefore, experimental models of FUS have 
focused on many NLS mutant forms (R521C, P525L or truncation of NLS, 
etc) or FUS knockout models to investigate the loss-of-function. 
Hypomethylation of arginine was also mimicked and examined to simulate 
more aggregative forms of FUS mediated pathology by reducing protein 
arginine methyltransferase 1 (PRMT1) (Hofweber et al., 2018; Tradewell et 
al., 2012) or adding additional arginine residues (Qamar et al., 2018), as 
utilised in this thesis study. 
Since expressing the FUS mutant leads to dendritic spine loss, it is of interest 
how this can be caused. To extend the study further and strengthen the direct 
connection to the pathology, it would be a good idea to utilise neuronal 
activity-dependent experimental models in the future. One of the most 
adaptable approach is utilisation of optogenetics such as channelrhodopsin-
2 (ChR2) and cryptochrome 2 (CRY2). ChR2 is a light sensitive ion channel 
that is opened by blue wavelength light, causing the influx of Na+, therefore, 
inducing action potentials. This approach may prove that additional neuronal 
activity can boost the FUS-mediated pathophysiology in CA1 neurons. Since 
hyperactivation of glutamate receptors causes neuronal excitotoxicity and 
 
 






was mediated by Ca2+ (Tischbein et al., 2019), fine tuning of the neuronal 
activity can be tested by using ChR2. In terms of CRY2, it is activated by blue 
light to be clustered to quickly form SG-like inclusions. Therefore, tagging 
FUS with CRY2 and blue light activation can simulate the LLPS of FUS (Shin 
et al., 2017) to be utilised to investigate the toxic physiology of FUS 
inclusions under spatiotemporal control of FUS-FUS interaction. 
Since a diverse range of animal models were utilised for the pathology of 
FUS from the past, it is hard to say which animal model is the best above all. 
In that sense, many different kinds of FUS models, such as yeast, fruit fly, 
nematode, zebra fish and rodent models were used to uncover the roles of 
FUS either by overexpressing or knocking out FUS-WT and/or mutant FUS 
(Lanson and Pandey, 2012). As utilised in this thesis study, rodent models 
are reliable and versatile tools to investigate the neurodegenerative diseases 
and have genetic similarities to human. It is also, there are many difficulties 
and ethical issues with using human tissues, however, it is always good to 
crosscheck with the neuronal models from human origin because there 
would be always unpredicted and possible differences between species that 
can result in misleading perspectives. One effort to challenge that difficulties 
is using induced pluripotent stem cells (iPSCs). One big advantage of iPSC 
is the source cells containing actual genes from diseased patients can be 
directly harvested and also, it is relatively free of the ethical issues. In 
addition, iPSCs can be differentiated into diverse range of cell types such as 
brain neurons and motor neurons (Rowe and Daley, 2019). However, those 
iPSC models have conceptual limitation since it does not form clustered and 
unidirectional circuits that delivers excitatory and inhibitory inputs and 
outputs, therefore, the rodent hippocampal circuit model approach is still 
valid and both iPSC and rodent models can be complimentary models for 
each other.  
 
 






6.4. Extending the study in the future 
There would be great opportunities to extend the study by utilising those 
ideas and experimental tools mentioned in section 6.3. in the future. Cry2 
domain has been conjugated to neurodegenerative disease-related proteins 
(e.g. Aβ, TDP-43 and FUS) to investigate the aggregating nature of the 
proteins (Hsien et al., 2019; Shin et al., 2017; Zhang et al., 2018). Cry2 
domain has been identified and utilised for decades, however, it is relatively 
recent for the optogenetic tool to be used for recruiting aggregative proteins 
to form inclusions. Therefore, the conjugated form of Cry2 and FUS, so-
called OptoFUS, has a lot of potential for studying physiological changes 
during aging and FUS-mediated neurodegenerations. In this thesis, NLS 
mutant FUS and enhanced cation-π form of FUS have been utilised to 
simulate cytosolic accumulation of FUS and formation of inclusions but it was 
not available to control their aggregation in a spatiotemporal manner even 
though the main purpose of the study was to investigate the dendritic 
accumulation of FUS inclusions and measure the synaptic changes. With a 
fine local photostimulation of OptoFUS to either soma or dendrites near 
spines, it would be possible to know the direct effects of FUS inclusions in 
the local area and which compartment has more toxic phenotypes. This can 
be applied together with electrophysiology and morphological changes. 
In addition to Cry2 domain, ChR2 or similar optogenetic domains would be 
utilised for the local induction of neuronal activity by photo-stimulation. The 
relationship between neuronal activity and translocation of FUS inclusions 
has been studies in some occasions, however, those studies mostly aimed 
to induce global excitotoxicity rather than local and physiological activation 
of neurons (Tischbein et al., 2019). Therefore, with ChR2, it would be 
available to investigate how physiological activity of neurons can cause 
translocation and accumulation of FUS through dendrites to result in 
excitotoxicity and/or neurodegeneration. 
Overall, simulating physiological condition would give us better insights of 
the early pathophysiology of the neurodegenerative disease.  
 
 






6.5. Linking FUS pathology models to neurodegenerative diseases 
As mentioned before, FUS is implicated in the subtypes of ALS and FTLD. 
Since TDP-43 is also pathogenic inclusion factor in ALS and FTLD, they are 
overlapped in many ways with FUS-type ALS and FTLD in the clinical 
phenotypes. Both TDP-43 and FUS form the inclusions frequently reported 
with ubiquitination (Farrawell et al., 2015; Neumann et al., 2006; Seelaar et 
al., 2010), however, the progression and pathogenic features of neuronal 
pathology between FUS and TDP-43 are quite distinct (Nolan et al., 2016). 
For instance, FUS pathology is involved in the interaction with FET protein 
(MacKenzie et al., 2011), TRN-1 (Suárez-Calvet et al., 2016) and arginine 
methylation (Guerrero et al., 2016) whereas TDP-43 pathology is involved in 
the cleavage of TDP-43 itself (Ito and Suzuki, 2011; Neumann et al., 2006). 
Furthermore, FUS inclusions from ALS-FUS and FTLD-FUS have different 
features, such as FET and TRN-1 are only found from FUS inclusions of 
FTLD-FUS (MacKenzie et al., 2011; Suárez-Calvet et al., 2016). Also in 
terms of arginine methylations, ALS-FUS inclusions are dimethylated 
(ADMA), while FTLD-FUS is either unmethylated (UMA) or monomethylated 
(MMA) (Suárez-Calvet et al., 2016). FUS mutations, especially NLS forms 
are only obvious in ALS-FUS, not in FTLD-FUS (Nolan et al., 2016), therefore, 
it is plausible to say FUS-P525L model represents more likely the pathology 
of ALS-FUS, on the other hand, FUS-16R model represents more likely the 
pathology of FTLD-FUS. 
With those distinguished pathologies in mind, fast accumulation of cytosolic 
FUS inclusions are more likely linked to ALS-FUS, therefore, most findings 
from NLS mutant form FUS-P525L might be categorised into this pathology. 
In addition, arginine methylation is mostly ADMA and NLS mutation inhibits 
TRN-1 binding, therefore, increased expression of cytosolic FUS protein 
itself is the core factor for the toxic alterations of local translations than what 
formation of irreversible inclusions do (Shiihashi et al., 2016) but still, those 
inclusions will trap the RNAs and translation related factors to accelerate the 
toxicity (Kamelgarn et al., 2018; Reber et al., 2016). Another point to be noted 
 
 






here is that excitotoxicity has been reported in a greater number of ALS than 
FTLD cases (Starr and Sattler, 2018). These previous findings are closely 
related to the increased excitability in FUS-P525L expressing neurons, which 
was not shown in FUS-16R expressing neurons in this PhD study. 
Furthermore, this excitability change is thought to be related to the increased 
composition of CP-AMPARs and altered conductance, which ended up with 
the decreased apical dendritic spines that implies it is neuronal activity-
dependent. Collecting the thoughts and data from previous studies and the 
current PhD study, high expression of cytosolic FUS (mainly FUS-P525L and 
other NLS mutant FUS) increased the synaptic component of CP-AMAPRs 
and this CP-AMPAR mediated excitotoxicity causes synaptic weakening and 
it is neuronal activity-dependent. 
On the other hand, hypomethylated (UMA and MMA) FUS inclusions are 
more likely linked to FTLD-FUS, therefore, findings from arginine mutant form 
FUS-16R might be categorised into this pathology. Hypomethylation of FUS 
causes the formation of inclusions by LLPS (Hofweber et al., 2018) both in 
and out of the nucleus even without the mutations (Snowden et al., 2011) 
and also recruits other FET proteins and TRN-1 into the inclusions (Neumann 
et al., 2011, 2012; Suárez-Calvet et al., 2016). Collectively, therefore, it can 
interrupt the homeostasis of RNAs more severely both in the nucleus and 
cytosol.  
Although distinction between ALS/FTLD-FUS pathologies, the main purpose 
of this study was to find how those dysfunctions of FUS affect the synapses 
and neuronal circuits, therefore, the aspects can be applied to any other 
types of neurons or circuits. Furthermore, the ALS/FTLD-FUS pathologies 
can show a comorbidity, and can co-exist in multiple neuron types in one 
diseased individual (Mochizuki et al., 2012) and also, other pathology-related 
proteins (e.g. TDP-43) can interact with FUS (Honda et al., 2014; Ishigaki et 
al., 2017; Ling et al., 2010). This coexpression results in numerous 
pathophysiological scenarios and eventually, it would be important to draw 










Ahmed, R.M., Devenney, E.M., Irish, M., Ittner, A., Naismith, S., Ittner, L.M., 
Rohrer, J.D., Halliday, G.M., Eisen, A., Hodges, J.R., et al. (2016). Neuronal 
network disintegration: Common pathways linking neurodegenerative 
diseases. J. Neurol. Neurosurg. Psychiatry 87, 1234–1241. 
Aizawa, H., Sawada, J., Hideyama, T., Yamashita, T., Katayama, T., Hasebe, 
N., Kimura, T., Yahara, O., and Kwak, S. (2010). TDP-43 pathology in 
sporadic ALS occurs in motor neurons lacking the RNA editing enzyme 
ADAR2. Acta Neuropathol. 120, 75–84. 
Aizawa, H., Hideyama, T., Yamashita, T., Kimura, T., Suzuki, N., Aoki, M., 
and Kwak, S. (2016). Deficient RNA-editing enzyme ADAR2 in an 
amyotrophic lateral sclerosis patient with a FUS(P525L) mutation. J. Clin. 
Neurosci. 32, 128–129. 
Akiyama, T., Suzuki, N., Ishikawa, M., Fujimori, K., Sone, T., Kawada, J., 
Funayama, R., Fujishima, F., Mitsuzawa, S., Ikeda, K., et al. (2019). Aberrant 
axon branching via Fos-B dysregulation in FUS-ALS motor neurons. 
EBioMedicine 45, 362–378. 
Allen, T.A., and Fortin, N.J. (2013). The evolution of episodic memory. Proc. 
Natl. Acad. Sci. U. S. A. 110, 10379–10386. 
Altemus, K.L., and Almli, C.R. (1997). Neonatal hippocampal damage in rats: 
Long-term spatial memory deficits and associations with magnitude of 
hippocampal damage. Hippocampus 7, 403–415. 
Ambegaokar, S.S., and Jackson, G.R. (2011). Functional genomic screen 
and network analysis reveal novel modifiers of tauopathy dissociated from 
tau phosphorylation. Hum. Mol. Genet. 20, 4947–4977. 
Amin, J.B., Salussolia, C.L., Chan, K., Regan, M.C., Dai, J., Zhou, H.X., 
Furukawa, H., Bowen, M.E., and Wollmuth, L.P. (2017). Divergent roles of a 
peripheral transmembrane segment in AMPA and NMDA receptors. J. Gen. 









Anderson, W.W., and Collingridge, G.L. (2007). Capabilities of the WinLTP 
data acquisition program extending beyond basic LTP experimental 
functions. J. Neurosci. Methods 162, 346–356. 
Andersson, M.K., Ståhlberg, A., Arvidsson, Y., Olofsson, A., Semb, H., 
Stenman, G., Nilsson, O., and Aman, P. (2008). The multifunctional FUS, 
EWS and TAF15 proto-oncoproteins show cell type-specific expression 
patterns and involvement in cell spreading and stress response. BMC Cell 
Biol. 9, 37. 
Aoki, N., Higashi, S., Kawakami, I., Kobayashi, Z., Hosokawa, M., Katsuse, 
O., Togo, T., Hirayasu, Y., and Akiyama, H. (2012). Localization of fused in 
sarcoma (FUS) protein to the post-synaptic density in the brain. Acta 
Neuropathol. 124, 383–394. 
Armstrong, R.A., Gearing, M., Bigio, E.H., Cruz-Sanchez, F.F., Duyckaerts, 
C., MacKenzie, I.R.A., Perry, R.H., Skullerud, K., Yokoo, H., and Cairns, N.J. 
(2011). The spectrum and severity of FUS-immunoreactive inclusions in the 
frontal and temporal lobes of ten cases of neuronal intermediate filament 
inclusion disease. Acta Neuropathol. 121, 219–228. 
Atkinson, R.C., and Shiffrin, R.M. (1968). Human Memory: A Proposed 
System and its Control Processes. Psychol. Learn. Motiv. 2, 89–195. 
Aulas, A., and Velde, C. Vande (2015). Alterations in stress granule 
dynamics driven by TDP-43 and FUS: A link to pathological inclusions in ALS? 
Front. Cell. Neurosci. 9, 1–13. 
Baars, B.J., Gage, N.M., Baars, B.J., and Gage, N.M. (2010). Learning and 
memory. Cogn. Brain, Conscious. 304–343. 
Baddeley, A. (2000). The episodic buffer: a new component of working 
memory? Trends Cogn. Sci. 4, 417–423. 
Baddeley, A.D., and Hitch, G. (1974). Working Memory. Psychol. Learn. 









Bamburg, J.R., and Bernstein, B.W. (2010). Roles of ADF/cofilin in actin 
polymerization and beyond. F1000 Biol. Rep. 2, 1–7. 
Beattie, E.C., Carroll, R.C., Yu, X., Morishita, W., Yasuda, H., von Zastrow, 
M., and Malenka, R.C. (2000). Regulation of AMPA receptor endocytosis by 
a signaling mechanism shared with LTD. Nat. Neurosci. 3, 1291–1300. 
Belly, A., Moreau-Gachelin, F., Sadoul, R., and Goldberg, Y. (2005). 
Delocalization of the multifunctional RNA splicing factor TLS/FUS in 
hippocampal neurones: Exclusion from the nucleus and accumulation in 
dendritic granules and spine heads. Neurosci. Lett. 379, 152–157. 
Bertolotti, A., Lutz, Y., Heard, D.J., Chambon, P., and Tora, L. (1996). 
hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-
oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA 
polymerase II. EMBO J. 15, 5022–5031. 
Bertolotti, A., Melot, T., Acker, J., Vigneron, M., Delattre, O., and Tora, L. 
(1998).  EWS, but Not EWS-FLI-1, Is Associated with Both TFIID and RNA 
Polymerase II: Interactions between Two Members of the TET Family, EWS 
and hTAF II 68, and Subunits of TFIID and RNA Polymerase II Complexes . 
Mol. Cell. Biol. 18, 1489–1497. 
Binder, J.R., and Desai, R.H. (2011). The neurobiology of semantic memory. 
Trends Cogn. Sci. 15, 527–536. 
Bliss, T. V, and Lomo, T. (1973). Long-lasting potentiation of synaptic 
transmission in the dentate area of the anaesthetized rabbit following 
stimulation of the perforant path. J. Physiol. 232, 331–356. 
Bliss, T.V.P., and Collingridge, G.L. (1993). A synaptic model of memory: 
long-term potentiation in the hippocampus. Nature 361, 31–39. 
Bliss, T.V.P., and Collingridge, G.L. (2013). Expression of NMDA receptor-
dependent LTP in the hippocampus: bridging the divide. Mol. Brain 6, 1–14. 









Long-term potentiation in the hippocampus: Discovery, mechanisms and 
function. Neuroforum 24, A103–A120. 
Blokhuis, A.M., Groen, E.J.N., Koppers, M., Van Den Berg, L.H., and 
Pasterkamp, R.J. (2013). Protein aggregation in amyotrophic lateral 
sclerosis. Acta Neuropathol. 125, 777–794. 
Borovac, J., Bosch, M., and Okamoto, K. (2018). Regulation of actin 
dynamics during structural plasticity of dendritic spines: Signaling 
messengers and actin-binding proteins. Mol. Cell. Neurosci. 91, 122–130. 
Bourne, J.N., and Harris, K.M. (2008). Balancing structure and function at 
hippocampal dendritic spines. Annu. Rev. Neurosci. 31, 47–67. 
Bowie, D., and Mayer, M.L. (1995). Inward rectification of both AMPA and 
kainate subtype glutamate receptors generated by polyamine-mediated ion 
channel block. Neuron 15, 453–462. 
Boyer, P., Phillips, J.L., Rousseau, F.L., and Ilivitsky, S. (2007). Hippocampal 
abnormalities and memory deficits: New evidence of a strong 
pathophysiological link in schizophrenia. Brain Res. Rev. 54, 92–112. 
Braak, H., and Braak, E. (1991). Neuropathological stageing of Alzheimer-
related changes. Acta Neuropathol. 82, 239–259. 
Bredt, D.S., and Nicoll, R.A. (2003). Review AMPA Receptor Trafficking at 
Excitatory Synapses Characterization of Silent Synapses A resolution came 
with the discovery of ‘silent syn-apses’ (Durand et al. Neuron 40, 361–379. 
Broadbent, N.J., Squire, L.R., and Clark, R.E. (2004). Spatial memory, 
recognition memory, and the hippocampus. Proc. Natl. Acad. Sci. 101, 
14515–14520. 
Buchsbaum, B.R., Hickok, G., and Humphries, C. (2001). Role of left 
posterior superior temporal gyrus in phonological processing for speech 
perception and production. Cogn. Sci. 25, 663–678. 









Residue View of In Vitro FUS Granules that Bind the C-Terminal Domain of 
RNA Polymerase II. Mol. Cell 60, 231–241. 
Cajal, S.R. y (1894). The Croonian lecture.—La fine structure des centres 
nerveux. Proc. R. Soc. London 55, 444–468. 
Camina, E., and Güell, F. (2017). The neuroanatomical, neurophysiological 
and psychological basis of memory: Current models and their origins. Front. 
Pharmacol. 8, 1–16. 
Von Campenhausen, S., Bornschein, B., Wick, R., Bötzel, K., Sampaio, C., 
Poewe, W., Oertel, W., Siebert, U., Berger, K., and Dodel, R. (2005). 
Prevalence and incidence of Parkinson’s disease in Europe. Eur. 
Neuropsychopharmacol. 15, 473–490. 
Capauto, D., Colantoni, A., Lu, L., Santini, T., Peruzzi, G., Biscarini, S., 
Morlando, M., Shneider, N.A., Caffarelli, E., Laneve, P., et al. (2018). A 
Regulatory Circuitry Between Gria2, miR-409, and miR-495 Is Affected by 
ALS FUS Mutation in ESC-Derived Motor Neurons. Mol. Neurobiol. 55, 
7635–7651. 
Chen, L. (2009). A global comparison between nuclear and cytosolic 
transcriptomes reveals differential compartmentalization of alternative 
transcript isoforms. Nucleic Acids Res. 38, 1086–1097. 
Citri, A., and Malenka, R.C. (2008). Synaptic plasticity: Multiple forms, 
functions, and mechanisms. Neuropsychopharmacology 33, 18–41. 
Clayton, N.S., and Dickinson, A. (1998). Episodic-like memory during cache 
recovery by scrub jays. Nature 395, 272–274. 
Collingridge, G. (1987). The role of NMDA receptors in learning and memory. 
Nature 330, 604–605. 
Collingridge, G.L., Isaac, J.T.R.R., Yu, T.W., and Wang, Y.T. (2004). 
Receptor trafficking and synaptic plasticity. Nat. Rev. Neurosci. 5, 952–962. 









Silani, V., and Ratti, A. (2012). TDP-43 and FUS RNA-binding proteins bind 
distinct sets of cytoplasmic messenger RNAs and differently regulate their 
post-transcriptional fate in motoneuron-like cells. J. Biol. Chem. 287, 15635–
15647. 
Costa-Mattioli, M., Sossin, W.S., Klann, E., and Sonenberg, N. (2009). 
Translational control of long-lasting synaptic plasticity and memory. Neuron 
61, 10–26. 
Cowan, N. (2008). What are the differences between long-term, short-term, 
and working memory? Prog. Brain Res. 169, 323–338. 
Crozat, A., Aman, P., Mandahl, N., and Ron, D. (1993). Fusion of CHOP to 
a novel RNA-binding protein in human myxoid liposarcoma. Nature 363, 
640–644. 
Van Damme, P., Dewil, M., Robberecht, W., and Van Den Bosch, L. (2005). 
Excitotoxicity and amyotrophic lateral sclerosis. Neurodegener. Dis. 2, 147–
159. 
Deng, H., Gao, K., and Jankovic, J. (2014). The role of FUS gene variants in 
neurodegenerative diseases. Nat. Rev. Neurol. 10, 337–348. 
Deng, H.X., Zhai, H., Bigio, E.H., Yan, J., Fecto, F., Ajroud, K., Mishra, M., 
Ajroud-Driss, S., Heller, S., Sufit, R., et al. (2010). FUS-immunoreactive 
inclusions are a common feature in sporadic and non-SOD1 familial 
amyotrophic lateral sclerosis. Ann. Neurol. 67, 739–748. 
Deng, J., Yang, M., Chen, Y., Chen, X., Liu, J., Sun, S., Cheng, H., Li, Y., 
Bigio, E.H., Mesulam, M., et al. (2015). FUS Interacts with HSP60 to Promote 
Mitochondrial Damage. PLoS Genet. 11, 1–30. 
Dingledine, R., Borges, K., Bowie, D., and Traynelis, S.F. (1999). The 
glutamate receptor ion channels. Pharmacol. Rev. 51, 7–61. 
Djinovic-Carugo, K., Young, P., Gautel, M., and Saraste, M. (1999). Structure 









Actinin is composed of an amino-terminal actin-binding region consisting of 
two calponin homology (CH) domains, a central rod containing four spectrin-
like re. Cell 98, 537–546. 
Dong, H., O’Brien, R.J., Fung, E.T., Lanahan, A.A., Worley, P.F., and 
Huganir, R.L. (1997). GRIP: a synaptic PDZ domain-containing protein that 
interacts with AMPA receptors. Nature 386, 279–284. 
Dormann, D. (2016).  FUS cinating insights into motor neuron degeneration . 
EMBO J. 35, 1015–1017. 
Dormann, D., and Haass, C. (2011). TDP-43 and FUS: A nuclear affair. 
Trends Neurosci. 34, 339–348. 
Dormann, D., and Haass, C. (2013). Fused in sarcoma (FUS): An oncogene 
goes awry in neurodegeneration. Mol. Cell. Neurosci. 56, 475–486. 
Dormann, D., Rodde, R., Edbauer, D., Bentmann, E., Fischer, I., Hruscha, 
A., Than, M.E., MacKenzie, I.R.A., Capell, A., Schmid, B., et al. (2010). ALS-
associated fused in sarcoma (FUS) mutations disrupt transportin-mediated 
nuclear import. EMBO J. 29, 2841–2857. 
Dormann, D., Madl, T., Valori, C.F., Bentmann, E., Tahirovic, S., Abou-Ajram, 
C., Kremmer, E., Ansorge, O., MacKenzie, I.R.A., Neumann, M., et al. (2012). 
Arginine methylation next to the PY-NLS modulates Transportin binding and 
nuclear import of FUS. EMBO J. 31, 4258–4275. 
Douglas, R.M., and Goddard, G. V. (1975). Long-term potentiation of the 
perforant path-granule cell synapse in the rat hippocampus. Brain Res. 86, 
205–215. 
Easton, A., Webster, L.A.D., and Eacott, M.J. (2012). The episodic nature of 
episodic-like memories. Learn. Mem. 19, 146–150. 
Ebrahimi, S., and Okabe, S. (2014). Structural dynamics of dendritic spines: 
Molecular composition, geometry and functional regulation. Biochim. 









Ederle, H., and Dormann, D. (2017). TDP-43 and FUS en route from the 
nucleus to the cytoplasm. FEBS Lett. 591, 1489–1507. 
Eichenbaum, H. (2004). Hippocampus: Cognitive Processes and Neural 
Representations that Underlie Declarative Memory. Neuron 44, 109–120. 
Erkkinen, M.G., Kim, M., and Geschwind, M.D. (2019). Major 
Neurodegenerative Diseases. 
Farg, M.A., Soo, K.Y., Warraich, S.T., Sundaramoorthy, V., Blair, I.P., and 
Atkin, J.D. (2013). Ataxin-2 interacts with FUS and intermediate-length 
polyglutamine expansions enhance FUS-related pathology in amyotrophic 
lateral sclerosis. Hum. Mol. Genet. 22, 717–728. 
Farrawell, N.E., Lambert-Smith, I.A., Warraich, S.T., Blair, I.P., Saunders, 
D.N., Hatters, D.M., and Yerbury, J.J. (2015). Distinct partitioning of ALS 
associated TDP-43, FUS and SOD1 mutants into cellular inclusions. Sci. Rep. 
5, 1–14. 
Finkel, A., Wittel, A., Yang, N., Handran, S., Hughes, J., and Costantin, J. 
(2006). Population patch clamp improves data consistency and success 
rates in the measurement of ionic currents. J. Biomol. Screen. 11, 488–496. 
Van Der Flier, W.M., and Scheltens, P. (2005). Epidemiology and risk factors 
of dementia. Neurol. Pract. 76, 2–7. 
Fu, H., Hardy, J., and Duff, K.E. (2018). Selective vulnerability in 
neurodegenerative diseases. Nat. Neurosci. 21, 1350–1358. 
Fujii, R., and Takumi, T. (2005). TLS facilitates transport of mRNA encoding 
an actin-stabilizing protein to dendritic spines. J. Cell Sci. 118, 5755–5765. 
Fujii, R., Okabe, S., Urushido, T., Inoue, K., Yoshimura, A., Tachibana, T., 
Nishikawa, T., Hicks, G.G., and Takumi, T. (2005). The RNA binding protein 
TLS is translocated to dendritic spines by mGluR5 activation and regulates 
spine morphology. Curr. Biol. 15, 587–593. 









Katsuno, M., Ohno, K., and Sobue, G. (2013). FUS-regulated region- and 
cell-type-specific transcriptome is associated with cell selectivity in 
ALS/FTLD. Sci. Rep. 3. 
Gallagher, M. (1997). Animal models of memory impairment. Philos. Trans. 
R. Soc. B Biol. Sci. 352, 1711–1717. 
Gan, L., Cookson, M.R., Petrucelli, L., and La Spada, A.R. (2018). 
Converging pathways in neurodegeneration, from genetics to mechanisms. 
Nat. Neurosci. 21, 1300–1309. 
Geiger, J.R.P., Melcher, T., Koh, D.S., Sakmann, B., Seeburg, P.H., Jonas, 
P., and Monyer, H. (1995). Relative abundance of subunit mRNAs 
determines gating and Ca2+ permeability of AMPA receptors in principal 
neurons and interneurons in rat CNS. Neuron 15, 193–204. 
Goedert, M., Clavaguera, F., and Tolnay, M. (2010). The propagation of 
prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci. 
33, 317–325. 
Golde, T.E., and Miller, V.M. (2009). Proteinopathy-induced neuronal 
senescence: a hypothesis for brain failure in Alzheimer’s and other 
neurodegenerative diseases. Alzheimers. Res. Ther. 1, 5. 
Golpich, M., Amini, E., Mohamed, Z., Azman Ali, R., Mohamed Ibrahim, N., 
and Ahmadiani, A. (2017). Mitochondrial Dysfunction and Biogenesis in 
Neurodegenerative diseases: Pathogenesis and Treatment. CNS Neurosci. 
Ther. 23, 5–22. 
Gomez-Pastor, R., Burchfiel, E.T., Neef, D.W., Jaeger, A.M., Cabiscol, E., 
McKinstry, S.U., Doss, A., Aballay, A., Lo, D.C., Akimov, S.S., et al. (2017). 
Abnormal degradation of the neuronal stress-protective transcription factor 
HSF1 in Huntington’s disease. Nat. Commun. 8, 1–17. 
Greger, I.H., Watson, J.F., and Cull-Candy, S.G. (2017). Structural and 
Functional Architecture of AMPA-Type Glutamate Receptors and Their 









Gregory, R.I., Yan, K.P., Amuthan, G., Chendrimada, T., Doratotaj, B., 
Cooch, N., and Shiekhattar, R. (2004). The Microprocessor complex 
mediates the genesis of microRNAs. Nature 432, 235–240. 
Guerrero, E.N., Wang, H., Mitra, J., Hegde, P.M., Stowell, S.E., Liachko, N.F., 
Kraemer, B.C., Garruto, R.M., Rao, K.S., and Hegde, M.L. (2016). TDP-
43/FUS in motor neuron disease: Complexity and challenges. Prog. 
Neurobiol. 145–146, 78–97. 
Guo, L., Kim, H.J., Wang, H., Monaghan, J., Freyermuth, F., Sung, J.C., 
O’Donovan, K., Fare, C.M., Diaz, Z., Singh, N., et al. (2018). Nuclear-Import 
Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins 
with Prion-like Domains. Cell 173, 677-692.e20. 
Haass, C., and Selkoe, D.J. (2007). Soluble protein oligomers in 
neurodegeneration: Lessons from the Alzheimer’s amyloid β-peptide. Nat. 
Rev. Mol. Cell Biol. 8, 101–112. 
Hebb, D.O. (1949). The organization of behavior; a neuropsychological 
theory. (Oxford,  England: Wiley). 
Hee Jung Chung, Xia, J., Scannevin, R.H., Zhang, X., and Huganir, R.L. 
(2000). Phosphorylation of the AMPA receptor subunit GluR2 differentially 
regulates its interaction with PDZ domain-containing proteins. J. Neurosci. 
20, 7258–7267. 
Hely, M.A., Reid, W.G.J., Adena, M.A., Halliday, G.M., and Morris, J.G.L. 
(2008). The Sydney Multicenter Study of Parkinson’s disease: The 
inevitability of dementia at 20 years. Mov. Disord. 23, 837–844. 
Henriksen, E.J., Colgin, L.L., Barnes, C.A., Witter, M.P., Moser, M.B., and 
Moser, E.I. (2010). Spatial representation along the proximodistal axis of 
CA1. Neuron 68, 127–137. 
Hering, H., and Sheng, M. (2001). Dentritic spines: structure, dynamics and 









Hicks, G.G., Singh, N., Nashabi, A., Mai, S., Bozek, G., Klewes, L., Arapovic, 
D., White, E.K., Koury, M.J., Oltz, E.M., et al. (2000). Fus deficiency in mice 
results in defective B-lymphocyte development and activation, high levels of 
chromosomal instability and perinatal death. Nat. Genet. 24, 175–179. 
Hideyama, T., and Kwak, S. (2011). When Does ALS Start? ADAR2?GluA2 
Hypothesis for the Etiology of Sporadic ALS. Front. Mol. Neurosci. 4, 1–11. 
Higelin, J., Demestre, M., Putz, S., Delling, J.P., Jacob, C., Lutz, A.-K., 
Bausinger, J., Huber, A.-K., Klingenstein, M., Barbi, G., et al. (2016). FUS 
Mislocalization and Vulnerability to DNA Damage in ALS Patients Derived 
hiPSCs and Aging Motoneurons. Front. Cell. Neurosci. 10, 1–21. 
Hirokawa, N., and Takemura, R. (2005). Molecular motors and mechanisms 
of directional transport in neurons. Nat. Rev. Neurosci. 6, 201–214. 
Hjelmstad, G.O., Nicoll, R.A., and Malenka, R.C. (1997). Synaptic refractory 
period provides a measure of probability of release in the hippocampus. 
Neuron 19, 1309–1318. 
Ho, V.M., Lee, J.A., and Martin, K.C. (2011). The cell biology of synaptic 
plasticity. Science (80-. ). 334, 623–628. 
Hock, E.M., Maniecka, Z., Hruska-Plochan, M., Reber, S., Laferrière, F., 
Sahadevan M.K., S., Ederle, H., Gittings, L., Pelkmans, L., Dupuis, L., et al. 
(2018). Hypertonic Stress Causes Cytoplasmic Translocation of Neuronal, 
but Not Astrocytic, FUS due to Impaired Transportin Function. Cell Rep. 24, 
987-1000.e7. 
Hofweber, M., Hutten, S., Bourgeois, B., Spreitzer, E., Niedner-Boblenz, A., 
Schifferer, M., Ruepp, M.D., Simons, M., Niessing, D., Madl, T., et al. (2018). 
Phase Separation of FUS Is Suppressed by Its Nuclear Import Receptor and 
Arginine Methylation. Cell 173, 706-719.e13. 
Hogan, D.B., Jetté, N., Fiest, K.M., Roberts, J.I., Pearson, D., Smith, E.E., 
Roach, P., Kirk, A., Pringsheim, T., and Maxwell, C.J. (2016). The prevalence 









Neurol. Sci. 43, S96–S109. 
Honda, D., Ishigaki, S., Iguchi, Y., Fujioka, Y., Udagawa, T., Masuda, A., 
Ohno, K., Katsuno, M., and Sobue, G. (2014). The ALS/FTLD-related RNA-
binding proteins TDP-43 and FUS have common downstream RNA targets 
in cortical neurons. FEBS Open Bio 4, 1–10. 
Hotulainen, P., and Hoogenraad, C.C. (2010). Actin in dendritic spines: 
Connecting dynamics to function. J. Cell Biol. 189, 619–629. 
Hsien, L.C., Kaur, P., Teo, E., Lam, V., Zhu, F., Kibat, C., Mathuru, A., Gruber, 
J., and Tolwinski, N.S. (2019). Application of Optogenetic Amyloid-β 
Distinguishes Between Metabolic and Physical Damage in 
Neurodegeneration. BioRxiv 1–21. 
Huang, E.J., Zhang, J., Geser, F., Trojanowski, J.Q., Strober, J.B., Dickson, 
D.W., Brown, R.H., Shapiro, B.E., and Lomen-Hoerth, C. (2010). Extensive 
FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with 
basophilic inclusions. Brain Pathol. 20, 1069–1076. 
Ichetovkin, I., Grant, W., and Condeelis, J. (2002). Cofilin produces newly 
polymerized actin filaments that are preferred for dendritic nucleation by the 
Arp2/3 complex. Curr. Biol. 12, 79–84. 
Ichiyanagi, N., Fujimori, K., Yano, M., Ishihara-Fujisaki, C., Sone, T., 
Akiyama, T., Okada, Y., Akamatsu, W., Matsumoto, T., Ishikawa, M., et al. 
(2016). Establishment of in Vitro FUS-Associated Familial Amyotrophic 
Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells. Stem 
Cell Reports 6, 496–510. 
Imamura, K., Sahara, N., Kanaan, N.M., Tsukita, K., Kondo, T., Kutoku, Y., 
Ohsawa, Y., Sunada, Y., Kawakami, K., Hotta, A., et al. (2016). Calcium 
dysregulation contributes to neurodegeneration in FTLD patient iPSC-
derived neurons. Sci. Rep. 6, 34904. 
Ionescu-Zanetti, C., Shaw, R.M., Seo, J., Jan, Y.N., Jan, L.Y., and Lee, L.P. 









Acad. Sci. U. S. A. 102, 9112–9117. 
Irish, M., and Piguet, O. (2013). The pivotal role of semantic memory in 
remembering the past and imagining the future. Front. Behav. Neurosci. 7, 
1–11. 
Isaac, J.T.R., Ashby, M., and McBain, C.J. (2007). The Role of the GluR2 
Subunit in AMPA Receptor Function and Synaptic Plasticity. Neuron 54, 
859–871. 
Ishigaki, S., and Sobue, G. (2018). Importance of functional loss of FUS in 
FTLD/ALS. Front. Mol. Biosci. 5, 1–8. 
Ishigaki, S., Fujioka, Y., Okada, Y., Riku, Y., Udagawa, T., Honda, D., Yokoi, 
S., Endo, K., Ikenaka, K., Takagi, S., et al. (2017). Altered Tau Isoform Ratio 
Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes. 
Cell Rep. 18, 1118–1131. 
Ito, D., and Suzuki, N. (2011). Conjoint pathologic cascades mediated by 
ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS. Neurology 77, 
1636–1643. 
Jarrard, L.E. (1993). On the role of the hippocampus in learning and memory 
in the rat. Behav. Neural Biol. 60, 9–26. 
Jarsky, T., Roxin, A., Kath, W.L., and Spruston, N. (2005). Conditional 
dendritic spike propagation following distal synaptic activation of 
hippocampal CA1 pyramidal neurons. Nat. Neurosci. 8, 1667–1676. 
Jia, Z., Agopyan, N., Miu, P., Xiong, Z., Henderson, J., Gerlai, R., Taverna, 
F.A., Velumian, A., MacDonald, J., Carlen, P., et al. (1996). Enhanced LTP 
in mice deficient in the AMPA receptor GluR2. Neuron 17, 945–956. 
Jonas, P., and Burnashev, N. (1995). Molecular mechanisms controlling 
calcium entry through AMPA-type glutamate receptor channels. Neuron 15, 
987–990. 









Alzheimer disease and other neurodegenerative disorders. Ann. Neurol. 70, 
532–540. 
Jung, M.W., Wiener, S.I., and McNaughton, B.L. (1994). Comparison of 
spatial firing characteristics of units in dorsal and ventral hippocampus of the 
rat. J. Neurosci. 14, 7347–7356. 
Kamelgarn, M., Chen, J., Kuang, L., Jin, H., Kasarskis, E.J., and Zhu, H. 
(2018). ALS mutations of FUS suppress protein translation and disrupt the 
regulation of nonsense-mediated decay. Proc. Natl. Acad. Sci. U. S. A. 115, 
E11904–E11913. 
Kameoka, S., Duque, P., and Konarska, M.M. (2004). P54Nrb Associates 
With the 5′ Splice Site Within Large Transcription/Splicing Complexes. 
EMBO J. 23, 1782–1791. 
Kanai, Y., Dohmae, N., and Hirokawa, N. (2004). Kinesin Transports RNA. 
Neuron 43, 513–525. 
Kandel, E.R. (1976). Cellular basis of behavior: An introduction to behavioral 
neurobiology. (Oxford,  England: W. H. Freeman). 
Kang, J., Lim, L., Lu, Y., and Song, J. (2019). A unified mechanism for LLPS 
of ALS/FTLD-causing FUS as well as its modulation by ATP and oligonucleic 
acids. 
King, A.E., Woodhouse, A., Kirkcaldie, M.T.K., and Vickers, J.C. (2016). 
Excitotoxicity in ALS: Overstimulation, or overreaction? Exp. Neurol. 275, 
162–171. 
Kino, Y., Washizu, C., Kurosawa, M., Yamada, M., Miyazaki, H., Akagi, T., 
Hashikawa, T., Doi, H., Takumi, T., Hicks, G.G., et al. (2015). FUS/TLS 
deficiency causes behavioral and pathological abnormalities distinct from 
amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 3, 24. 
Klausberger, T., and Somogyi, P. (2008). Neuronal diversity and temporal 










Koganezawa, N., Hanamura, K., Sekino, Y., and Shirao, T. (2017). The role 
of drebrin in dendritic spines. Mol. Cell. Neurosci. 84, 85–92. 
Konorski, J. (1948). Conditioned reflexes and neuron organization. (New 
York,  NY,  US: Cambridge University Press). 
Kosik, K.S., and Finch, E.A. (1987). MAP2 and tau segregate into dendritic 
and axonal domains after the elaboration of morphologically distinct neurites: 
an immunocytochemical study of cultured rat cerebrum. J. Neurosci. 7, 
3142–3153. 
Kryndushkin, D., Wickner, R.B., and Shewmaker, F. (2011). FUS/TLS forms 
cytoplasmic aggregates, inhibits cell growth and interacts with TDP-43 in a 
yeast model of amyotrophic lateral sclerosis. Protein Cell 2, 223–236. 
Kullmann, D.M., and Nicoll, R.A. (1992). Long-term potentiation is associated 
with increases in quantal content and quantal amplitude. Nature 357, 240–
244. 
Kumar, S.S., Bacci, A., Kharazia, V., and Huguenard, J.R. (2002). A 
developmental switch of AMPA receptor subunits in neocortical pyramidal 
neurons. J. Neurosci. 22, 3005–3015. 
Kuroda, M., Sok, J., Webb, L., Baechtold, H., Urano, F., Yin, Y., Chung, P., 
de Rooij, D.G., Akhmedov, A., Ashley, T., et al. (2000). Male sterility and 
enhanced radiation sensitivity in TLS(-/-) mice. EMBO J. 19, 453–462. 
Kwak, S., and Weiss, J.H. (2006). Calcium-permeable AMPA channels in 
neurodegenerative disease and ischemia. Curr. Opin. Neurobiol. 16, 281–
287. 
Kwiatkowski, T.J., Bosco, D.A., Leclerc, A.L., Tamrazian, E., Vanderburg, 
C.R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E.J., Munsat, T., et al. 
(2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial 









Kwon, I., Kato, M., Xiang, S., Wu, L., Theodoropoulos, P., Mirzaei, H., Han, 
T., Xie, S., Corden, J.L., and McKnight, S.L. (2013). Phosphorylation-
regulated binding of RNA polymerase II to fibrous polymers of low-complexity 
domains. Cell 155, 1049–1060. 
Lagier-Tourenne, C., and Cleveland, D.W. (2009). Rethinking ALS: The FUS 
about TDP-43. Cell 136, 1001–1004. 
Lagier-Tourenne, C., Polymenidou, M., and Cleveland, D.W. (2010). TDP-43 
and FUS/TLS: Emerging roles in RNA processing and neurodegeneration. 
Hum. Mol. Genet. 19, 46–64. 
Van Langenhove, T., Van Der Zee, J., and Van Broeckhoven, C. (2012). The 
molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral 
sclerosis spectrum. Ann. Med. 44, 817–828. 
Lanson, N.A., and Pandey, U.B. (2012). FUS-related proteinopathies: 
Lessons from animal models. Brain Res. 1462, 44–60. 
Lattante, S., Conte, A., Zollino, M., Luigetti, M., Del Grande, A., Marangi, G., 
Romano, A., Marcaccio, A., Meleo, E., Bisogni, G., et al. (2012). Contribution 
of major amyotrophic lateral sclerosis genes to the etiology of sporadic 
disease. Neurology 79, 66–72. 
Law, W.J., Cann, K.L., and Hicks, G.G. (2006). TLS, EWS and TAF15: A 
model for transcriptional integration of gene expression. Briefings Funct. 
Genomics Proteomics 5, 8–14. 
Leal, S.S., and Gomes, C.M. (2015). Calcium dysregulation links ALS 
defective proteins and motor neuron selective vulnerability. Front. Cell. 
Neurosci. 9, 225. 
Lee, S.H., Liu, L., Wang, Y.T., and Sheng, M. (2002). Clathrin adaptor AP2 
and NSF interact with overlapping sites of GluR2 and play distinct roles in 
AMPA receptor trafficking and hippocampal LTD. Neuron 36, 661–674. 









Caliendo, V., Chiò, A., Rosa, A., and Bozzoni, I. (2015). ALS mutant FUS 
proteins are recruited into stress granules in induced pluripotent stem cell-
derived motoneurons. Dis. Model. Mech. 8, 755–766. 
Li, D.-P., Byan, H.S., and Pan, H.-L. (2012). Switch to glutamate receptor 2-
lacking AMPA receptors increases neuronal excitability in hypothalamus and 
sympathetic drive in hypertension. J. Neurosci. 32, 372–380. 
Li, Y.R., King, O.D., Shorter, J., and Gitler, A.D. (2013). Stress granules as 
crucibles of ALS pathogenesis. J. Cell Biol. 201, 361–372. 
Ling, S., Albuquerque, C.P., Han, J.S., Lagier-Tourenne, C., Tokunaga, S., 
Zhou, H., and Cleveland, D.W. (2010). ALS-associated mutations in TDP-43 
increase its stability and promote TDP-43 complexes with FUS/TLS. Proc. 
Natl. Acad. Sci. U. S. A. 107, 13318–13323. 
Ling, S.C., Polymenidou, M., and Cleveland, D.W. (2013). Converging 
mechanisms in als and FTD: Disrupted RNA and protein homeostasis. 
Neuron 79, 416–438. 
Liu, B., Liao, M., Mielke, J.G., Ning, K., Chen, Y., Li, L., El-Hayek, Y.H., 
Gomez, E., Zukin, R.S., Fehlings, M.G., et al. (2006). Ischemic insults direct 
glutamate receptor subunit 2-lacking AMPA receptors to synaptic sites. J. 
Neurosci. 26, 5309–5319. 
Liu, S.H., Lau, L., Wei, J.S., Zhu, D.Y., Zou, S., Sun, H.S., Fu, Y.P., Liu, F., 
and Lu, Y.M. (2004). Expression of Ca2+-permeable AMPA receptor 
channels primes cell death in transient forebrain ischemia. Neuron 43, 43–
55. 
Loebel, A., Jean-Vincent, L.B., Richardson, M.J.E., Markram, H., and Herz, 
A.V.M. (2013). Matched pre-and post-synaptic changes underlie synaptic 
plasticity over long time scales. J. Neurosci. 33, 6257–6266. 
López-Erauskin, J., Tadokoro, T., Baughn, M.W., Myers, B., McAlonis-
Downes, M., Chillon-Marinas, C., Asiaban, J.N., Artates, J., Bui, A.T., Vetto, 









axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-
Function of FUS. Neuron 0, 1–15. 
Lu, W., Shi, Y., Jackson, A.C., Bjorgan, K., During, M.J., Sprengel, R., 
Seeburg, P.H., and Nicoll, R.A. (2009). Subunit Composition of Synaptic 
AMPA Receptors Revealed by a Single-Cell Genetic Approach. Neuron 62, 
254–268. 
Luk, K.C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J.Q., 
and Lee, V.M.-Y. (2012). Pathological α-synuclein transmission initiates 
Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949–
953. 
Lüscher, C., and Malenka, R.C. (2012). NMDA receptor-dependent long-
term potentiation and long-term depression (LTP/LTD). Cold Spring Harb. 
Perspect. Biol. 4, 3. 
Lüthi, A., Chittajallu, R., Duprat, F., Palmer, M.J., Benke, T.A., Kidd, F.L., 
Henley, J.M., Isaac, J.T.., and Collingridge, G.L. (1999). Hippocampal LTD 
Expression Involves a Pool of AMPARs Regulated by the NSF–GluR2 
Interaction. Neuron 24, 389–399. 
Lynch, M.A. (2004). Long-Term Potentiation and Memory. Physiol. Rev. 84, 
87–136. 
Machamer, J.B., Woolums, B.M., Fuller, G.G., and Lloyd, T.E. (2018). FUS 
causes synaptic hyperexcitability in Drosophila dendritic arborization 
neurons. Brain Res. 1693, 55–66. 
Mackenzie, I.R.A., Neumann, M., Bigio, E.H., Cairns, N.J., Alafuzoff, I., Kril, 
J., Kovacs, G.G., Ghetti, B., Halliday, G., Holm, I.E., et al. (2010a). 
Nomenclature and nosology for neuropathologic subtypes of frontotemporal 
lobar degeneration: an update. Acta Neuropathol. 119, 1–4. 
Mackenzie, I.R.A., Rademakers, R., and Neumann, M. (2010b). TDP-43 and 
FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet 









MacKenzie, I.R.A., Munoz, D.G., Kusaka, H., Yokota, O., Ishihara, K., 
Roeber, S., Kretzschmar, H.A., Cairns, N.J., and Neumann, M. (2011). 
Distinct pathological subtypes of FTLD-FUS. Acta Neuropathol. 121, 207–
218. 
Makino, H., and Malinow, R. (2011). Compartmentalized versus global 
synaptic plasticity on dendrites controlled by experience. Neuron 72, 1001–
1011. 
Malenka, R.C., and Bear, M.F. (2004). LTP and LTD: an embarrassment of 
riches. Neuron 44, 5–21. 
Malinow, R., and Tsien, R.W. (1990). Presynaptic enhancement shown by 
whole-cell recordings of long-term potentiation in hippocampal slices. Nature 
346, 177–180. 
Marrone, L., Qamar, S., Mannini, B., St George-Hyslop, P., and Vendruscolo, 
M. (2020). P525L promotes the aggregation of FUS by altering its 
biochemical and biophysical properties. Matters 6, e202004000008. 
Martel, M.A., Wyllie, D.J.A., and Hardingham, G.E. (2009). In developing 
hippocampal neurons, NR2B-containing N-methyl-d-aspartate receptors 
(NMDARs) can mediate signaling to neuronal survival and synaptic 
potentiation, as well as neuronal death. Neuroscience 158, 334–343. 
Martel, M.A., Ryan, T.J., Bell, K.F.S., Fowler, J.H., McMahon, A., Al-Mubarak, 
B., Komiyama, N.H., Horsburgh, K., Kind, P.C., Grant, S.G.N., et al. (2012). 
The Subtype of GluN2 C-terminal Domain Determines the Response to 
Excitotoxic Insults. Neuron 74, 543–556. 
Martin, S.J., Grimwood, P.D., and Morris, R.G. (2000). Synaptic plasticity and 
memory: an evaluation of the hypothesis. Annu. Rev. Neurosci. 23, 649–711. 
Mastrocola, A.S., Kim, S.H., Trinh, A.T., Rodenkirch, L.A., and Tibbetts, R.S. 
(2013). The RNA-binding protein fused in sarcoma (FUS) functions 
downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA 









Masuda, A., Takeda, J. ichi, and Ohno, K. (2016). FUS-mediated regulation 
of alternative RNA processing in neurons: Insights from global transcriptome 
analysis. Wiley Interdiscip. Rev. RNA 7, 330–340. 
Masurkar, A. V (2018). Towards a Circuit-Level Understanding of 
Hippocampal CA1 Dysfunction in Alzheimer’s Disease Across Anatomical 
Axes. J. Alzheimer’s Dis. Park. 08, 1–6. 
Mattson, M.R. (2007). Calcium and neurodegeneration. Aging Cell 6, 337–
350. 
Mayeux, R., and Stern, Y. (2012). Epidemiology of Alzheimer disease. Cold 
Spring Harb. Perspect. Med. 2. 
Mayford, M., Siegelbaum, S.A., and Kandel, E.R. (2012). Synapses and 
memory storage. Cold Spring Harb. Perspect. Biol. 4, 1–18. 
McAllister, A.K. (2000). Biolistic Transfection of Neurons. Sci. Signal. 2000, 
pl1–pl1. 
McKay, S., Ryan, T.J., McQueen, J., Indersmitten, T., Marwick, K.F.M., 
Hasel, P., Kopanitsa, M. V., Baxter, P.S., Martel, M.A., Kind, P.C., et al. 
(2018). The Developmental Shift of NMDA Receptor Composition Proceeds 
Independently of GluN2 Subunit-Specific GluN2 C-Terminal Sequences. Cell 
Rep. 25, 841-851.e4. 
Miglio, G., Varsaldi, F., and Lombardi, G. (2005). Human T lymphocytes 
express N-methyl-D-aspartate receptors functionally active in controlling T 
cell activation. Biochem. Biophys. Res. Commun. 338, 1875–1883. 
Mitchell, J.C., McGoldrick, P., Vance, C., Hortobagyi, T., Sreedharan, J., 
Rogelj, B., Tudor, E.L., Smith, B.N., Klasen, C., Miller, C.C.J., et al. (2013). 
Overexpression of human wild-type FUS causes progressive motor neuron 
degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 125, 
273–288. 









Hosokawa, M., Kawata, A., Oyanagi, K., Mihara, B., et al. (2012). Familial 
ALS with FUS P525L mutation: two Japanese sisters with multiple systems 
involvement. J. Neurol. Sci. 323, 85–92. 
Morris, R.G., Garrud, P., Rawlins, J.N., and O’Keefe, J. (1982). Place 
navigation impaired in rats with hippocampal lesions. Nature 297, 681–683. 
Morris, R.G., Anderson, E., Lynch, G.S., and Baudry, M. (1986). Selective 
impairment of learning and blockade of long-term potentiation by an N-
methyl-D-aspartate receptor antagonist, AP5. Nature 319, 774–776. 
Morrison, B.M., Hof, P.R., and Morrison, J.H. (1998). Determinants of 
neuronal vulnerability in neurodegenerative diseases. Ann. Neurol. 44, S32-
44. 
Moser, M.-B., Rowland, D.C., and Moser, E.I. (2015). Place cells, grid cells, 
and memory. Cold Spring Harb. Perspect. Biol. 7, a021808. 
Mulkey, R.M., Endo, S., Shenolikar, S., and Malenka, R.C. (1994). 
Involvement of a calcineurin/inhibitor-1 phosphatase cascade in 
hippocampal long-term depression. Nature 369, 486–488. 
Murakami, T., Yang, S.-P., Xie, L., Kawano, T., Fu, D., Mukai, A., Bohm, C., 
Chen, F., Robertson, J., Suzuki, H., et al. (2012). ALS mutations in FUS 
cause neuronal dysfunction and death in Caenorhabditis elegans by a 
dominant gain-of-function mechanism. Hum. Mol. Genet. 21, 1–9. 
Murakami, T., Qamar, S., Lin, J.Q., Schierle, G.S.K., Rees, E., Miyashita, A., 
Costa, A.R., Dodd, R.B., Chan, F.T.S., Michel, C.H., et al. (2015). ALS/FTD 
Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible 
Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function. 
Neuron 88, 678–690. 
Murthy, A.C., Dignon, G.L., Kan, Y., Zerze, G.H., Parekh, S.H., Mittal, J., and 
Fawzi, N.L. (2019). Molecular interactions underlying liquid−liquid phase 










Nadel, L., and Hardt, O. (2011). Update on memory systems and processes. 
Neuropsychopharmacology 36, 251–273. 
Nagy, Z., Jobst, K.A., Esiri, M.M., Morris, J.H., King, E.M., MacDonald, B., 
Litchfield, S., Barnetson, L., and Smith, A.D. (1996). Hippocampal pathology 
reflects memory deficit and brain imaging measurements in Alzheimer’s 
disease: clinicopathologic correlations using three sets of pathologic 
diagnostic criteria. Dementia 7, 76–81. 
Naujock, M., Stanslowsky, N., Bufler, S., Naumann, M., Reinhardt, P., 
Sterneckert, J., Kefalakes, E., Kassebaum, C., Bursch, F., Lojewski, X., et al. 
(2016). 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor 
Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced 
Pluripotent Stem Cells. Stem Cells 34, 1563–1575. 
Naumann, M., Pal, A., Goswami, A., Lojewski, X., Japtok, J., Vehlow, A., 
Naujock, M., Günther, R., Jin, M., Stanslowsky, N., et al. (2018). Impaired 
DNA damage response signaling by FUS-NLS mutations leads to 
neurodegeneration and FUS aggregate formation. Nat. Commun. 9. 
Naumann, M., Peikert, K., Günther, R., van der Kooi, A.J., Aronica, E., 
Hübers, A., Danel, V., Corcia, P., Pan-Montojo, F., Cirak, S., et al. (2019). 
Phenotypes and malignancy risk of different FUS mutations in genetic 
amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 6, 2384–2394. 
Nelson, S.B., and Turrigiano, G.G. (2008). Strength through Diversity. 
Neuron 60, 477–482. 
Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., 
Chou, T.T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M., et al. (2006). 
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and 
Amyotrophic Lateral Sclerosis. Science (80-. ). 314, 130–133. 
Neumann, M., Rademakers, R., Roeber, S., Baker, M., Kretzschmar, H.A., 
and MacKenzie, I.R.A. (2009). A new subtype of frontotemporal lobar 









Neumann, M., Bentmann, E., Dormann, D., Jawaid, A., Dejesus-Hernandez, 
M., Ansorge, O., Roeber, S., Kretzschmar, H.A., Munoz, D.G., Kusaka, H., 
et al. (2011). FET proteins TAF15 and EWS are selective markers that 
distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with 
FUS mutations. Brain 134, 2595–2609. 
Neumann, M., Valori, C.F., Ansorge, O., Kretzschmar, H.A., Munoz, D.G., 
Kusaka, H., Yokota, O., Ishihara, K., Ang, L.-C.C., Bilbao, J.M., et al. (2012). 
Transportin 1 accumulates specifically with FET proteins but no other 
transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with 
FUS mutations. Acta Neuropathol. 124, 705–716. 
Neves, G., Cooke, S.F., and Bliss, T.V.P. (2008). Synaptic plasticity, memory 
and the hippocampus: a neural network approach to causality. Nat. Rev. 
Neurosci. 9, 65–75. 
Newcomer, J.W., Farber, N.B., and Olney, J.W. (2000). NMDA receptor 
function, memory, and brain aging. Dialogues Clin. Neurosci. 2, 219–232. 
Nichols, E., Szoeke, C.E.I., Vollset, S.E., Abbasi, N., Abd-Allah, F., Abdela, 
J., Aichour, M.T.E., Akinyemi, R.O., Alahdab, F., Asgedom, S.W., et al. 
(2019). Global, regional, and national burden of Alzheimer’s disease and 
other dementias, 1990–2016: a systematic analysis for the Global Burden of 
Disease Study 2016. Lancet Neurol. 18, 88–106. 
Nicoll, R.A. (2017). A Brief History of Long-Term Potentiation. Neuron 93, 
281–290. 
Nishimune, A., Isaac, J.T.R., Molnar, E., Noel, J., Nash, S.R., Tagaya, M., 
Collingridge, G.L., Nakanishi, S., and Henley, J.M. (1998). NSF binding to 
GluR2 regulates synaptic transmission. Neuron 21, 87–97. 
Niu, C., Zhang, J., Gao, F., Yang, L., Jia, M., Zhu, H., and Gong, W. (2012). 
FUS-NLS/Transportin 1 Complex Structure Provides Insights into the 










Noh, K.M., Yokota, H., Mashiko, T., Castillo, P.E., Zukin, R.S., and Bennett, 
M.V.L. (2005). Blockade of calcium-permeable AMPA receptors protects 
hippocampal neurons against global schemia-induced death. Proc. Natl. 
Acad. Sci. U. S. A. 102, 12230–12235. 
Nolan, M., Talbot, K., and Ansorge, O. (2016). Pathogenesis of FUS-
associated ALS and FTD: insights from rodent models. Acta Neuropathol. 
Commun. 4, 99. 
Nover, L., Scharf, K.D., and Neumann, D. (1989). Cytoplasmic heat shock 
granules are formed from precursor particles and are associated with a 
specific set of mRNAs. Mol. Cell. Biol. 9, 1298–1308. 
Okada, T., Yamada, N., Kakegawa, W., Tsuzuki, K., Kawamura, M., Nawa, 
H., Iino, M., and Ozawa, S. (2001). Sindbis viral-mediated expression of 
Ca2+-permeable AMPA receptors at hippocampal CA1 synapses and 
induction of NMDA receptor-independent long-term potentiation. Eur. J. 
Neurosci. 13, 1635–1643. 
Okamoto, K.I., Narayanan, R., Lee, S.H., Murata, K., and Hayashi, Y. (2007). 
The role of CaMKII as an F-actin-bundling protein crucial for maintenance of 
dendritic spine structure. Proc. Natl. Acad. Sci. U. S. A. 104, 6418–6423. 
Okreglak, V., and Drubin, D.G. (2010). Loss of Aip1 reveals a role in 
maintaining the actin monomer pool and an in vivo oligomer assembly 
pathway. J. Cell Biol. 188, 769–777. 
Okuyama, T., Kitamura, T., Roy, D.S., Itohara, S., and Tonegawa, S. (2016). 
Ventral CA1 neurons store social memory. Science 353, 1536–1541. 
Olypher, A. V., Lytton, W.W., and Prinz, A.A. (2012). Input-to-output 
transformation in a model of the rat hippocampal CA1 network. Front. 
Comput. Neurosci. 6, 1–8. 
Orozco, D., Tahirovic, S., Rentzsch, K., Schwenk, B.M., Haass, C., and 
Edbauer, D. (2012). Loss of fused in sarcoma (FUS) promotes pathological 









Osten, P., Khatri, L., Perez, J.L., Köhr, G., Giese, G., Daly, C., Schulz, T.W., 
Wensky, A., Lee, L.M., and Ziff, E.B. (2000). Mutagenesis reveals a role for 
ABP/GRIP binding to GluR2 in synaptic surface accumulation of the AMPA 
receptor. Neuron 27, 313–325. 
Pachernegg, S., Münster, Y., Muth-Köhne, E., Fuhrmann, G., and Hollmann, 
M. (2015). GluA2 is rapidly edited at the Q/R site during neural differentiation 
in vitro. Front. Cell. Neurosci. 9, 1–14. 
Palop, J.J., and Mucke, L. (2010). Amyloid-Β-induced neuronal dysfunction 
in Alzheimer’s disease: From synapses toward neural networks. Nat. 
Neurosci. 13, 812–818. 
Paoletti, P., Bellone, C., and Zhou, Q. (2013). NMDA receptor subunit 
diversity: impact on receptor properties, synaptic plasticity and disease. Nat. 
Rev. Neurosci. 14, 383–400. 
Park, P., Volianskis, A., Sanderson, T.M., Bortolotto, Z.A., Jane, D.E., Zhuo, 
M., Kaang, B.K., and Collingridge, G.L. (2014). NMDA receptor-dependent 
long-term potentiation comprises a family of temporally overlapping forms of 
synaptic plasticity that are induced by different patterns of stimulation. Philos. 
Trans. R. Soc. Lond. B. Biol. Sci. 369, 20130131. 
Park, P., Kang, H., Sanderson, T.M., Bortolotto, Z.A., Georgiou, J., Zhuo, M., 
Kaang, B.-K., and Collingridge, G.L. (2018). The Role of Calcium-Permeable 
AMPARs in Long-Term Potentiation at Principal Neurons in the Rodent 
Hippocampus. Front. Synaptic Neurosci. 10, 1–11. 
Park, P., Kang, H., Sanderson, T.M., Bortolotto, Z.A., Georgiou, J., Zhuo, M., 
Kaang, B.-K., and Collingridge, G.L. (2019). On the Role of Calcium-
Permeable AMPARs in Long-Term Potentiation and Synaptic Tagging in the 
Rodent Hippocampus. Front. Synaptic Neurosci. 11, 4. 
Parron, C., Poucet, B., and Save, E. (2006). Cooperation between the 
hippocampus and the entorhinal cortex in spatial memory: A disconnection 









Patel, A., Lee, H.O., Jawerth, L., Maharana, S., Jahnel, M., Hein, M.Y., 
Stoynov, S., Mahamid, J., Saha, S., Franzmann, T.M., et al. (2015). A Liquid-
to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease 
Mutation. Cell 162, 1066–1077. 
Pavlov, I.P. (1927). Conditioned reflexes: an investigation of the 
physiological activity of the cerebral cortex. (Oxford, England: Oxford Univ. 
Press). 
Pchitskaya, E., Popugaeva, E., and Bezprozvanny, I. (2018). Calcium 
signaling and molecular mechanisms underlying neurodegenerative 
diseases. Cell Calcium 70, 87–94. 
Penfield, W., and Milner, B. (1958). Memory deficit produced by bilateral 
lesions in the hippocampal zone. AMA. Arch. Neurol. Psychiatry 79, 475–
497. 
Perez, J.L., Khatri, L., Chang, C., Srivastava, S., Osten, P., and Ziff, E.B. 
(2001). PICK1 targets activated protein kinase Cα to AMPA receptor clusters 
in spines of hippocampal neurons and reduces surface levels of the AMPA-
type glutamate receptor subunit 2. J. Neurosci. 21, 5417–5428. 
Pievani, M., Filippini, N., Van Den Heuvel, M.P., Cappa, S.F., and Frisoni, 
G.B. (2014). Brain connectivity in neurodegenerative diseases - From 
phenotype to proteinopathy. Nat. Rev. Neurol. 10, 620–633. 
Protter, D.S.W., and Parker, R. (2016). Principles and Properties of Stress 
Granules. Trends Cell Biol. 26, 668–679. 
Qamar, S., Wang, G.Z., Randle, S.J., Ruggeri, F.S., Varela, J.A., Lin, J.Q., 
Phillips, E.C., Miyashita, A., Williams, D., Ströhl, F., et al. (2018). FUS Phase 
Separation Is Modulated by a Molecular Chaperone and Methylation of 
Arginine Cation-π Interactions. Cell 173, 720-734.e15. 
Qiu, H., Lee, S., Shang, Y., Wang, W.Y., Au, K.F., Kamiya, S., Barmada, S.J., 
Finkbeiner, S., Lui, H., Carlton, C.E., et al. (2014). ALS-associated mutation 










Rabbitts, T.H., Forster, A., Larson, R., and Nathan, P. (1993). Fusion of the 
dominant negative transcription regulator CHOP with a novel gene FUS by 
translocation t(12;16) in malignant liposarcoma. Nat. Genet. 4, 175–180. 
Rappsilber, J., Friesen, W.J., Paushkin, S., Dreyfuss, G., and Mann, M. 
(2003). Detection of arginine dimethylated peptides by parallel precursor ion 
scanning mass spectrometry in positive ion mode. Anal. Chem. 75, 3107–
3114. 
Reber, S., Stettler, J., Filosa, G., Colombo, M., Jutzi, D., Lenzken, S.C., 
Schweingruber, C., Bruggmann, R., Bachi, A., Barabino, S.M., et al. (2016).  
Minor intron splicing is regulated by FUS and affected by ALS -associated 
FUS mutants . EMBO J. 35, 1504–1521. 
Regan, P., Whitcomb, D.J., and Cho, K. (2017). Physiological and 
Pathophysiological Implications of Synaptic Tau. Neuroscientist 23, 137–151. 
Riggi, N., Cironi, L., Suvà, M.-L., and Stamenkovic, I. (2007). Sarcomas: 
genetics, signalling, and cellular origins. Part 1: The fellowship of TET. J. 
Pathol. 213, 4–20. 
Rochefort, N.L., and Konnerth, A. (2012). Dendritic spines: From structure to 
in vivo function. EMBO Rep. 13, 699–708. 
Rowe, R.G., and Daley, G.Q. (2019). Induced pluripotent stem cells in 
disease modelling and drug discovery. Nat. Rev. Genet. 20, 377–388. 
Sahoo, P.K., Smith, D.S., Perrone-Bizzozero, N., and Twiss, J.L. (2018). 
Axonal mRNA transport and translation at a glance. J. Cell Sci. 131. 
Sama, R.R. anjit. K., Ward, C.L., and Bosco, D.A. (2014). Functions of 
FUS/TLS from DNA repair to stress response: implications for ALS. ASN 
Neuro 6. 
Sama, R.R.K., Ward, C.L., Kaushansky, L.J., Lemay, N., Ishigaki, S., Urano, 









a prosurvival factor during hyperosmolar stress. J. Cell. Physiol. 228, 2222–
2231. 
Sama, R.R.K., Fallini, C., Gatto, R., McKeon, J.E., Song, Y., Rotunno, M.S., 
Penaranda, S., Abdurakhmanov, I., Landers, J.E., Morfini, G., et al. (2017). 
ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK 
activation. Sci. Rep. 7, 115. 
Sanz-Clemente, A., Nicoll, R.A., and Roche, K.W. (2013). Diversity in NMDA 
receptor composition: Many regulators, many consequences. Neuroscientist 
19, 62–75. 
Scekic-Zahirovic, J., Sendscheid, O., El Oussini, H., Jambeau, M., Sun, Y., 
Mersmann, S., Wagner, M., Dieterlé, S., Sinniger, J., Dirrig-Grosch, S., et al. 
(2016). Toxic gain of function from mutant FUS protein is crucial to trigger 
cell autonomous motor neuron loss. EMBO J. 35, 1077–1097. 
Schacter, D.L., and Tulving, E. (1994). What are the memory systems of 
1994? In Memory Systems 1994, D.L. Schacter, and E. Tulving, eds. 
(Cambridge: MIT Press), pp. 1–38. 
Schlesinger, F., Tammena, D., Krampfl, K., and Bufler, J. (2005). Two 
mechanisms of action of the adamantane derivative IEM-1460 at human 
AMPA-type glutamate receptors. Br. J. Pharmacol. 145, 656–663. 
Schoen, M., Reichel, J.M., Demestre, M., Putz, S., Deshpande, D., Proepper, 
C., Liebau, S., Schmeisser, M.J., Ludolph, A.C., Michaelis, J., et al. (2016). 
Super-resolution microscopy reveals presynaptic localization of the ALS/FTD 
related protein FUS in hippocampal neurons. Front. Cell. Neurosci. 9, 1–16. 
Schwartz, J.C., Ebmeier, C.C., Podell, E.R., Heimiller, J., Taatjes, D.J., and 
Cech, T.R. (2012). FUS binds the CTD of RNA polymerase II and regulates 
its phosphorylation at Ser2. Genes Dev. 26, 2690–2695. 
Schwartz, J.C., Cech, T.R., and Parker, R.R. (2015). Biochemical Properties 









Seelaar, H., Klijnsma, K.Y., De Koning, I., Van Der Lugt, A., Chiu, W.Z., 
Azmani, A., Rozemuller, A.J.M., and Van Swieten, J.C. (2010). Frequency of 
ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar 
degeneration. J. Neurol. 257, 747–753. 
Sephton, C.F., and Yu, G. (2015). The function of RNA-binding proteins at 
the synapse: Implications for neurodegeneration. Cell. Mol. Life Sci. 72, 
3621–3635. 
Sephton, C.F., Tang, A.A., Kulkarni, A., West, J., Brooks, M., Stubblefield, 
J.J., Liu, Y., Zhang, M.Q., Green, C.B., Huber, K.M., et al. (2014). Activity-
dependent FUS dysregulation disrupts synaptic homeostasis. Proc. Natl. 
Acad. Sci. U. S. A. 111, E4769-78. 
Shang, Y., and Huang, E.J. (2016). Mechanisms of FUS mutations in familial 
amyotrophic lateral sclerosis. Brain Res. 1647, 65–78. 
Sheldon, A.L., and Robinson, M.B. (2007). The role of glutamate transporters 
in neurodegenerative diseases and potential opportunities for intervention. 
Neurochem. Int. 51, 333–355. 
Shelkovnikova, T.A., Robinson, H.K., Southcombe, J.A., Ninkina, N., and 
Buchman, V.L. (2014). Multistep process of FUS aggregation in the cell 
cytoplasm involves RNA-dependent and RNA-independent mechanisms. 
Hum. Mol. Genet. 23, 5211–5226. 
Shiihashi, G., Ito, D., Yagi, T., Nihei, Y., Ebine, T., and Suzuki, N. (2016). 
Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral 
sclerosis phenotypes in mice. Brain 139, 2380–2394. 
Shiihashi, G., Ito, D., Arai, I., Kobayashi, Y., Hayashi, K., Otsuka, S., 
Nakajima, K., Yuzaki, M., Itohara, S., and Suzuki, N. (2017). Dendritic 
Homeostasis Disruption in a Novel Frontotemporal Dementia Mouse Model 
Expressing Cytoplasmic Fused in Sarcoma. EBioMedicine 24, 102–115. 
Shin, Y., Berry, J., Pannucci, N., Haataja, M.P., Toettcher, J.E., and 









Transitions Using Light-Activated optoDroplets. Cell 168, 159-171.e14. 
Skinner, B.F. (1938). The behavior of organisms: an experimental analysis. 
(Oxford, England: Appleton-Century). 
Snowden, J.S., Hu, Q., Rollinson, S., Halliwell, N., Robinson, A., Davidson, 
Y.S., Momeni, P., Baborie, A., Griffiths, T.D., Jaros, E., et al. (2011). The 
most common type of FTLD-FUS (aFTLD-U) is associated with a distinct 
clinical form of frontotemporal dementia but is not related to mutations in the 
FUS gene. Acta Neuropathol. 122, 99–110. 
Soo, K.Y., Halloran, M., Sundaramoorthy, V., Parakh, S., Toth, R.P., 
Southam, K.A., McLean, C.A., Lock, P., King, A., Farg, M.A., et al. (2015). 
Rab1-dependent ER–Golgi transport dysfunction is a common pathogenic 
mechanism in SOD1, TDP-43 and FUS-associated ALS. Acta Neuropathol. 
130, 679–697. 
Soto, C., and Estrada, L.D. (2008). Protein misfolding and 
neurodegeneration. Arch. Neurol. 65, 184–189. 
Squire, L.R. (2009). Memory and brain systems: 1969-2009. J. Neurosci. 29, 
12711–12716. 
Starr, A., and Sattler, R. (2018). Synaptic dysfunction and altered excitability 
in C9ORF72 ALS/FTD. Brain Res. 1693, 98–108. 
Stoica, R., Paillusson, S., Gomez-Suaga, P., Mitchell, J.C., Lau, D.H., Gray, 
E.H., Sancho, R.M., Vizcay-Barrena, G., De Vos, K.J., Shaw, C.E., et al. 
(2016). ALS/FTD-associated FUS activates GSK-3β to disrupt the VAPB–
PTPIP51 interaction and ER–mitochondria associations. EMBO Rep. 17, 
1326–1342. 
Suárez-Calvet, M., Neumann, M., Arzberger, T., Abou-Ajram, C., Funk, E., 
Hartmann, H., Edbauer, D., Kremmer, E., Göbl, C., Resch, M., et al. (2016). 
Monomethylated and unmethylated FUS exhibit increased binding to 










Südhof, T.C., and Malenka, R.C. (2008). Understanding Synapses: Past, 
Present, and Future. Neuron 60, 469–476. 
Sun, Z., Diaz, Z., Fang, X., Hart, M.P., Chesi, A., Shorter, J., and Gitler, A.D. 
(2011). Molecular determinants and genetic modifiers of aggregation and 
toxicity for the als disease protein fus/tls. PLoS Biol. 9. 
Sundaramoorthy, V., Sultana, J.M., and Atkin, J.D. (2015). Golgi 
fragmentation in amyotrophic lateral sclerosis, an overview of possible 
triggers and consequences. Front. Neurosci. 9, 1–11. 
Svetoni, F., Frisone, P., and Paronetto, M.P. (2016). Role of FET proteins in 
neurodegenerative disorders. RNA Biol. 13, 1089–1102. 
Swanson, G.T., Kamboj, S.K., and Cull-Candy, S.G. (1997). Single-channel 
properties of recombinant AMPA receptors depend on RNA editing, splice 
variation, and subunit composition. J. Neurosci. 17, 58–69. 
Tai, H.C., Serrano-Pozo, A., Hashimoto, T., Frosch, M.P., Spires-Jones, T.L., 
and Hyman, B.T. (2012). The synaptic accumulation of hyperphosphorylated 
tau oligomers in alzheimer disease is associated with dysfunction of the 
ubiquitin-proteasome system. Am. J. Pathol. 181, 1426–1435. 
Takehara-Nishiuchi, K. (2014). Entorhinal cortex and consolidated memory. 
Neurosci. Res. 84, 27–33. 
Talbott, E.O., Malek, A.M., and Lacomis, D. (2016). Chapter 13 - The 
epidemiology of amyotrophic lateral sclerosis. In Neuroepidemiology, M.J. 
Aminoff, F. Boller, and D.F.B.T.-H. of C.N. Swaab, eds. (Elsevier), pp. 225–
238. 
Taylor, J.P., Brown, R.H., and Cleveland, D.W. (2016). Decoding ALS: from 
genes to mechanism. Nature 539, 197–206. 
Templer, V.L., and Hampton, R.R. (2013). Episodic memory in nonhuman 
animals. Curr. Biol. 23, R801–R806. 









and Bosco, D.A. (2019). The RNA-binding protein FUS/TLS undergoes 
calcium-mediated nuclear egress during excitotoxic stress and is required for 
GRIA2 mRNA processing. J. Biol. Chem. 294, jbc.RA118.005933. 
Tønnesen, J., and Nägerl, U.V. (2016). Dendritic spines as tunable 
regulators of synaptic signals. Front. Psychiatry 7. 
Tradewell, M.L., Yu, Z., Tibshirani, M., Boulanger, M.C., Durham, H.D., and 
Richard, S. (2012). Arginine methylation by prmt1 regulates nuclear-
cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked 
mutations. Hum. Mol. Genet. 21, 136–149. 
Traynelis, S.F., Wollmuth, L.P., McBain, C.J., Menniti, F.S., Vance, K.M., 
Ogden, K.K., Hansen, K.B., Yuan, H., Myers, S.J., and Dingledine, R. (2010). 
Glutamate receptor ion channels: structure, regulation, and function. 
Pharmacol. Rev. 62, 405–496. 
Tulving, E. (1972). Episodic and semantic memory. In Organization of 
Memory., (Oxford,  England: Academic Press), pp. xiii, 423–xiii, 423. 
Tulving, E. (2002). Episodic memory: from mind to brain. Annu. Rev. Psychol. 
53, 1–25. 
Tyzack, G.E., Luisier, R., Taha, D.M., Neeves, J., Modic, M., Mitchell, J.S., 
Meyer, I., Greensmith, L., Newcombe, J., Ule, J., et al. (2019). Widespread 
FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis. 
Brain 142, 1–9. 
Udagawa, T., Fujioka, Y., Tanaka, M., Honda, D., Yokoi, S., Riku, Y., Ibi, D., 
Nagai, T., Yamada, K., Watanabe, H., et al. (2015). FUS regulates AMPA 
receptor function and FTLD/ALS-associated behaviour via GluA1 mRNA 
stabilization. Nat. Commun. 6, 1–13. 
Vance, C., Rogelj, B., Hortobágyi, T., De Vos, K.J., Nishimura, A.L., 
Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P., et al. (2009). 
Mutations in FUS, an RNA processing protein, cause familial amyotrophic 









Vance, C., Scotter, E.L., Nishimura, A.L., Troakes, C., Mitchell, J.C., Kathe, 
C., Urwin, H., Manser, C., Miller, C.C., Hortobágyi, T., et al. (2013). ALS 
mutant FUS disrupts nuclear localization and sequesters wild-type FUS 
within cytoplasmic stress granules. Hum. Mol. Genet. 22, 2676–2688. 
Vandenberghe, W., Robberecht, W., and Brorson, J.R. (2000). AMPA 
receptor calcium permeability, GluR2 expression, and selective motoneuron 
vulnerability. J. Neurosci. 20, 123–132. 
Wang, W.Y., Pan, L., Su, S.C., Quinn, E.J., Sasaki, M., Jimenez, J.C., 
MacKenzie, I.R.A., Huang, E.J., and Tsai, L.H. (2013). Interaction of FUS 
and HDAC1 regulates DNA damage response and repair in neurons. Nat. 
Neurosci. 16, 1383–1391. 
Wang, X., Schwartz, J.C., and Cech, T.R. (2015). Nucleic acid-binding 
specificity of human FUS protein. Nucleic Acids Res. 43, 7535–7543. 
Ward, C.L., Boggio, K.J., Johnson, B.N., Boyd, J.B., Douthwright, S., Shaffer, 
S.A., Landers, J.E., Glicksman, M.A., and Bosco, D.A. (2014). A loss of 
FUS/TLS function leads to impaired cellular proliferation. Cell Death Dis. 5, 
1–12. 
Washburn, M.S., Numberger, M., Zhang, S., and Dingledine, R. (1997). 
Differential dependence on GluR2 expression of three characteristic features 
of AMPA receptors. J. Neurosci. 17, 9393–9406. 
Watkins, J.C., and Jane, D.E. (2006). The glutamate story. Br. J. Pharmacol. 
147, 100–108. 
Waugh, N.C., and Norman, D.A. (1965). Primary memory. Psychol. Rev. 72, 
89–104. 
Weber, S.C., and Brangwynne, C.P. (2012). Getting RNA and protein in 
phase. Cell 149, 1188–1191. 
Weber, J.P., Andrásfalvy, B.K., Polito, M., Magó, Á., Ujfalussy, B.B., and 









dendritic spine cooperativity. Nat. Commun. 7. 
Whitcomb, D.J., Hogg, E.L., Regan, P., Piers, T., Narayan, P., Whitehead, 
G., Winters, B.L., Kim, D.H., Kim, E., St George-Hyslop, P., et al. (2015). 
Intracellular oligomeric amyloid-beta rapidly regulates GluA1 subunit of 
AMPA receptor in the hippocampus. Sci. Rep. 5, 1–12. 
Whitehead, G., Jo, J., Hogg, E.L., Piers, T., Kim, D.H., Seaton, G., Seok, H., 
Bru-Mercier, G., Son, G.H., Regan, P., et al. (2013). Acute stress causes 
rapid synaptic insertion of Ca2+ -permeable AMPA receptors to facilitate 
long-term potentiation in the hippocampus. Brain 136, 3753–3765. 
Whitlock, J.R., Heynen, A.J., Shuler, M.G., and Bear, M.F. (2006). Learning 
induces long-term potentiation in the hippocampus. Science (80-. ). 313, 
1093–1097. 
Wiegert, J.S., and Oertner, T.G. (2013). Long-Term depression triggers the 
selective elimination of weakly integrated synapses. Proc. Natl. Acad. Sci. U. 
S. A. 110. 
Wishart, T.M., Parson, S.H., and Gillingwater, T.H. (2006). Synaptic 
vulnerability in neurodegenerative disease. J. Neuropathol. Exp. Neurol. 65, 
733–739. 
Wolozin, B. (2012). Regulated protein aggregation: stress granules and 
neurodegeneration. Mol. Neurodegener. 7, 56. 
Wright, A., and Vissel, B. (2012). The essential role of AMPA receptor GluA2 
subunit RNA editing in the normal and diseased brain. Front. Mol. Neurosci. 
5, 1–13. 
Wu, S., and Green, M.R. (1997). Identification of a human protein that 
recognizes the 3’ splice site during the second step of pre-mRNA splicing. 
EMBO J. 16, 4421–4432. 
Wu, H., Nash, J.E., Zamorano, P., and Garner, C.C. (2002). Interaction of 









AMPA receptor trafficking. J. Biol. Chem. 277, 30928–30934. 
Yamashita, T., and Kwak, S. (2014). The molecular link between inefficient 
GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of 
sporadic amyotrophic lateral sclerosis patients. Brain Res. 1584, 28–38. 
Yamashita, T., Hideyama, T., Hachiga, K., Teramoto, S., Takano, J., Iwata, 
N., Saido, T.C., and Kwak, S. (2012). A role for calpain-dependent cleavage 
of TDP-43 in amyotrophic lateral sclerosis pathology. Nat. Commun. 3, 
1307–1313. 
Yamazaki, T., Chen, S., Yu, Y., Yan, B., Haertlein, T.C., Carrasco, M.A., 
Tapia, J.C., Zhai, B., Das, R., Lalancette-Hebert, M., et al. (2012). FUS-SMN 
Protein Interactions Link the Motor Neuron Diseases ALS and SMA. Cell Rep. 
2, 799–806. 
Yang, L., Zhang, J., Kamelgarn, M., Niu, C., Gal, J., Gong, W., and Zhu, H. 
(2015). Subcellular localization and RNAs determine FUS architecture in 
different cellular compartments. Hum. Mol. Genet. 24, 5174–5183. 
Yasuda, K., Zhang, H., Loiselle, D., Haystead, T., Macara, I.G., and Mili, S. 
(2013). The RNA-binding protein Fus directs translation of localized mrnas 
in APC-RNP granules. J. Cell Biol. 203, 737–746. 
Yokoi, S., Udagawa, T., Fujioka, Y., Honda, D., Okado, H., Watanabe, H., 
Katsuno, M., Ishigaki, S., and Sobue, G. (2017). 3′UTR Length-Dependent 
Control of SynGAP Isoform α2 mRNA by FUS and ELAV-like Proteins 
Promotes Dendritic Spine Maturation and Cognitive Function. Cell Rep. 20, 
3071–3084. 
Zhang, W., and Linden, D.J. (2003). The other side of the engram: 
experience-driven changes in neuronal intrinsic excitability. Nat. Rev. 
Neurosci. 4, 885–900. 
Zhang, P., Fan, B., Yang, P., Temirov, J., Messing, J., Kim, H.J., and Taylor, 
J.P. (2018). OptoGranules reveal the evolution of stress granules to ALS-









Zhou, Y., Liu, S., Liu, G., Öztürk, A., and Hicks, G.G. (2013). ALS-Associated 
FUS Mutations Result in Compromised FUS Alternative Splicing and 
Autoregulation. PLoS Genet. 9. 
Zhou, Z., Licklider, L.J., Gygi, S.P., and Reed, R. (2002). Comprehensive 
proteomic analysis of the human spliceosome. Nature 419, 182–185. 
Zhu, H., Pleil, K.E., Urban, D.J., Moy, S.S., Kash, T.L., and Roth, B.L. (2014). 
Chemogenetic inactivation of ventral hippocampal glutamatergic neurons 
disrupts consolidation of contextual fear memory. 
Neuropsychopharmacology 39, 1880–1892. 
Zieglgänsberger, W., Parsons, C.G., and Danysz, W. (2005). Excitatory 
Amino Acid Neurotransmission. In Anxiety and Anxiolytic Drugs, 
(Berlin/Heidelberg: Springer-Verlag), pp. 249–303. 
Zinszner, H., Sok, J., Immanuel, D., Yin, Y., and Ron, D. (1997). TLS (FUS) 
binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J. Cell Sci. 
110, 1741–1750. 
Zola-Morgan, S., Squire, L.R., Clower, R.P., and Rempel, N.L. (1993). 
Damage to the perirhinal cortex exacerbates memory impairment following 
lesions to the hippocampal formation. J. Neurosci. 13, 251–265. 
Zsurka, G., and Kunz, W.S. (2015). Mitochondrial dysfunction and seizures: 
The neuronal energy crisis. Lancet Neurol. 14, 956–966. 
Zucker, R.S., and Regehr, W.G. (2002). Short-term synaptic plasticity. Annu. 
Rev. Physiol. 64, 355–405. 
 
  
Appendix 
 
 
  
Appendix 
 
 
 
Appendix 
 
 
 
Appendix 
 
 
 
Appendix 
 
 
  
Appendix 
 
 
  
Appendix 
 
 
  
Appendix 
 
 
  
Appendix 
 
 
  
Appendix 
 
 
  
Appendix 
 
 
  
Appendix 
 
 
  
Appendix 
 
 
  
Appendix 
 
 
  
Appendix 
 
 
  
Appendix 
 
 
  
Appendix 
 
 
  
Appendix 
 
 
 
